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Abstract 
The vertebrate sensory system is enabled to differentiate between a vast variety of sensory 
information under different behavioral and environmental conditions. The required 
flexibility is provided by complex brain functions including neuromodulation. Specific 
structures contributing in neuromodulation of sensory processing are the noradrenergic 
nucleus locus coeruleus and the dopaminergic ventral tegmental area (VTA), combined 
referred to as catecholaminergic system. However, how catecholaminergic 
neuromodulation affects sensory processing in functionally different brain regions is not 
well discovered. To approach this question, experiments in anesthetized rats were 
conducted in order to examine qualitative differences of noradrenergic modulation of 
sensory processing between the functionally distinct primary somatosensory cortex (S1) 
and the associative medial prefrontal cortex (mPFC). These experiments confirmed the 
already reported function of noradrenaline (NE) in activation of the cortical state and 
increase of the signal-to-noise ratio (SNR) of sensory-evoked responses, however only for 
S1. In mPFC, reorganization of neuronal activity, orchestrated by NE, is suggested in order 
to adequately evaluate the biological relevance of the stimulus and integrate sensory and 
non-sensory information. Further results show that NE improves noxious somatosensory 
processing within the VTA to induce the observed reorganization of local networks in 
mPFC in synergy with dopamine (DA). A possible outcome includes enhanced sensory 
gating by suppression of irrelevant and accentuation of relevant network information. This 
prefrontal cortical function was finally specifically explored in awake rats. Target specific 
manipulation of DA release revealed that prefrontal DA is essential to ensure adequate 
prefronto-accumbal interactions which, in turn, are necessary for sensory gating. Together, 
this work demonstrated that catecholamines are needed to improve sensory processing in 
functionally distinct cortical and subcortical brain regions. Thereby, classical improvement 
of SNR is not the only mechanism but also the catecholaminergic modulation of complex 
local network dynamics contributes to processing of relevant or irrelevant sensory 
information. 
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1. Introduction 
A vast variety of sensory stimuli under different behavioral and environmental conditions 
requires highly flexible neuronal information processing for adequate orientation. In the 
vertebrate central nervous system, this is achieved by a complex synergy between different 
sensory systems, each optimized for its own modality: auditory, visual, olfactory, gustatory 
and somatosensory. The somatosensory system is specifically complex because it processes 
information of four different modalities: discriminative touch, pain (nociception), body 
position and movement (proprioception) and temperature (thermoreception). The work 
presented in this thesis is primarily focused on sensory processing of strong salient tactile 
stimuli while proprioception and thermoreception is not relevant. 
1.1. Noradrenergic modulation of sensory processing in two functionally distinct 
cortical regions 
1.1.1. Transmission of innocuous and noxious tactile somatosensory 
information 
Information about tactile stimuli is conveyed by primary sensory afferents differing in axon 
diameter and degree of myelination, which determine the velocity of information transfer. 
So-called mechanoreceptors transmit sensory information of discriminative touch via 
myelinated A β-fibers with a conduction velocity of ~45 m/sec. Painful stimuli, perceived 
by nociceptors, are conveyed either via A δ-fibers, which are myelinated but exhibit a 
slower conduction velocity of ~9 m/sec, or non-myelinated C-fibers with a very slow 
conduction velocity of < 1m/sec1. Once entering the dorsal horn of the spinal cord, primary 
afferents of mechanoreceptors project ipsilaterally dorsal to the medulla and make their first 
synapse onto cells, referred to as the second order neurons. Second order neuronal axons 
then cross to the contralateral side of the brainstem and project via the medial lemniscal 
tract to the somatosensory thalamus in the midbrain and from there to sensory cortical 
regions. Primary afferents of nociceptive modality enter the dorsal horn and synapse almost 
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immediately onto second order neurons, which then cross the midline and project dorsally 
to the brain via the spinothalamic tract. 
Despite differentiated sensory pathways, the transmission of mechanoreceptive and 
nociceptive sensory information is not exclusive. It has been shown that noxious 
stimulation of the exposed sural nerve evoked neuronal responses in the primary 
somatosensory cortex (S1) which were transferred by mechanoreceptive A β-fibers in 
addition to nociceptive A δ- and C-fibers2 indicating that a tactile component is 
contributing to the neuronal response evoked by nociceptive electrical stimulation. 
Thus, the transfer of sensory information of painful stimuli is slower than of discriminative 
touch and the neural pathways within the central nervous system are different. 
Nevertheless, painful stimuli simultaneously activate the innocuous mechanoreceptive 
system. 
1.1.2. Two pain pathways for the physiological and the psychological aspects 
of pain 
In contrast to discriminative touch, pain is not primarily represented in somatosensory 
structures. The International Association for the Study of Pain (IASP) defines pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage”. This interpretation implements the 
physical perception of noxious stimuli in addition to a subjective experience associated 
with attention3-5, anxiety6, anticipation7-9 or empathy10. In this sense, the physiological as 
well as the psychological aspects of pain perception are centrally processed within the so-
called “pain-matrix”11. Subcortical and cortical structures, which contribute to the pain 
matrix, are divided into a lateral and a medial pain pathway dependent on the networks 
related to the lateral or medial thalamic structures12-18. The lateral pathway projects via the 
ventroposterior lateral and the ventroposterior inferior nucleus of the thalamus to 
somatosensory areas and mediates the localization and intensity of nociceptive stimuli. The 
medial pathway projects via intralaminar and ventromedial thalamic nuclei to limbic 
structures like the frontal cortices mediating the emotional, cognitive and affective 
component of noxious stimulation19-24. Thereby, the insula is believed to build a bridge 
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between the lateral and the medial system in order to promote integration of information 
from both12,13. 
1.1.3. The cortical activity state and its behavioral correlates 
The neuronal response to sensory stimulation can be detected on different levels of cortical 
neuronal activity including cortical activity state, sensory evoked potentials (SEPs) and unit 
activity. The cortical activity state, which was initially explored as oscillation patterns in 
the electroencephalogram (EEG), is also reflected in the low frequency component 
(< 300 Hz) of the extracellular electrophysiological signal recorded within the brain and 
referred to as the Local Field Potential (LFP). Electric currents from all active cellular 
processes within a volume of brain tissue in addition to “volume conducted” potentials 
from distant sites are averaged at a given location in the extracellular medium determining 
the LFP25. The characteristics of the LFP waveform depend on the spontaneous oscillatory 
behavior of neurons in accordance to shifts in behavioral states of vigilance26,27. During 
awake state and rapid-eye-movement (REM) sleep, the cortical activity is operating in an 
activated state defined by low amplitude-high frequency oscillations. During so-called quiet 
awake state, when the animal is awake but drowsy, and during non-REM sleep also known 
as slow wave sleep, the cortical state activity operates in a deactivated state defined by high 
amplitude-low frequency oscillations. Under this condition, neuronal ensembles in 
thalamocortical networks synchronize their firing resulting in rhythmic shifting between 
high (Up-states) and low (Down-states) excitability states28. 
The different frequency components which characterize the cortical activity states are 
superimposed in the LFP signal. They can be separated and quantified as band-limited 
power (BLP) in different predefined frequency bands in order to analyze the cortical state 
in detail. Segmentation of the frequency bands varies nowadays between publications but 
classically, the frequency ranges are defined as Delta (< 3.5 Hz), Theta (4-7.5 Hz), Alpha 
(8-13 Hz), Beta (14-30 Hz) and Gamma (> 30 Hz)29. In addition, two frequency bands have 
been introduced as specifically related to sleep states: a frequency band below 1 Hz called 
slow oscillations (SLO)30-32 and a frequency band from 12-15 Hz which was determined as 
sleep spindles33,34 and later referred to as Sigma frequency band35. 
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Each of these denoted frequency bands has been associated with behavioral correlates 
under different cortical activity states. SLO and Delta frequency band are associated with 
deep sleep while power in Sigma frequency band is enhanced during slow wave sleep36,37. 
Compelling evidence suggests that sleep contributes to long-term memory 
consolidation38,39. Power in Theta frequency range is believed to result from long-range 
interaction between hippocampus (HPC) and cortex during learning and memory 
processes40-42. Enhanced power in Alpha frequency range is assumed to be related to 
internally directed cognitive processes during awake resting state in absence of sensory 
input43-45. Power in Beta frequency band is considerably high in primary motor cortex46,47 
and is classically linked to motor functions48,49. However, interestingly, it has additionally 
been shown to be related to sensory processing in S150. Finally, generation of Gamma band 
activity is associated with an activated cortical network related to different cognitive 
processes like attention, multisensory integration or sensory stimulus detection27,37,51. 
Accordingly, activation of cortical neuronal activity during spontaneous state changes or by 
sensory stimulation enhances Gamma band activity which is, in turn, frequently associated 
with suppression of power in low frequency range in human and animals52-56. Increased 
Gamma band activity is, however, also detected during REM sleep57-59 which is highly 
associated with dreaming58,60. 
The cortical state activity under anesthesia, induced by commonly used general anesthetics 
(ketamine, propofol, pentobarbital, isofluran, etc.) is considered as artificial sleep-like state 
although without REM occurrence61-63. Concomitantly, the power in the frequency 
spectrum shifts to lower frequencies64,65. Cortical state under urethane anesthesia is 
however particularly interesting, since it has been shown in rats to be characterized by 
spontaneous shifts between activated and deactivated state resembling state shifts observed 
during natural sleep66,67. In addition to spontaneous transition, noxious sensory stimulation 
is also able to induce a shift from high amplitude slow waves to an activated state under 
urethane anesthesia in rats. Such an activated state is usually associated with increased 
neuronal firing activity68-70.  
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1.1.4. SEPs and single unit responses to noxious stimulation in the primary 
somatosensory cortex versus the medial prefrontal cortex 
Beyond cortical state activation, stimulus-related neuronal activation is reflected in SEPs 
which basically represent evoked changes in the electric potential revealed by averaging the 
low pass filtered signal. It has been shown that SEP characteristics are closely related to the 
ongoing cortical state before stimulus presentation because magnitude and dynamics 
change with variation in cortical activity state in awake human71 and also urethane 
anesthetized rats72,73. However, laminar recordings show that SEP profiles also change 
depending on cortical layer exhibiting positive deflections in superficial layers which 
reverse with increasing cortical depth74-78. Reversal of SEP polarity is associated with 
increased responsiveness of unit activity in deep cortical layers77 which is, in turn, 
positively related to magnitude of cortical state activation68-70. 
In the lateral pain pathway, the response profiles of the SEPs as well as the stimulus-related 
unit responses represent the transfer of sensory information via aforementioned primary 
somatosensory afferents. For example, the mechanoreceptive A β-fibers are enabled to 
convey discriminative information about the stimulus intensity which is reflected in the 
incrementally increased amplitude of the SEP. As soon as the stimulation is strong enough 
to additionally activate A δ- or C-fibers, the response amplitude reaches a plateau and only 
reports the presence of the stimulus79. Moreover, the latencies of the response components 
are dependent on peripheral conduction velocities. Non-specific innocuous electrical or 
mechanical stimulation commonly evokes a phasic response in S1 with a very short latency 
of 10 – 20 ms mediated by A β-fibers2,80-84. Nociceptive mechanical stimulation or 
electrical median or sural nerve stimulation evoked neuronal responses with longer 
latencies related to transmission via A δ- (50 – 60 ms peak latency) and C-fibers (~300 ms 
peak latency)2,80,82,83,85. 
The latencies closely resemble those measured in response to specific electrical stimulation 
of individual isolated afferent somatosensory fibers in pentobarbital anesthetized cats79,86. 
Furthermore, stimulation with noxious CO2-laser radiation, which has been shown to 
specifically activate nociceptors without activating low-threshold mechanoreceptors in 
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rats87 and human88,89, confirmed latencies of 50 – 60 ms and ~300 ms for Aδ- and C-fiber 
mediated cortical neuronal responses, respectively82-84,90-92. Somatosensory stimulation in 
most of the aforementioned studies conducted in rats was applied to the middle part of the 
tail or the contralateral hind paw and thus with comparable distance to the recording site. 
Additionally, peak latencies of response components assigned to A β-, A δ- and C-fiber 
transmission were comparable between evoked potentials and unit responses82,92 as well as 
between anesthetized and awake preparations82,83.  
Sensory processing of nociceptive stimuli in the medial pain pathway has been very well 
documented in the anterior cingulate cortex in rodents24,93-95 and human96-100. In addition, 
the medial prefrontal cortex (mPFC) has been shown to be similarly involved19,94,101-103. 
Studies combining recordings from prelimbic (PrL) and cingulate subdivision of rat 
mPFC68,69,94,104 indicate similar electrophysiological properties of the nociception-related 
neuronal activity in these structures. Types of noxious peripheral stimuli which activate 
neuronal activity in mPFC in awake and anesthetized rats include mechanical pressure 
stimulation68-70,102,104,105, electrical stimulation of exposed sciatic nerve95, noxious heat 
stimulation102 and CO2 laser heat stimulation94,106. Albeit the stimulation is of a noxious 
nature, the sensitivity of prefrontal neuronal activation is lower than in S1 as only 6 – 50 % 
of recorded single units in mPFC respond to nociceptive stimuli70,94,102 compared to ~90 % 
in primary sensorimotor cortex94. The response profiles of unit activity were both tonic and 
phasic with various response latencies ranging between 80 – 600 ms68,70,94,107 resulting in a 
merged single voltage deflection on the population level. Converse decomposition of SEPs 
in prefrontal cortex by independent component analysis confirmed complex processing of 
sensory information reflected in different response patterns with variable latencies106. 
Accordingly, it was suggested that the population evoked field potential is a mixture of 
integrated sensory information in cognitive processes transferred from different brain 
structures with overlapping time courses108,109. Therefore, sensory processing in prefrontal 
cortex was mostly studied related to cognitive functions like sensory discrimination, 
association or attention110 rather than the representation of a sensory stimulus per se111. 
In summary, SEPs in the somatosensory cortex, a terminal region of the lateral pain 
pathway, differ dependent on ongoing cortical state and cortical depth. Differentiable 
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response components with different peak latencies inform about type of afferents, and thus 
type of modality, which convey the information to the cortex. In contrast, the SEP profile in 
the medial prefrontal cortex, a terminal region of the medial pain pathway, is monophasic 
merged from various incoming information from different structures with different 
latencies. Additionally, the neuronal excitability in response to noxious somatosensory 
stimulation in medial prefrontal cortex is lower than in primary somatosensory cortex. 
1.1.5. Neuromodulation as a source of flexible information processing 
The necessary flexibility to process complex and variable somatosensory information in 
contributing brain structures is promoted by neuromodulation, one of two different 
mechanisms providing the chemical transfer of information in the brain. In contrast to fast 
synaptic transmission, which is enabled by ligand-gated ion channels and affects the target 
cell within a few milliseconds, neuromodulation is achieved by slow metabotropic 
receptors involving sequences of biochemical processes including different enzymes and 
second messenger systems. It may take hundreds of milliseconds to even minutes until 
synaptic transmission is completed. In addition, neuromodulatory effects are longer-lasting 
and more spatially diffuse than fast synaptic transmission112. These properties enable 
neuromodulators to rather regulate than mediate neuronal activity by changing the electrical 
properties of target neurons in many different ways113 which provides highly flexible 
information processing. Catecholamines, a group of neuromodulators including dopamine 
and its derivate noradrenaline, also known as norepinephrine (NE), have been shown to 
play a very important role in modulation of sensory processing. The sources for 
catecholamines are the brain nuclei A1 – A14, mapped and named by Annica Dahlström 
and Kjell Fuxe who implemented the “aminergic” property in the name as an “A”114. 
1.1.6. The locus coeruleus noradrenergic system 
The pontine A6 group, Nucleus Locus Coeruleus (LC), is a very small nucleus comprised 
of only ~15.000 cells per hemisphere in humans115 and ~1.500 in the rat116. LC has been 
found to be the major source of NE117 to the entire central nervous system except the basal 
ganglia118-123. Spontaneously, single neurons of LC exhibit regular tonic discharge rates of 
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1 – 5 Hz124,125 and phasic firing occurs in addition to this spontaneous activity in response 
to top-down input resulting from cognitive processes or bottom-up input like incoming 
sensory information126,127. Under anesthetized condition, LC neurons respond only to direct 
electrical stimulation of peripheral nerves or noxious somatosensory stimuli125,128-130. The 
activity state of LC noradrenergic neurons is directly related to rates of NE release in 
terminal regions. Local pharmacological activation or inhibition of LC noradrenergic 
neurons results respectively in enhanced or decreased turnover of NE in mPFC131,132 and 
S1133. Electrical microstimulation of LC neuronal activity induces a frequency dependent 
increase of NE efflux in the cortex134,135 up to a fourfold higher release of NE in response to 
a phasic stimulation pattern when compared to tonic stimulation at 1 Hz134. Similarly, the 
extracellular concentration of NE is elevated in response to electrical foot-shock (FS) 
stimulation in awake rats136,137. 
Ascending LC afferents arise from only two nuclei located in the rostral medulla: the 
nucleus prepositus hypoglossi and the nucleus paragigantocellularis (PGi)138. The former 
has been shown to be involved in gaze control139,140 and the latter in the integration of 
autonomic and environmental stimuli arising from other sensory nuclei or directly from the 
spinal cord141,142. This includes nociceptive somatosensory information143-145 which is then 
transferred from PGi to LC146 where noradrenergic neurons respond with a biphasic 
neuronal activation. The response components exhibit latencies reflecting the transfer of 
somatosensory information via peripheral afferents just as it was demonstrated for S1 
sensory-evoked responses described earlier147. 
From LC, the neuronal information is transferred via thin (< 1 µm) and non-
myelinated124,130,148 axons to LC terminal regions with a low conduction velocity of 
< 0.6 m/sec124,130,149,150. After activation of LC terminals, NE is released by axonal 
varicosities via volume transmission151-153 acting on two families of G-protein coupled 
receptors: alpha and beta-adrenoceptors. Based on their pharmacological properties, the 
alpha-adrenoceptors have been subdivided into alpha 1- and alpha 2-adrenoceptors154-156. 
Binding of NE to alpha 1-adrenoceptors activates a signal cascade which results in the 
release of Ca2+ from intracellular stores and thus in enhanced excitatory processes. Actions 
on alpha 2- and beta-adrenoceptors both modulate the intracellular concentration of cyclic 
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adenosine monophosphate (cAMP), albeit in opposite directions: activation of 
alpha 2-adrenoceptors decreases cAMP and leads to hyperpolarization of the affected 
neuron while activation of beta-adrenoceptors increases cAMP thus resulting in 
excitation157. 
1.1.7. Noradrenergic modulation of the cortical activity state 
In spite of its tiny size, LC exerts global impact on brain functions like attention158,159, 
perception160-163, memory164-166 or the behavioral state of vigilance160,167-169. The latter is 
represented in the cortical activity state which has been shown to be directly related to the 
activity state of LC noradrenergic neurons. Their discharge rate successively decreases 
from awake state over the course of quiet awake state to slow wave sleep until it ceases 
during REM sleep in rats170-173, cats174 and monkeys175. A causal role of LC activity in the 
regulation of behavioral vigilance can be suggested by the fact that changes in the firing 
activity of LC neurons precede changes in cortical activity state170,172,174-177. Supporting 
experiments showed that manipulation of LC neuronal activity in anesthetized and non-
anesthetized rats modulates cortical state activity. Specifically, pharmacological or 
optogenetic activation of LC induced cortical activation in frontal178-181 as well as sensory 
cortical areas182. Conversely, decrease of noradrenergic transmission by bilateral 
pharmacological inhibition of LC activity resulted in deactivated cortical state183 as has 
been also described for systemic injection of alpha 2-noradrenergic agonists184-186. A 
specific example shows that systemic injection of clonidine increases power between 
1 - 30 Hz with maximum power increase between 14 – 24 Hz and systemic blockade of 
alpha 2-adrenoceptors showed the opposite effect in PFC cortical surface EEG186. 
Behaviorally, cortical deactivation induces a sleep-like behavioral state of sedation in 
humans187-192 and animals193-196, a property which has been medically exploited for the use 
in clinics197-199. 
Nevertheless, rather than fulfilling these functions alone, LC exerts a modulatory influence 
on neurons in other structures contributing to the regulation of sleep-wake states including 
regions of the so-called brainstem arousal system (reticular formation, cholinergic 
laterodorsal tegmentum and pedunculopontine tegmental nucleus), serotonergic raphe 
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nuclei, midbrain dopaminergic neurons, non-specific thalamocortical activation system, 
hypothalamic activation systems and cholinergic neurons in the basal forebrain160,200-202. In 
summary, LC neuronal activity and related release of NE affects the behavioral state of 
vigilance. Increase of LC activity leads to cortical and behavioral activation while decrease 
of the noradrenergic tone results in cortical deactivation and behavioral sedation. 
1.1.8. Heterogeneous neuromodulation of neuronal activity in functionally 
distinct cortical regions by the LC noradrenergic system 
Activation and deactivation of cortical state are global phenomena and, indeed, the classical 
belief about noradrenergic modulation was a homogeneous action in all cortical regions 
because of the densely packed population of purely noradrenergic cells114,123, synchronous 
firing pattern170,203 and simultaneous activation in response to electrical or sensory 
stimulation204. Additionally, LC sends extensive projections throughout the brain and the 
spinal cord118-122,205 including vast axonal collateralization of single noradrenergic neurons 
in LC to cytoarchitectonically and functionally distinct brain regions206-210. Finally, NE is 
released via volume transmission121,135,148,211 by LC terminals originally defined to be 
uniformly distributed in the cortex212. Yet, how does a small and homogeneous structure, 
like LC, impressively provide the flexibility which is needed to integrate intrinsic and 
environmentally driven neuronal information during the processing of aforementioned 
cognitive functions? The answer developed with the innovation of methodology providing 
increased accuracy and resolution during functional and anatomical studies. Increasing 
evidence suggests that the LC noradrenergic system is actually a heterogeneous structure 
exhibiting properties which provide high flexibility in modulation of neuronal activity. 
Specific anatomical work revealed, for example, that subpopulations of LC neurons can be 
differentiated by cell morphology and localization within LC116,118,213. Furthermore, LC 
neurons can be differentiated based on their molecular composition214 and the intra-LC 
receptor composition215. Finally, anatomical projection studies have revealed topographic 
organization of neurons in the LC depending upon their target regions in the brain210,216-222. 
A heterogeneity in noradrenergic activity has been observed not only at the level of LC but 
also in its target regions. For example, the highest density of noradrenergic fibers are 
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observed in frontal areas208,223,224 which provides the PFC with a higher concentration of 
extracellular NE in comparison to sensory cortical areas223,225,226. A greater demand for NE 
in higher order cognitive brain regions has been confirmed by a study showing that 
segregated LC populations innervating functionally different cortical regions (PFC and 
motor cortex) are phenotypically, biochemically and electrophysiologically distinct from 
each other223. Laminar inspection demonstrated localization of noradrenergic terminals in 
PFC superficial layers148,212 while in sensory cortical areas the terminals were additionally 
located in deeper layers212. As a consequence, PFC cells in superficial layers were more 
sensitive to local administration of NE227 while in S1 cells in all cortical layers could be 
modulated228,229. 
Distribution of noradrenergic receptors has been found to be similarly specific between 
cortical regions and layers. However, this applies only to alpha-adrenoceptors while beta-
adrenoceptors are homogeneously distributed over cortical regions225. The highest 
concentration of alpha 1-adrenoceptors was detected in the PFC while the lowest 
concentration was found in sensory cortical areas225. Alpha 2-adrenoceptors were most 
prominent in temporal and parietal cortical regions225,230,231 distributed to all cortical layers 
in comparison to frontal regions where alpha 2-adrenoceptors are rather localized in deep 
layers231. Interestingly, activation of alpha 2-adrenoceptors in PFC does not necessarily 
result in hyperpolarization of target cells but also in enhanced excitability dependent on 
postsynaptic receptor composition. If so-called hyperpolarization-activated cyclic 
nucleotide-gated cation (HCN) channels are co-localized with alpha 2-adrenoceptors on 
dendritic spines of pyramidal neurons in PFC, activation of alpha 2-adrenoceptors results in 
depolarization232. Originally, activation of alpha 2-adrenoceptors inhibits intracellular 
cAMP production which is needed to open HCN channels in response to membrane 
potential fluctuations. Inhibition of HCN currents hyperpolarizes the resting membrane 
potential but significantly enhances the temporal integration of synaptic input by increasing 
the input resistance. The net effect is an increase in the overall gain of the response of PFC 
pyramidal neurons to excitatory synaptic input233. 
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Finally, a specific activation pattern is, however not only dependent on the presence and 
distribution of the receptors in a given brain structure but also on their affinity to NE which 
is alpha 2 >> alpha 1 > beta234. 
In summary, a huge diversity among anatomical targets and physiological effects of 
noradrenergic actions demonstrates that noradrenergic modulation of cortical functions is 
inhomogeneous, highly flexible and complex. 
1.1.9. Noradrenergic modulation of sensory evoked neuronal responses in 
functionally distinct cortical regions 
Despite a vast divergence of noradrenergic properties in hierarchically distinct brain 
regions like S1 and PFC, activation of cortical state and related noradrenergic modulation is 
consistent over cortical regions160,169. Therefore, a finer scale is necessary in order to 
characterize region-specific functional differences in sensory processing. At the level of 
single unit activity, it has been shown that NE classically optimizes information processing 
in primary sensory cortical regions. Increase of noradrenergic concentration in sensory 
cortical areas by local infusion of NE or electrical stimulation of LC leads to alpha 2-
adrenoceptor related inhibition of spontaneous neuronal activity228,229,235-239 and concurrent 
alpha 1-adrenoceptor mediated enhancement of sensory evoked neural 
responses229,236,238,240-244. These effects confirm the major view about improvement of 
stimulus-coding by increase of the signal-to-noise ratio in sensory cortical areas. Similarly 
to S1, spontaneous activity in mPFC was commonly found to be decreased after electrical 
microstimulation of LC or local infusion of NE227,245-248 which was also mediated by 
alpha 2-adrenoceptors249-253. However in contrast to S1, the suppressant effect of alpha 2-
adrenoceptor activation was shown to be dose-dependent in mPFC since iontophoretic 
clonidine injection resulted in enhanced spontaneous activity with increased ejection 
current251. This effect was also demonstrated for neuronal activation in response to either 
glutamate infusion or electrical microstimulation of synaptic afferents246,254,255. When 
clonidine was iontophoretically infused into PFC with low ejection currents, excitatory 
synaptic currents were decreased251,252,256 but turned to enhancement with increasing 
concentration of clonidine251,252. In vitro studies demonstrated a contribution of alpha 2-
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adrenoceptor-releated inhibition of HCN channels to increased excitatory postsynaptic 
currents233,246. However, studies reporting enhancement of excitatory drive in PFC by 
noradrenergic modulation were only performed in vitro. Less artificial in vivo neuronal 
responses to noxious somatosensory stimulation in mPFC were either inhibited245 or 
preserved247,248 after priming electrical microstimulation of LC. The latter effect resulted in 
increased signal-to-noise ratio (SNR) comparable to the role of NE in sensory regions. 
The modulation of cortical neuronal activity by beta-adrenoceptors is not very well studied 
and discrepant actions have been reported. Mostly studied in vitro, infusion of beta-
adrenoceptor agonists into the bath led to enhanced, suppressed or unaffected neuronal 
responses to depolarizing current pulse or iontophoretic glutamate pulse to PFC or S1 
cells235,240,257,258. The suppressant effect, however, was only shown under high 
concentration of NE. Initially, excitatory discharges evoked by iontophoretic glutamate 
pulse in single units of S1 were enhanced after NE infusion into the bath. With an increase 
in concentration of NE, the neuronal discharges showed a so-called ‘inverted U’ dose-
response relationship and turned to suppressed neuronal activity. More specific 
pharmacological experiments showed that initial facilitation was mediated by postsynaptic 
alpha 1-noradrenergic actions and the suppression under high NE concentration was 
mediated by postsynaptic low affine beta-adrenoceptors240. 
Suppression of spontaneous activity as well as neuronal activation in response to 
iontophoretic acetylcholine pulses was confirmed in vivo after local infusion of beta-
adrenoceptor agonist isoproterenol into S1238. It is believed that beta-receptor mediated 
suppression of neuronal activity in pyramidal neurons is induced indirectly by postsynaptic 
activation of GABAergic interneurons160,259-261. 
In summary, NE in S1 classically increases SNR by decrease of spontaneous neuronal 
activity and increase of evoked activity mediated by alpha 2- and alpha 1-adrenoceptors, 
respectively. Decrease of spontaneous activity has been also reported for PFC neuronal 
activity, however only for low doses of NE in the cortical tissue. Increased concentration of 
NE results in faster neuronal firing. Evoked activity in PFC was either inhibited or 
preserved dependent on the receptor composition of the postsynaptic membrane. Thus, 
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noradrenergic modulation of neuronal activity in PFC is, in contrast to S1, not 
homogeneous but differs between neuronal subpopulations. 
1.1.10. Research question study 1 
Target specific populations of noradrenergic neurons within LC and region specific 
noradrenergic innervation and receptor composition give rise to the idea of differential 
noradrenergic modulation of sensory processing in functionally distinct cortical regions. 
Previous work supports the notion (see section 1.1.8). However, because of the independent 
examination of the effects under different experimental conditions, it is uncertain whether 
these results reflect mechanisms of noradrenergic modulation of neural activity or 
methodological differences. The first study of the present work was designed to directly 
compare how anatomical and physiological differences of the noradrenergic system in 
functionally distinct cortical regions affect neuromodulation of spontaneous and sensory-
evoked responses to intradermal electrical FSs. The LFP and unit activity was 
simultaneously recorded in LC, S1 hindlimb representation (S1HL) and mPFC in the 
anesthetized rat. The noradrenergic system was manipulated by 1) systemic injection of 
clonidine which acts globally on alpha 2-adrenoceptors, suppresses LC spontaneous 
activity205,262 and decreases NE turnover in the brain by presynaptic inhibition of NE 
release263-265 and 2) local infusion of clonidine into LC, which suppresses LC spontaneous 
activity205,266-268 and decreases release of NE in the cortex132,266,269-271. 
1.2. Noradrenergic modulation of the midbrain dopaminergic system 
1.2.1. The ventral midbrain dopaminergic system 
Especially for neuromodulation of sensory and cognitive processes in mPFC it is known 
that NE acts in synergy with its direct precursor Dopamine (DA)136,272-275.  They even share 
the norepinephrine transporter (NET)276,277, which, surprisingly, has a higher affinity for 
DA than the dopamine transporter (DAT) itself278-280. Since NET is exclusively localized in 
the membrane of NE neurons281, DA is transported from the extracellular space into 
noradrenergic terminals and, after endocytosis into vesicles and activation of the 
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presynaptic terminal, co-released with NE282-287, for example upon electrical 
microstimulation of LC288,289. 
The sources for DA are the midbrain nuclei A8 – A14114 besides two more nuclei which 
were identified in diencephalon and olfactory bulb290. Major sources are A 9, the substantia 
nigra pars compacta (SNc) and A 10, the ventral tegmental area (VTA) both located in the 
ventral midbrain. The efferent pathways of this midbrain DA complex are subdivided into 
three major divisions. The nigrostriatal pathway projects from the SNc to the dorsal 
striatum and basal ganglia291-294 and is greatly involved in execution of voluntary motor 
actions291,295-297. The mesolimbic pathway projects from the paranigral subdivision of the 
VTA to Nucleus Accumbens (NAc)298-301 and regulates reward and motivation302-305. 
Lastly, the mesocortical pathway, which projects from the parabrachial subdivision of the 
VTA to mPFC, HPC and amygdala299,300  contributes to goal-directed behavior as well as 
aversive behavior302,306. Classical electrophysiological properties of dopaminergic neurons 
are based on studies performed in the SNc in which > 90% of the neurons are 
dopaminergic307,308. In contrast, the VTA is a heterogeneous structure composed of 
60 - 70 % dopaminergic, ~30 % GABAergic and ~ 5 % glutamatergic neurons309-320. 
VTA dopaminergic neurons receive input from a vast variety of sources including striatum, 
pallidum, hypothalamus, amygdala, cortex, thalamus, hindbrain and other midbrain regions 
meaning that GABAergic, glutamatergic, serotonergic, noradrenergic and cholinergic 
projections converge in the VTA321-325. In addition, DA neurons receive input from local 
GABAergic, glutamatergic and other dopaminergic neurons321-323,325. 
1.2.2. Stimulus-related activation of the midbrain dopaminergic system   
Midbrain dopaminergic neurons display phasic excitation in response to sensory events of 
alerting (unexpected sensory cues which generally trigger immediate reactions) or aversive 
(unpleasant sensations like air puffs, bitter tastes, electrical shocks, pinch) character326-328. 
This implies that basically every salient sensory stimulus of any intensity or modality as 
well as every novel stimulus is able to activate VTA dopaminergic neurons resulting in 
phasic release of DA into VTA target regions329-339. Accordingly, VTA dopaminergic 
neurons are also excited in response to noxious somatosensory stimulation340-342. Related 
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cortical activation and release of DA has been shown to be restricted to mPFC and 
cingulate cortex which is why it was suggested that noxious stimuli are specifically 
processed in the mesocortical dopaminergic pathway300,332,343-345. Functionally, the denoted 
target structures of the mesocortical dopaminergic system (PFC, HPC and amygdala) might 
contribute to cognitive processes after the initial reflexive behavior which terminates 
noxious stimulation. This implies the association between the unpleasant experience and 
preceding actions, learning the association and attributing the cause adequately for future 
prevention. 
1.2.3. Dopaminergic modulation of neuronal activity in ventral midbrain 
target regions 
Ventral midbrain dopaminergic neurons show 3 main types of activation pattern: 
1) inactive, hyperpolarized346,347 by a strong GABAergic inhibition from ventral 
pallidum348,349, 2) regular tonic, induced by either intrinsic pacemaker potential346,350,351 or 
glutamatergic afferents352-354 and 3) phasic or burst activity in response to short-term 
glutamatergic afferents308,348,352,355-357. While regular tonic firing of dopaminergic neurons 
provides a baseline tone of DA release in VTA terminals, which is dependent on the size of 
active dopaminergic population348,353,358, burst activity produces a larger synaptic release of 
DA albeit only transiently348,359-366. 
DA exerts its actions on at least 5 distinct subtypes of G-protein coupled DA receptors 
which are divided into D1-like (D1 and D5) and D2-like (D2, D3 and D4) receptor subtypes 
according to their intracellular signaling events. D1-like receptors are positively coupled to 
signaling molecules and thus enhance the intracellular concentration of cAMP which 
results in depolarization of the membrane while on the contrary, D2-like receptors exert 
negative coupling and hyperpolarize the membrane367. 
In NAc and the dorsal striatum, the phasic release of DA is restricted by presynaptic actions 
on inhibitory D2-receptors368-370 and released DA is rapidly removed from the synapse by 
DAT reuptake371. However, properties like axon collateralization of single dopaminergic 
neurons, topographic overlapping, synchronous firing of dopaminergic neurons and the use 
of gap junctions contribute to massive increase of DA concentrations which compensate for 
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rapid removal353. In contrast, dopaminergic neurons of the mesocortical system do not 
express D2-receptors and therefore the release of DA is prolonged which enables the 
neuromodulator to accumulate and diffuse in the target tissue299,361,372-374. Furthermore, DA 
provision is much faster in PFC in comparison to other target areas of the VTA375,376. 
Lastly, mesocortical dopaminergic neurons display a higher firing rate than mesolimbic or 
mesostriatal dopaminergic neurons374,377. In combination, this suggests a greater demand of 
dopamine in PFC compared to other VTA target structures. This might be related to a high 
functional significance of D1-receptors which is illustrated by a higher abundancy 
(10 - 20 times higher expression than D2-receptors) in the PFC of human378, monkey379 and 
rodent380. Activation of D1-receptors requires more DA since the affinity in binding DA is 
naturally lower than of D2-receptors381. This implies a preferential activation of D2-
receptors when dopaminergic neurons are tonically activated and additional activation of 
D1-receptors occurs with increased release of DA, such as during phasic firing in response 
to cognitive engagement or salient stimuli382-384. Given this background, it must be assumed 
that phasic release of DA in mPFC increases the SNR of sensory-evoked responses. 
However, experimental manipulation of the PFC DA concentration by intra-PFC infusion 
of DA, pharmacological and electrical stimulation of VTA DA neuron activity or 
neurotoxic lesion of VTA DA neurons in anesthetized rats revealed that DA in PFC has an 
inhibitory effect on both spontaneous firing activity227,247,248,385-396 as well as neuronal 
response to MD-thalamus stimulation or peripheral noxious stimulation247,386. Since both 
D1- and D2-receptors are expressed in the membrane of deep-layer pyramidal as well as 
non-pyramidal neurons in PFC380,397-400, DA exerts both direct and indirect effects on 
pyramidal cell activity401-403. Further, it has been shown that DA and GABA mutually 
contribute to the inhibitory actions of VTA DA input to PFC393,402,404-406. 
Complex modulation of mPFC neuronal activity might additionally result from DA-
glutamate coactivation. The importance of glutamate was repeatedly emphasized for 
several PFC functions407-409 and glutamate is even co-released from mesocortical 
dopaminergic neurons410-413. Anatomical studies revealed a close proximity between 
mesocortical dopaminergic neurons and glutamatergic terminals arising from cortical and 
subcortical afferents414-422 which converge onto the same postsynaptic pyramidal cell in 
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mPFC423-427 creating so-called “synaptic triads”424,428,429 (Figure 1.1). Thus, a simultaneous 
presynaptic and postsynaptic dopaminergic modulation of excitatory synaptic transmission 
by glutamate is possible. At the postsynaptic site, DA generally increases the amplitudes of 
N-methyl-D-aspartate (NMDA)-mediated currents by acting on D1-receptors430-436. Reports 
about the actions on the presynaptic site are discrepant. Certain studies have demonstrated 
that the presynaptic activation of D1-receptors results in elevated release of 
glutamate406,429,436,437 while other studies have reported a reduction of glutamate 
release438,439. In this context, it has been shown that both D1-receptor hypoactivation440-442 
as well as hyperactivation443-445 in PFC disrupts performance in certain prefrontal-related 
cognitive tasks implying that an optimal level of D1-receptor activation, in the sense of an 
inverted U-shaped function, is required for adequate performance in rodents, monkeys and 
human443,446-453. 
 
 
Figure 1.1: Schematic illustration of a 
so-called ‘synaptic triad’ in PFC. 
Mesocortical dopaminergic neurons 
from the ventral midbrain terminate in 
close proximity to glutamatergic 
afferents from cortical or subcortical 
structures. Both afferents converge 
mutually onto the postsynaptic 
pyramidal neuron. This configuration 
enables a simultaneous dopaminergic 
modulation of presynaptic glutamate 
release and postsynaptic response in 
addition to presynaptic dopamine 
release by auto-inhibition mechanisms. 
Modified from Rhodes et al. 2005. 
 
 
In summary, DA exerts a variety of modulatory effects on prefrontal neuronal activity in 
order to regulate functions like memory110,455,456 including working memory452,457-459, 
behavioral flexibility110,460-462, attention110,458, motivation463-466 and other cognitive 
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operations455,459,462,467. Functional impairment of the dopaminergic modulation of prefrontal 
activity results in neurological and psychiatric impairments, for example schizophrenia468-
472 or attention-deficit-hyperactivity-disorder473-476. 
1.2.4. Noradrenergic modulation of the midbrain dopaminergic system 
The activity of dopaminergic neurons and related engagement in sensory processing or 
cognitive functions is modulated by the activity state of LC noradrenergic neurons. 
Anatomical studies reveal a dense projection of noradrenergic neurons from LC to the 
VTA119,477-482 where alpha 1-483 and alpha 2-adrenoceptors484-487 are expressed on 
dopaminergic neurons and activation results in a complex local modulation pattern. 
Presynaptic blockade of alpha 2-adrenoceptors within the VTA, which blocks auto-
inhibition processes and thereby increases NE release488-491, resulted in either decreased492 
or increased493 dopaminergic firing activity. Also, neurotoxic lesion of LC noradrenergic 
neurons revealed contrasting results. While increased dopaminergic discharge rate was 
shown after bilateral lesion of LC noradrenergic neurons by infusion of 
6-Hydroxydopamine494, another study reported decreased release of DA in VTA terminal 
regions495 indicating decreased dopaminergic discharge. Nevertheless, direct enhancement 
of NA concentration by infusion of NE into VTA or systemic injection of a selective NE 
reuptake inhibitor (NERI) resulted consistently in suppression of the discharge rate of VTA 
DA neurons496,497 which, accordingly, reduced the release of DA in NAc498.  
Alpha 2-adrenoceptors are the most abundant noradrenergic receptors499 with the highest 
affinity234 in the VTA. Therefore, a low concentration of NE activates alpha 2-
adrenoceptors leading to inhibition of dopaminergic cell activity in contrast to high NE 
concentration in response to phasic NE release or experimentally induced 
hypernoradrenergic state. However, receptor-specific pharmacological experiments suggest 
a mutual contribution of alpha 2-adrenoceptors in addition to D2-receptors in suppression of 
dopaminergic activity377,496,500-503, the latter presumably by presynaptic inhibition of 
glutamate transmission504. On the contrary, enhancement of dopaminergic activity is 
enabled by actions on alpha 1-adrenoceptors493,505. Correspondingly, phasic release of NE 
in response to electrical microstimulation of LC evoked transient burst activity in putative 
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VTA and SNc DA neurons506,507 in accordance with the idea that NE in high concentration 
affects alpha 1-adrenoceptors in addition to alpha 2-adrenoceptors. 
Furthermore, noradrenergic modulation of the firing pattern but not the firing rate of 
midbrain DA neurons has been reported. A reduced burst firing and regularized firing 
pattern in VTA and SNc putative dopaminergic neurons was observed after systemic 
injection of alpha 2-noradrenergic agonist and alpha 1-noradrenergic antagonist493,508,509 
indicating that NE induces burst firing in ventral midbrain dopaminergic neurons and thus, 
leads to increased release of DA in related target regions359,361-366,510. 
Finally, a presynaptic location of noradrenergic alpha 1-receptors511,512 and alpha 2-
adrenoceptors504 on glutamatergic and GABAergic terminals within the VTA have been 
reported indicating a noradrenergic modulation of glutamate and GABA release, which 
indirectly modulates VTA dopaminergic activity311,513-516. 
In summary, noradrenergic modulation of the activity of VTA dopaminergic neurons is 
dependent on receptor composition, local network connectivity and firing pattern of LC 
noradrenergic neurons. Low concentration of NE by tonic activity of LC neurons primarily 
activates alpha 2-adrenoceptors and D2-receptors which results in suppression of 
dopaminergic, GABAergic and glutamatergic activity within the VTA. When LC neurons 
are phasically activated, alpha 1-adrenoceptors are additionally activated, leading to 
increased firing of VTA neurons. Additionally, NE shifts the firing pattern of VTA 
dopaminergic neurons to burst activity, which results in increased release of DA in VTA 
target structures. 
1.2.5. Research question study 2 
Phasic excitation of dopaminergic neurons in the VTA in response to salient stimulation326-
328 including noxious somatosensory stimulation332,336,337,340,516-520 is well documented. 
However, noradrenergic modulation of sensory evoked neuronal responses in VTA DA 
neurons has not been explored in detail. The response latency of noradrenergic neurons in 
LC is 20 – 50 ms129,147,521 and thus shorter than the reported response latency of VTA 
dopaminergic neurons (40 – 100 ms)341,516-519,522. This implicates that both tonic and 
stimulus-related phasic release of NE is able to modulate sensory processing in the VTA. 
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Therefore, in the second part of this work, LC activity was unilaterally inactivated by local 
infusion of alpha 2-noradrenergic agonist.  Next, modulation of population sensory-evoked 
responses to electrical FSs in ipsilateral VTA was examined in the anesthetized rat. 
1.3. Dopaminergic modulation of sensory gating 
1.3.1. Catecholaminergic interactions in prefrontal cortex 
Interestingly, the interactions of NE and DA in the VTA seem to specifically affect the 
mesocortical dopaminergic system. It has been demonstrated that systemic injection of a 
selective NERI increased DA release in PFC but not in the striatum283,523, an effect which 
was abolished by neurotoxic lesion of LC523. Furthermore, systemic injection of a selective 
DA reuptake inhibitor increased DA concentration in PFC only in rats with neurotoxically 
lesioned LC while DA release in NAc was independent from neuronal activity in LC523. 
Finally, neurotoxic lesion of the LC – VTA noradrenergic pathway decreased DA 
utilization in PFC while the level in NAc remained unchanged524. Accordingly, stimulation 
of LC increases extracellular levels of DA in PFC525. 
The mPFC receives convergent projections of LC noradrenergic and VTA dopaminergic 
neurons209,224,421,526,527 and it has been demonstrated that NE regulates extracellular DA and 
vice versa within mPFC528. For example, local infusion of NE or a selective NERI into PFC 
has been shown to increase extracellular NE as well as DA in anesthetized rats272,283,528. 
The DA release seems to be primarily mediated by alpha 1-adrenoceptors272. However, 
systemic or intra-mPFC infusion of alpha 2-adrenoceptor antagonist without prior 
manipulation of the noradrenergic tone also enhances extracellular levels of DA and NE in 
mPFC528-531 suggesting co-release of catecholamines by presynaptic blockade of auto-
inhibition mechanisms on LC terminals284-287. Concomitantly, a decrease has been observed 
after local infusion of alpha 2-noradrenergic agonist528. On the other hand, NE and DA 
exert pronounced compensatory mechanisms on each other. Loss of noradrenergic input by 
local neurotoxic lesion of LC terminals or lesion of ascending NE pathways, for example, 
increased DA release in PFC up to 70%532,533 presumably by missing noradrenergic 
suppression of dopaminergic firing activity in VTA496-498. 
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Vice versa, the noradrenergic tone in mPFC is modulated by dopaminergic actions. So was 
the extracellular NE release increased by local infusion of DA into mPFC of anesthetized 
rats. This effect was reversed by blockade of D1- but not D2-receptors272. Comparable to 
modulation of extracellular DA release in mPFC by noradrenergic alpha 2-receptors, it was 
shown that pharmacological manipulation of D2-receptors without prior increase of DA 
concentration actually increased NE release after D2-receptor blockade and decreased it 
after D2-receptor activation534. Nonetheless, a co-release of catecholamines from 
dopaminergic terminals is not reported. 
In summary, DA and NE interact with each other on the somatodendritic level in the VTA 
as well as in the mutual terminal projection area mPFC. Presentation of noxious tail shocks 
increase both NE and DA in PFC528 suggesting synergistic modulation of higher order 
processing of nociceptive stimuli. Optimal processing of sensory information is a 
prerequisite for optimal cognitive performance. This is because only well perceived 
environmental stimuli of all modalities during a variety of conditions may be adequately 
integrated and processed to determine an appropriate behavioral outcome535. Thereby, NE 
and DA play a complementary and critical role in PFC function and small perturbations of 
the neurochemical environment may contribute substantially to cognitive 
deficits275,446,451,536. Such a deficit might be as severe as surgical ablation of the cortical 
region440. 
1.3.2. Sensory gating deficits in schizophrenia 
A chronic and severe mental disorder induced by catecholamine imbalance is 
schizophrenia. The complex and heterogeneous symptoms are divided into cognitive 
symptoms (attention deficits, working memory deficits, poor executive functions), negative 
symptoms (reduced expression of emotions, inactivity, social withdrawal, anhedonia) and 
positive symptoms (hallucinations, delusions, thought disorders, movement 
disorders)471,537. Specific positive symptoms in schizophrenia are so-called sensory gating 
deficits which refer to the basic inability of the brain to extract biologically relevant sensory 
information from “noise” in the environment538-540. The consequence is a sensory overload 
or sensory “flooding” by uncontrollable, overwhelming sensory stimulation541. In 1985, a 
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mother describes the sensory gating deficits of her schizophrenic son very illustrative: “If 
he isn’t hallucinating, his hearing is different when he’s ill. One of the first things we notice 
when he’s deteriorating is his heightened sense of hearing. He cannot filter out anything. 
He hears each and every sound around him with equal intensity. He hears the sounds from 
the street, in the yard and in the house, and they are all much louder than normal.”542. 
Experimentally, the ability of sensory gating is tested by using two different standard 
sensory-gating paradigms in animals and humans: Prepulse Inhibition (PPI) and Auditory 
Sensory Gating (ASG). In the PPI paradigm, the acoustic startle response (ASR), a 
substantial reflexive behavioral response to sudden loud stimuli, is reduced in healthy 
subjects when a mild stimulus, the prepulse, is presented 30 – 500 ms prior to the startle 
stimulus543-545. The prepulse might be of any modality although experimentally, an acoustic 
prepulse is commonly used545-547. The face, predictive and construct validity for the rat 
model of PPI has been demonstrated548. In ASG, paired auditory stimuli consisting of two 
tones usually 500 ms apart, are presented. In a healthy subject, the neuronal response to the 
second stimulus (test stimulus) is reduced due to sensory gating mechanisms evoked by the 
first stimulus (condition stimulus). A behavioral response is not expected in ASG549,550. 
Convergent or divergent underlying mechanisms between these two paradigms are still a 
matter of debate551-554. The general assumption for the mediation and modulation of ASG is 
a polysynaptic co-activation of non-specific inhibitory afferents along the sensory neuraxis, 
possibly from areas like the reticular formation or thalamus555-557. Additionally, cortical 
inhibitory mechanisms by simple contribution of GABAergic neurons, acting on 
metabotropic GABAB receptors have been proposed550,553. While the exploration of the 
contributing circuits for ASG attracted less attention, the underlying mechanisms of PPI are 
very well explored and will be discussed in the next section.  
1.3.3. Mediation and modulation of sensory gating in rats 
The ASR is mediated by an oligosynaptic pathway located in the pontomedullary brainstem 
with a latency of only 10 ms558-561. The acoustic startle stimulus is transferred from the 
auditory nerve via the cochlear nuclei to the nuclei of the lateral lemniscus and from there 
to the nucleus reticularis pontis caudalis (PnC) down the reticulo-spinal tract to the lower 
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motor neurons which transfer the information for muscle contraction562-564 (Figure 1.2 
white boxes). 
 
Figure 1.2: Schematic illustration of the pathway mediating the acoustic startle response (white) in 
addition to the pathway mediating (orange) and modulating (blue) auditory prepulse inhibition. Red 
arrows illustrate inhibitory connections. mPFC = medial prefrontal cortex, VTA = ventral tegmental 
area, HPC = Hippocampus, NAc = Nucleus Accumbens, VP = Ventral Pallidum, IC/SC = Colliculus 
inferior/superior, PPTg = Pedunculopontine tegmental nucleus, SNr = Substantia nigra pars reticulata, 
PnC = Nucleus reticularis pontis caudalis, ASR = acoustic startle response. 
Within this pathway, the giant reticulospinal neurons in PnC are critical for attenuation of 
the ASR by presentation of a prepulse565-567. The mediating primary auditory PPI circuit 
projects from the auditory nerve to the cochlear nuclei and from there via colliculus inferior 
and colliculus superior to the pedunculopontine tegmental nucleus (PPTg) (Figure 1.2 
orange boxes). This nucleus exerts cholinergic inhibition on the PnC568-572 and, thus, 
directly intervenes in the pathway of the ASR. In addition, an excitation of the GABAergic 
substantia nigra pars reticulata by PPTg has been suggested, which in turn inhibits PnC 
activity573. Higher order brain structures including mPFC, NAc, HPC, amygdala, midbrain 
dopaminergic and serotonergic systems and the ventral pallidum contribute to a circuitry 
which  modulates PPI571,574,575 (Figure 1.2 blue boxes). 
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1.3.4. Dopaminergic modulation of sensory gating deficits in rats 
The contribution of DA to sensory gating was subject of a number of studies which 
generally showed an impairment of PPI or ASG in rats after systemic increase of 
extracellular DA levels in DAT-KO mice576 or by injection of amphetamine or 
apomorphine554,577-584. Other studies reported impaired PPI after systemic injection of a D2-
receptor antagonist in humans585-587 and rodents588,589. The latter might be able to induce a 
hyperdopaminergic state by actions on presynaptic autoreceptors of dopaminergic 
terminals369,377,590. It is worth mentioning that PPI deficits induced by hyperdopaminergic 
state are reversed by increasing extracellular NE by NET inhibitors576,582,591 confirming the 
previously mentioned complementary and compensating synergy between the 
catecholamines. 
Originally, PPI deficits were consistently found to be related to hyperactivity in the 
mesolimbic DA system leading to a hyperdopaminergic state in ventral striatum, 
specifically NAc570,592-594. In support, it has been shown that PPI impairment induced by 
systemic amphetamine was reversed by neurotoxic lesion of dopaminergic terminals in 
NAc592. However, further region-specific exploration also provided strong evidence for the 
contribution of mPFC in modulation of PPI and also ASG595-598. Such mPFC-related 
modulation of PPI has been explored in much more detail. Both hyperactivation of mPFC 
by local infusion of a GABA-receptor antagonist599 and hypoactivation by cytotoxic lesion 
of mPFC600,601 impair PPI. In contrast to the hyperdopaminergic state in NAc, a 
hypodopaminergic state in mPFC has been reported to be related to PPI deficits. This was 
revealed by detailed pharmacological experiments involving local neurotoxic lesion of 
dopaminergic terminals in mPFC602,603 or infusion of D1- or D2-receptor antagonist580,604,605. 
However, since the mPFC controls the tonic release of DA in the limbic striatum, these two 
mechanisms are not independent from each other. It has been demonstrated that electrical 
and pharmacological stimulation of mPFC neuronal activity increases the release of DA in 
NAc606-608 and pharmacological inhibition by GABA-receptor agonists accordingly 
decreased it607-609. Furthermore, local infusion of DA-receptor agonists into mPFC 
reduced609-611 while opposing depletion of DA by neurotoxic lesion in mPFC increased DA 
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metabolism in NAc612,613. It was suggested that the extracellular DA concentration in NAc 
is modulated by the activity state of prefrontal glutamatergic efferents. Since DA in mPFC 
inhibits neuronal activity of pyramidal neurons386,392,395, depletion of prefrontal DA 
disinhibits glutamatergic projections to NAc and VTA614-616. The cortico-accumbal 
glutamatergic input naturally maintains a tonic release of DA into NAc by presynaptic 
activation of mesolimbic dopaminergic terminals614,617-620 ( 
 
Figure 1.3). Thus, mPFC can control the extracellular level of DA either directly in NAc or 
indirectly by excitation of mesolimbic dopaminergic projections in the VTA607,614,621,622. 
 
 
 
Figure 1.3: Schematic illustration of a 
‘synaptic triad’ in NAc. Under 
physiological condition the glutamate 
release from prefronto-accumbal 
terminals activates postsynaptic 
GABAergic medium spiny neurons in 
NAc and simultaneously ensures a 
tonic release of DA by activation of 
presynaptic mesolimbic dopaminergic 
terminals. Thus, glutamate from 
mPFC directly mediates and 
indirectly modulates postsynaptic 
release of GABA from NAc neurons. 
Modified from Rhodes et al. 2005. 
 
A resulting hyperdopaminergic state in NAc might impair PPI by suppression of the NAc 
spontaneous activity, as has been demonstrated in response to electrical stimulation of 
VTA623-627, and related decreased release of accumbal GABA into the ventral pallidum. The 
ventral pallidum is hereafter disinhibited releasing more GABA into PPTg. As a 
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consequence the inhibitory impact of PPTg on PnC giant neurons is removed and the ASR 
is mediated unfiltered. 
Nevertheless, PPI was similarly disrupted after increasing the extracellular DA 
concentration in mPFC by local infusion of apomorphine628,629 indicating that a 
hyperdopaminergic state in NAc is not the only reason for sensory gating deficits. An 
alternative hypothesis suggests a dopaminergic hyper-responsivity in the ventral striatum 
due to decreased excitatory input from mPFC353,630. More specific, the tonic release of DA 
into NAc recedes with pathological decrease of the glutamatergic drive from mPFC. In 
consequence, DA system activity is upregulated by compensatory processes (e.g. decreased 
autoreceptor-mediated inhibition of DA synthesis and release, increase in the number of 
postsynaptic receptors, DA axon sprouting, increased receptor sensitivity) to ensure 
sufficient tonic DA receptor stimulation. Under this pathological condition, normally 
irrelevant and thus gated environmental stimuli produce phasic DA responses. In addition, 
strong salient sensory stimulation of aversive or alerting character326-328 cause 
extraordinarily strong phasic activation of dopaminergic receptors in NAc which, in 
combination, results in sensory flooding353. 
In summary, it was suggested that sensory gating deficits are induced by neural circuit 
dysfunction in the prefrontal-striatal network612,613,631. In support, a comparable extent of 
PPI impairment was reported after depletion of DA in mPFC and local infusion of DA in 
NAc593,603. 
1.3.5. Research question study 3 
Two alternative hypotheses have been proposed regarding how DA modulates sensory 
gating deficits in patients suffering from schizophrenia. The main question is whether the 
symptoms result from a hyperdopaminergic or a hypodopaminergic state in mPFC and, in 
consequence in NAc. It was suggested that a chronic hypodopaminergic state in NAc 
impairs sensory gating after compensatory mechanisms which enhance the sensitivity to 
phasically released DA. However, acute enhancement of DA concentration impairs sensory 
gating554,576-584 and hence, it would be interesting whether acute reduction of DA 
concentration in NAc also modulates PPI. If this would be true, then an inverted U-shaped 
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dose-response function could be assumed. Supportive studies have shown that local 
infusion of dopaminergic D2-agonists into NAc impair PPI632,633 and that presynaptic 
dopaminergic autoreceptors are involved634. This implicates a presynaptic inhibition of DA 
release and, thus, a reduced DA transmission into NAc which disrupts sensory gating. 
In the third study of this work, a VTA-target specific pharmacological approach was 
performed in order to clarify the importance of the contribution of DA release in mPFC or 
NAc to impairments in PPI as well as ASG. Therefore, target-specific receptor composition 
of VTA dopaminergic neurons was exploited for pharmacological inhibition of DA release 
in different VTA target structures. Dopaminergic neurons in the ventral midbrain express 
alpha 2-adrenoceptors on the presynaptic as well as alpha 1- and alpha 2-adrenoceptors on 
the postsynaptic membrane493,494,496,505. Commonly, tonic NE in the VTA has an inhibitory 
effect by actions on more abundant499 and affine234 alpha 2-adrenoceptors494,496,505,635. Local 
infusion of the alpha 2-noradrenergic agonist clonidine into the ventral midbrain 
additionally decreases potentially excitatory noradrenergic transmission by presynaptic 
actions493,496,636. Furthermore, activation of alpha 2-adrenoceptors by systemic or local 
infusion of clonidine into the VTA decreases burst activity and regularizes DA cell 
firing508,509. Accordingly, blockade of alpha 2-adrenoceptors increased burst activity in 
VTA DA neurons493,509. In summary, activation of alpha 2-adrenoceptors in VTA results in 
decreased dopaminergic turnover in VTA target regions like mPFC and NAc. 
Besides alpha 2-adrenoceptors, dopaminergic neurons in the VTA also carry κ-opioid 
receptors; yet, it has been shown that the expression is selective for dopaminergic neurons 
projecting to mPFC315,373. On the other hand, these neurons lack the expression of 
dopaminergic D2-receptors299,361,372-374, which are in turn carried by dopaminergic neurons 
in the VTA projecting to other targets than mPFC299,343,373. 
Based on these target-specific properties of VTA dopaminergic neurons, three drugs were 
separately infused into the ventral midbrain of awake rats previous to simultaneous tests on 
PPI and ASG:  
- alpha 2-adrenoceptor agonist clonidine in order to generally decrease dopaminergic 
transmission from VTA. 
- κ-opioid receptor agonist U69593 to decrease DA release specifically in mPFC. 
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- D2-receptor agonist quinpirole, which decreases DA release in structures besides 
mPFC. 
1.3.6. Brief summary of the research aims in this thesis 
The general question of this work is how the catecholaminergic neuromodulators NE and 
DA affect sensory processing in primary sensory and higher association cortex. To 
approach this question, a series of experiments were performed to first examine qualitative 
differences in sensory processing between these functionally distinct cortical regions and 
then explore the role of the LC noradrenergic system in modulation of cortical sensory 
processing in anesthetized rats. Since the catecholaminergic systems exert synergistic 
effects on cortical functions, next, the noradrenergic modulation of the ventral midbrain 
dopaminergic system was explored in an attempt to distinguish between noradrenergic and 
dopaminergic actions on cortical activity. Finally, the modulation of sensory gating and 
related neuronal activity in prefrontal association cortex was examined with an emphasis on 
the midbrain dopaminergic system in awake rats. 
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2. Material and Methods 
All rats used in this study were housed on a 12 h light/dark illumination cycle with constant 
access to food and water. All experimental procedures were approved by the local 
authorities (Regierungspräsidium) and were in full compliance with the European 
Parliament and Council Directive 2010/63/EU on the protection of animals used for 
experimental and other scientific purposes. 
2.1. Noradrenergic modulation of sensory processing in two functionally distinct 
cortical regions 
Two sets of experiments were performed in order to explore the catecholaminergic 
modulation of sensory processing in urethane-anesthetized rats. In one set, the neuronal 
activity was simultaneously recorded in LC, S1HL and PFC. In a second set of 
experiments, neuronal activity was recorded from LC and VTA. 
2.1.1. Surgery and electrophysiological recording 
Twenty-two male Sprague-Dawley rats (250 - 350 g) were used as part of the study. All 
procedures were conducted under deep anesthesia with urethane (1.5 g/kg, i.p. with drug 
supplements given if needed). Rectal temperature, heart rate and SpO2 levels were 
monitored and kept constant throughout the experiment. Once deeply anesthetized, each rat 
was mounted in a standard stereotaxic frame (David Kopf Instruments, Tujunga, CA, USA) 
with the head angle adjusted at zero degrees in the horizontal plane. The skull was 
surgically exposed and local anesthetic (1 % Lidocaine-hydrochloride; AstraZeneca, 
Wedel, Germany) was applied on the skin and bone. After approximately 3-5 min, small 
burr holes were drilled over the target brain regions. The following stereotaxic coordinates 
were used for the locus coeruleus (LC): AP= -4.1 mm from lambda, ML = 1.2 mm, medial 
prefrontal cortex (mPFC): AP = +3.5 to +4.5 mm, ML = 0.5 mm and primary 
somatosensory cortex (S1HL): AP= -0.5 to -2.5 mm from bregma, ML = 2 to 3.5 mm637. 
The final S1HL coordinates in the denoted window were determined according to the 
receptive field of the stimulation site in the contralateral hindlimb. Specifically, the S1HL 
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region was mapped by recording the epidural EEG responses to sensory stimulation (single 
FSs: 0.5 ms, 5 mA) and the site showing the maximal response amplitude was used for 
experiments. The recording depth was adjusted within a range of 3 – 4 mm for mPFC and 
1 – 1.5 mm for S1HL to obtain best possible extracellular activity on all electrodes. 
For extracellular recording in mPFC and S1HL, silicone-based multi-electrode arrays with 
tetrode configuration (Neuronexus Technologies, Ann Arbor, MI, USA) were used. Each 
electrode array consisted of four shanks, each equipped with one tetrode. In mPFC, the 
spacing between the shanks was 0.4 mm and covered ~ 1.2 mm in the antero-posterior 
direction. In S1HL, shank spacing was 0.15 mm, which covered ~ 0.45 mm in total. In LC, 
a three-barrel glass recording/iontophoresis microelectrode (Carbostar-3, Kation Scientific, 
MN, USA) enabled combined extracellular recording and drug injections. One barrel was 
incorporated with a carbon fiber electrode (6-7 μm) and a second barrel was filled with 
drug. The tip of the pipette, including the distal orifices of the barrels and the electrode did 
not exceed 10 μm. The electrode was fixed at 15 degrees in postero-anterior plane in order 
to avoid transverse sinus damage during the electrode penetration. The final position of the 
electrode in LC was electrophysiologically guided by the distinctive activity pattern of 
noradrenergic neurons. Specifically, the following criteria were applied for identification of 
LC neurons: 1) resumption of neuronal firing activity after absent electrophysiological 
activity due to passage of the IV ventricle; 2) broad spike width (~ 0.6 ms) and 3) a brief 
excitation followed by prolonged inhibition of neuronal activity in response to paw 
pinch125,262,638. The neurochemical nature of the recorded LC cells was further verified by 
inhibition of their firing due to systemic and/or intra-LC clonidine injection205,267,639.  
Signals were recorded by using a broad-band filter (0.1 Hz – 8 kHz) in at least one channel 
per cortical structure while the rest of the channels were recorded by application of a high-
pass filter (300 Hz – 8 kHz). After preamplification (x 25) using a custom-made 32-channel 
preamplifier, the signals were again amplified (x 2k and x 5k for broad band signal and unit 
activity, respectively) using an Alfa Omega multi-channel processor (MPC Plus, Alpha 
Omega Co., Alpharetta, GA, USA). The signals were digitized at 24 kHz using CED 
Power1401mkII converter and Spike2 data acquisition software (Cambridge Electronic 
Design, Cambridge, UK). 
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2.1.2. Somatosensory stimulation 
For somatosensory stimulation, electrical FSs were applied via two stainless steel needles 
which were placed subcutaneously ~ 1 cm apart in the paw of the hind limb contralateral to 
the recording sites. Electrical current was delivered using a biphasic stimulus isolator 
(BSI - 1, Bak Electronics, Inc., Mount Airy, MD). The stimulation parameters were 
digitally controlled by Spike2 software and transmitted to the current source via digital-to-
analogue converter built-in to the data acquisition unit CED Power 1401mkII (Cambridge 
Electronic Design, Cambridge, UK). Actually applied current was monitored on the 
oscilloscope via a custom-built voltage output unit and compared with the digital input. 
Examination of effective stimulation parameters was performed by using different 
stimulation protocols. In one protocol, amplitudes of neuronal responses to electrical FS-
stimulation were compared between single pulse (0.5 ms pulse duration, 5 mA) and train 
stimulation (0.5 ms pulse duration, 100 ms at 50 Hz) with a respective interstimulus 
interval of 10 sec. In another protocol, trains of pulses were applied using different 
stimulation currents: 1, 2, 3, 4 and 5 mA. Final stimulation protocol consisted of trains of 
rectangular pulses (0.5 ms pulse duration, 100 ms at 50 Hz) with a current intensity of 
5 mA. The stimulus was repeated 25 times every 10 sec for each experimental condition. 
2.1.3. Drug administration 
Clonidine chloride (Tocris Bioscience, Bristol, UK) was dissolved in 0.9 % saline to a 
concentration of 50 µg/ml and either injected systemically (50 mg/kg, i.p.) or 
iontophoretically into LC via the glass pipette attached to the recording electrode placed in 
LC using a custom-made current source. In order to prevent unwanted leakage of clonidine 
during LC targeting and baseline recording, a holding current of -40 nA was applied. To 
ensure extensive drug diffusion in the LC nucleus, a continuous current of +50 to +90 nA 
was applied for at least 20 minutes between onset of infusion and presentation of sensory 
stimuli. The activity of LC neurons was simultaneously monitored. The injection current 
was applied for the entire duration of the stimulation series and no spontaneous LC activity 
was observed during the drug injection period (30 - 45 min). In order to estimate the radius 
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of drug diffusion in LC, three-barrel recording/iontophoresis microelectrodes were glued to 
single tungsten electrodes (FHC Inc., Bowdoin, ME, USA). Three experiments were 
performed using different tip distances between the tungsten electrodes and the infusion 
barrels: 238 μm, 251 μm and 354 μm (Figure 2.1). The electrode-pair was implanted by 
targeting LC at least with the tip of the tungsten electrode. After successful placement, 
clonidine was iontophoretically injected with parameters described above and the firing 
frequency of LC neurons was recorded via the distant tungsten electrode in order to assess 
inhibition. 
 
 
Figure 2.1: Electrode configuration for 
electrophysiological monitoring of diffusion radius
of iontophoretically infused clonidine into LC. A 
standard tungsten microelectrode (1) was glued to 
a carbon-fiber microelectrode (2) attached to a 
barrel used for recording under simultaneous drug 
injection in LC. In this example, the tip of the 
tungsten electrode was 354 µm apart from the 
infusion site (3). 
 
In the majority of experiments (n = 14), the data was collected according to the following 
experimental design: 1) FS series before the drug manipulation (referred in text below as 
baseline condition); 2) FS series on the background of local clonidine injection (local 
clonidine); 3) FS series after termination of the iontophoretic drug injection and recovery of 
the LC spiking activity to the  baseline level (recovery); 4) another FS series under baseline 
condition; 5) systemic clonidine injection followed by the FS series repeated 4.2 ± 0.4 min, 
20.2 ± 0.5 min, 33.9 ± 0.6 min and 55.5 ± 0.7 min after injection (systemic clonidine). The 
start of the first FS series was dependent on the first period of complete inhibition of LC 
neuronal activity after systemic injection of clonidine. In the remaining 8 experiments the 
effects of either local (5 experiments) or systemic (3 experiments) clonidine injection were 
tested. 
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2.1.4. Data analysis  
All data analysis was performed using custom MATLAB functions (The MathWorks, 
Natick, MA, USA) unless otherwise stated. 
For extraction of SEP, the raw broad-band extracellular signal was resampled and low-pass 
filtered to < 300 Hz (Finite Impulse Response (FIR) digital filter) using Spike2 software. 
SEP was obtained by across trial averaging of the signal in the time-domain. 
For extraction of band-limited power (BLP), the broad-band extracellular signal was 
resampled at 300 Hz and band-pass filtered (butterworth Infinite Impulse Response digital 
filter) in seven non-overlapping frequency bands. The frequency distribution across the 
bands was adapted from what is classically used in human EEG29-34: SLO (0.1 – 1 Hz), 
Delta (1 – 4 Hz), Theta (5 – 8 Hz), Alpha (9 – 11 Hz), Sigma (12 – 15 Hz), Beta (16 – 
20 Hz) and Gamma (60 – 90 Hz). Rectification of the respective absolute values for each 
frequency band provided the BLP. The filtering method is described in detail elsewhere640. 
Composition of spectral power in response to electrical stimulation to FSs was analyzed by 
computing the change of BLP during 1 sec poststimulus period (postBLP) relative to BLP 
in 4 sec prestimulus period (preBLP) using the following formula: 
((postBLP - preBLP)/preBLP) x 100. 
For cortical single unit isolation, the signal was first high-pass filtered above 300 Hz and 
spike shapes, exceeding at least 2-fold the background activity were extracted. Next, the 
template matching algorithm complemented by manual cluster analysis based on principal 
components and on specific waveform measurements (amplitude, spike width, maximum 
slope, etc.) were applied using Spike2 software. The recording was classified as a single-
unit if a refractory period of at least 1 ms was present between two consecutive spikes. In 
cases when the recording quality and spike sorting method did not allow unambiguous 
single unit isolation, the recording was conservatively classified as multiunit activity 
(MUA). The cortical MUA data was excluded from further analysis. In LC, MUA was 
extracted from high-pass filtered signal (> 300 Hz) for exploration of neuronal activity. In 
case of systemic clonidine administration, the effects of clonidine on spontaneous neuronal 
discharge in LC was evaluated by extracting the firing rate over 60 sec before each FS 
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series and comparing it with the preinjection (baseline) activity level. Thereafter, the 
cortical effects were assessed by extraction of the firing rate over 60 sec before the FS 
series within the interval of maximum LC-inhibition (20.2 ± 0.5 min). The direction of 
firing rate modulation of each cortical neuron was determined by paired t-test between 
baseline and clonidine condition (average rate of 60 s spontaneous activity with 1 sec bin 
width). 
Based on previous studies, the population of single units in each cortical region was divided 
into putative interneurons and pyramidal neurons according to the duration of the 
afterhyperpolarization (AHP), spike width and peak-to-trough amplitude ratio. In nearly all 
cases, the waveform was initially negative-going. This negative voltage deflection was the 
maximum component of the waveform and it was assumed to be the inward sodium current 
of the action potential. After inversion of this waveform, the spike width was defined by the 
width between the peak and the following trough of the high-pass filtered signal641,642. The 
peak-to-trough ratio was computed out of the maximum amplitudes of the peak and the 
AHP643-645 and the duration of the AHP was defined by onset and end of AHP at resting 
potential. The distribution of all three parameters revealed two populations with a partition 
at duration of AHP of 0.87 ms, spike width of 0.56 ms and at peak-to-trough ratio of 3.95, 
respectively (Supplementary Figure 7.1). Neurons with spike width and AHP-duration 
exceeding the values at partition and neurons with peak-to-trough ratio below 4 were 
considered as putative pyramidal neurons and contributed to analysis. 
To characterize neuronal responses of S1HL and mPFC single units to FS, for each 
experimental condition the peristimulus time histograms (PSTH) of spike density converted 
into Z-Scores were plotted from -0.5 sec to +1.5 sec around stimulation onset with 10 ms 
bins smoothed by a Gaussian Filter with a filter width of 3 bins using NeuroExplorer 
software (Nex Technologies, Madison, AL, USA). A single unit was classified as 
responsive, if at least one bin during post-stimulus interval was below or above 95 % 
confidence interval. The response peak latency was calculated from the stimulus onset to 
the maximum amplitude of the PSTH during poststimulus interval. The bin size was still 
10 ms with exception of the latency for the early transient burst of the S1HL neurons which 
were extracted using 1 ms bin size. The duration of the response was defined between the 
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first and the last bin that exceeded threshold providing that the last bin was followed by at 
least 10 consecutive bins within the mean ± 2 SD boundary. The cortical neuronal 
responses were clustered according to the shape of the response profile using K-Means 
clustering algorithm. 
Due to complete absence of the LC spikes during pre-stimulus period in some experimental 
conditions, the LC firing rate was plotted in PSTH normalized by dividing each 10 ms-bin 
by the average baseline spontaneous activity in 0.5 sec pre-stimulus interval for each 
individual recording. For illustration all PSTH-series have been smoothed again using a 
moving average filter with a span of 3 bins. 
Magnitudes of SEPs or PSTHs of single unit responses to sensory stimulation were 
estimated as the integral of the area under or above the curve. Unless otherwise stated, the 
period for integration was generally defined as between response onset to offset, 
determined by exceeding 2 SD of baseline activity. 
2.1.5. Perfusion and histology. 
At the end of an experiment, the rat was euthanized with a lethal dose of sodium 
pentobarbital (100 mg/kg i.p.; Narcoren®, Merial GmbH, Germany) and perfused 
transcardially with 0.9 % saline followed by 4 % paraformaldehyde in 0.1 M phosphate 
buffer (PB, pH 7.4). The brain was removed and stored in the same fixative. Before 
sectioning, the whole brain was placed in 0.1 M PB containing 30 % sucrose until sinking. 
Serial 60 μm-thick coronal sections were then cut on a horizontal freezing microtome 
(Microm HM 440E, Walldorf, Germany) and collected in 0.1 M PB saline. After mounting 
and drying on glass microscope slides (Thermo Scientific Adhesion Slides SuperFrost® 
Plus), Nissl staining was performed on every other section following a standard procedure. 
Briefly, sections were defatted, stained with cresyl violet, rinsed with acetic acid, 
dehydrated and coverslipped (Depex Mounting Media, VWR International GmbH, 
Darmstadt, Germany). The sections in between were just coverslipped using 
polyvinylalcohol (Mowiol 4-88, Hoechst, Frankfurt, Germany) without previous staining. 
On these sections, the placement of silicone-based electrode arrays was visualized by 
preliminary coating of the back side of the shanks with fluorescent substance (DiI or DiO, 
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Life Technologies GmbH, Darmstadt, Germany) before tissue penetration. All cortical 
sections were examined using an AxioPhot or AxioImager microscope (Carl Zeiss, 
Goettingen, Germany). Nissl sections were examined under brightfield. Fluorescent 
sections were examined under epifluorescent illumination using custom-made sets of filters 
for Alexa Fluor® 546 (AHF, Tuebingen, Germany). 
2.1.6. Statistical analysis 
A significance level of 0.05 was applied for all statistical tests in this study which were 
computed in MATLAB. 
One-sample t-test against 0 was used when effects of drug condition on the population 
activity change within a cortical region was tested. Furthermore, this test was used to 
examine effective cortical state activation in response to sensory stimulation. 
Non-parametric Chi-square-test was performed to compare absolute numbers between 
conditions. If not otherwise stated, between-group comparison was performed using one- or 
n-way analysis of variance (ANOVA) followed by Bonferroni post-hoc multiple 
comparison. 
In order to evaluate which component of the single unit response profile was affected by 
drug manipulation, a pairwise comparison of each bin was applied in the post-stimulus 
period between 0 and 1.5 sec. The first and the last significantly modulated bin within this 
period provided the affected interval, which was then analyzed by two-way repeated 
measures ANOVA (condition x bins) followed by Bonferroni corrected multiple 
comparison analysis. 
2.2. Noradrenergic modulation of the midbrain dopaminergic system 
Fifteen male Sprague-Dawley rats (250 - 350 g) were used in this part of the study in which 
data was simultaneously recorded in LC and VTA. Stereotaxic coordinates for VTA 
recordings were AP = -5.3 mm from bregma, ML = 0.8 to 1 mm, DV = adjusted between 
8.0 to 9.0 dependent on signal quality637. 
Material and methods were used as described in section 2.1 except for the following 
changes: for extracellular MUA recording in VTA, a single-channel iridium microelectrode 
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(Neuronexus Technologies, Ann Arbor, Michigan) was used. Somatosensory stimulation 
was presented with parameters described in 2.1.2, except for the interstimulus interval 
which was randomized between 8 and 12 sec. Furthermore, the systemic injection of 
clonidine was spared and clonidine was only infused locally into LC with the parameters 
described above. 
2.3. Dopaminergic modulation of sensory gating 
2.3.1. Surgical procedures 
Thirteen male Sprague-Dawley rats (250 – 300 g at time of the surgery) were used in this 
study. Implantation of electrodes and cannulae was conducted under aseptic conditions and 
deep anesthesia with isoflurane. Anesthesia was initiated with isoflurane (4 %) in oxygen 
enriched air accumulating in an anesthesia box. Following loss of righting reflex, anesthesia 
was applied by using a nose cone and concentration was reduced to 1.5 to 2 %. Sufficient 
anesthesia was ensured throughout the experiment by monitoring withdrawal reflex in 
response to paw pinch. Rectal temperature, heart rate and SpO2 levels were monitored and 
kept constant throughout the experiment. Before placing the rat into a stereotactic frame 
(David Kopf Instruments, Tujunga, CA, USA), a xylocaine-gel (2 % Lidocaine-
hydrochloride; AstraZeneca, Wedel, Germany) was applied into the ear canal for analgesia. 
Three to five minutes later, each rat was fixed with the head angle adjusted at zero degrees 
in the horizontal plane. Before skin incision, anesthetic solution (1 % Lidocaine-
hydrochloride; AstraZeneca, Wedel, Germany) was injected at 4-5 different sites (0.01 to 
0.02 ml each) beneath the scalp. Three to five minutes later, the skull was surgically 
exposed and, after covering with lidocaine for further 3-5 min, small burr holes were drilled 
over the target brain regions. Great care was taken to avoid bleeding from cerebral arteries 
and veins throughout the surgical procedure. First, 3 anchor screws were fixed into the skull 
in addition to a grounding screw, which was placed into the parietal bone near lambda. For 
extracellular recordings in mPFC, a single tungsten electrode for chronic use (FHC Inc., 
Bowdoin, ME, USA) was aimed at the following stereotaxic coordinates: AP = +3.5 to 
+4.5 mm from bregma, ML = 0.5 mm, DV = 3.0 mm637. For drug infusion into the ventral 
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midbrain, bilateral stainless steel guide cannulae (PlasticsOne Inc., Minneapolis, MN) with 
diameter of 22 gauge were used. First, stylets were placed into the guides to prevent 
occlusion. After cutting small incisions into the dura, the bilateral cannulae were slowly 
placed at the stereotaxic coordinates AP = -5.3 mm from bregma, ML = 0.75 or 1.0 mm, 
DV 6.5 mm. The gaps between implants and skull were filled with grease and the implants 
were fixed to the skull with dental acrylic cement (PalaXpress ultra, Heraeus Kulzer 
GmbH, Hanau, Germany). The recording channel and the grounding screw were then 
soldered to a connector, which was in turn fixed to the rest of the implant by use of dental 
acrylic cement. Approximately 30 min before the end of the surgery, a cocktail containing 
analgesics (12.5 mg/kg Flunixine-Meglumin, MSD Tiergesundheit, Unterschleißheim, 
Germany) and antibiotics (5 mg/kg Baytril; Bayer AG, Leverkusen, Germany) was 
subcutaneously injected. This treatment was repeated on a daily basis for 5 days after 
surgery. 
2.3.2. Drug design 
The properties of receptor composition in VTA (Figure 2.2A) were exploited to achieve a 
target-specific pharmacological manipulation in the ventral midbrain. Specifically, in order 
to decrease general dopaminergic transmission, alpha 2-noradrenergic receptors were 
activated by local infusion of clonidine. Furthermore, infusion of κ-opioid agonist U69593 
and dopaminergic D2-receptor agonist quinpirole was used to selectively inhibit 
dopaminergic transmission to mPFC or non-PFC target structures, respectively. An 
overview of the individual effects is illustrated in Figure 2.2B. 
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Figure 2.2: Schematic illustration of receptor composition in dopaminergic neurons in the VTA 
exploited for target-specific dopaminergic manipulation. A) Two populations of dopamine (DA) 
releasing neurons in the VTA express different inhibitory receptors dependent on specific target 
regions. Additionally, both populations carry alpha 2-noradrenergic receptors. B) Drug effects induced 
by activation of specific inhibitory receptors in VTA: Infusion of alpha 2-noradrenergic agonist 
clonidine reduces dopaminergic transmission to all VTA target regions, infusion of κ-opioid receptor 
Agonist U69593 inhibits dopaminergic transmission specifically to prefrontal cortex (PFC) and infusion 
of dopaminergic D2-receptor agonist inhibits release of DA in target areas other than PFC. 
NAc = Nucleus Accumbens, HPC = Hippocampus. 
 
2.3.3. Drugs 
All drugs were purchased from Sigma Aldrich Chemie GmbH, Taufkirchen, Germany. 
Clonidine chloride was dissolved in 0.9 % saline to a concentration of 50 µg/ml It was 
shown to reliably inhibit neuronal activity of noradrenergic neurons in LC (see section 
3.1.2). Concentrations of U69593 and quinpirole were chosen according to reported 
behavioral modulation after local infusion into the VTA. U69593 was dissolved in 12 % 
aqueous propylene glycol to a concentration of 0.3 mg/ml646 and Quinpirole hydrochloride 
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was dissolved in 0.9 % saline to a concentration of 2 mg/ml647,648. Drug solutions were 
prepared weekly under aseptic conditions and stored at +7 °C. 
2.3.4. Drug infusion 
Three sessions were recorded under each drug condition. Distribution of the drugs over the 
9 sessions was randomly determined. Control sessions after saline infusion were performed 
in between, so that each session under drug condition has a corresponding saline control 
session. By this design, each rat underwent 18 sessions (9 x saline, 3 x clonidine, 3 x 
U69593 and 3 x quinpirole). 
For drug infusion, stylets were replaced by sterile stainless steel infusion cannulae 
(28 gauge), which were 2 mm longer than the guide cannulae, reaching a final depth of 
8.5 mm. The infusion cannulae were connected to two 2 – 5 µl Hamilton syringes by 
polyethylene tubing (ID 0.58 mm). By aid of a microdrive infusion pump (UMP3 Ultra 
micro pump, World Precision Instruments, Sarasota, FL, USA) 0.5 µl of the drug was 
infused into each hemisphere at a rate of 200 nl per minute. Rate and volume were 
computed such that tissue damage was prevented649-651 and a final drug diffusion of 
approximately 1 – 1.5 mm diameter was reached652. During the infusion the freely moving 
rat was placed in a small box (25 x 15 x 15 cm). After end of the infusion the cannulae 
were left in place for 60 sec to allow diffusion of the drug into the tissue. Thereafter, the 
cannulae were replaced with the stylets and the rat was placed into the behavioral box for 
testing. 
2.3.5. Behavioral testing 
One week after surgery the rats were tested simultaneously on two standard sensory gating 
paradigms in the same session: PPI and ASG. Feasibility of simultaneous assessment of 
both paradigms was confirmed before653. Rats were placed non-restricted in a box made of 
transparent plastic (25 x 15 x 15 cm) inside a custom-made chamber (30 cm x 20 cm x 
40 cm) consisting of three non-transparent walls and a front one made of plexiglas. The 
plastic box had two mesh-covered holes directed to the sides of the chamber where, in a 
distance of 3 cm, a speaker was mounted on each side. In addition, a custom-built 
42 
 
piezoelectric accelerometer was located under the floor for movement detection of the 
animal. 
Speakers and piezoelectric sensors were connected to a computer which automatically 
presented the stimuli and recorded the outcome by use of custom-written functions in 
Spike2 data acquisition software (Cambridge Electronic Design, Cambridge, UK). During 
the entire session a continuous white background noise of 50 dB was presented. After a 
short acclimatization period of 60 sec, sensory stimulation started on top of the background 
noise. Four different types of acoustic stimuli were randomly presented with variable inter-
stimulus interval of 15 – 20 sec. Three of them, namely acoustic startle stimulus (broad 
band noise, 20 ms, 100 dB), acoustic prepulse stimulus (10 kHz, 20 ms, 75 dB) and 
acoustic prepulse stimulus presented 100 ms prior to the startle stimulus, belong to the PPI-
paradigm (n = 50 each). The magnitude of the ASR was detected by the piezoelectric 
sensors in the floor and digitized at 1 kHz. The last stimulus type, 2 clicks presented 
500 ms apart from each other (parameters identical to acoustic prepulse stimulus, n = 100), 
belongs to the ASG paradigm in which no behavioral outcome is expected. 
During the sessions, the local field potential in mPFC was continuously monitored. After 
preamplification (x 25) using a custom-made preamplifier, the band-passed signal (1 Hz – 
1 kHz) was amplified (x 1k) using an Alfa Omega multi-channel processor (MPC Plus, 
Alpha Omega Co., Alpharetta, GA, USA). The signal was digitized at 1 kHz using CED 
Power1401mkII converter and Spike2 data acquisition software. 
To familiarize the animal with experimental conditions, each rat underwent the first session 
without any drug infusion. 
2.3.6. Perfusion and histology. 
At the end of experiment, the rat was euthanized, transcardially perfused and histology was 
performed as described in section 2.1.5, except that Nissl staining was performed on every 
section. The placement of the tungsten microelectrode and cannulae were examined under 
brightfield by using an AxioPhot or AxioImager microscope (Carl Zeiss, Goettingen, 
Germany). 
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2.3.7. Data analysis  
After data acquisition, both the converted signal of the movement and local field potential 
recorded in mPFC were down-sampled and filtered to < 100 Hz (FIR digital filter) by using 
custom Spike2-functions. Obvious artifacts created by excessive movements of the animal 
were removed from recording (Supplementary Figure 7.2). 
All further data analysis was performed using custom MATLAB functions (The 
MathWorks, Natick, MA). Due to variable delays between trigger and sensory stimulation, 
created by switching between recording and stimulus presentation in the Spike2 software, 
the minimum amplitudes of the voltage deflection of negative-going SEP and ASR during 
500 ms after trigger position were aligned to zero before averaging the signal across trials 
in the time domain. 
2.3.8. Statistical analysis 
A significance level of 0.05 was applied for all statistical tests in this study. All statistics 
was computed in MATLAB. 
Degree of sensory gating was analyzed as percentage of PPI or ASG by using the following 
formula: %PPI/ASG = 100 – ((response amplitude to prepulse followed by startle 
stimulus/response amplitude to startle stimuli alone) x 100). Grand average of %PPI and 
%ASG as well as grand average of maximum amplitudes of SEP and ASR over all sessions 
was compared between different stimuli and between conditions by using one-way 
ANOVA followed by Bonferroni post-hoc multiple comparison analysis. Data of the first 
session without any saline or drug infusion was discarded. 
3. Results 
The basic question of this study is how the catecholaminergic neuromodulators NE and DA 
affect sensory processing in the cortex. To answer this question, first, the differences 
between sensory processing in two functionally distinct cortical regions were examined. 
Afterwards, the role of NE in neuromodulation of the cortical neuronal activity during 
sensory processing was explored by pharmacological manipulation of the noradrenergic 
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system. Furthermore, by exploration of the noradrenergic modulation of the VTA-DA 
system, the synergistic effects of catecholaminergic neuromodulation of neuronal activity 
in the medial prefrontal cortex was examined. Finally, the role of DA in the modulation of 
neuronal and behavioral sensory gating effects was studied by target-specific dopaminergic 
manipulation of the midbrain dopaminergic system. While the first two studies were 
performed in urethane anesthetized rats, the last study was conducted in awake animals. 
3.1. Noradrenergic modulation of sensory processing in two functionally distinct 
cortical regions 
Neuronal activities during sensory processing in different brain regions have been 
extensively studied (see Introduction for detail), however, direct comparison to the 
literature is difficult because of the use of different methods related to specific rationales. 
Therefore, functional differences in neuronal processing of sensory-evoked responses were 
first characterized and compared between two functionally different brain regions. The 
S1HL and the PrL subdivision of the mPFC were chosen as representatives for a primary 
sensory and a higher association cortical area. Direct comparison requires identical 
experimental conditions, which was achieved by simultaneous recordings in S1HL and 
mPFC during experiments in 30 urethane anesthetized rats. Additionally, neuronal activity 
in LC was recorded to monitor the activity state of the noradrenergic system. 
Histological examination confirmed that the neuronal activity of all three target structures 
was simultaneously recorded in 8 rats. In additional 20 rats the simultaneous recordings 
were obtained from two out of three structures and in another two cases only data from LC 
recordings contributed to analysis (Table 3.1). 
Table 3.1: Number of simultaneous recorded structure combinations out of 30 anesthetized rats. 
Structure combinations 
LC 
S1HL 
mPFC 
LC 
mPFC 
LC 
S1HL 
S1HL 
mPFC 
LC 
Number of recordings 8 13 4 3 2 
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Most of the recordings in S1HL were performed in deeper cortical layers (> 1 mm depth,  
 
Figure 3.1A) while in mPFC the electrode positions were distributed over all layers in the PrL 
subregion ( 
 
Figure 3.1B). 
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Figure 3.1: Coronal schematic views showing the 
electrode positions under local infusion into LC 
(red), systemic injection (green) or local followed by 
systemic injection of clonidine (blue) in A) S1HL 
and B) prelimbic subregion of PFC (PrL) in 
urethane anesthetized rats. Numbers illustrate 
distance from bregma in mm for each section. 
Respective insets illustrate the antero-posterior 
extent of recording sites by aid of color coded bars 
in a sagittal plane of the brain. Top numbers 
indicate distance from bregma, bottom numbers
distance from interaural line and vertical numbers 
depth in mm, respectively. 
 
From these locations in the cortex, neuronal activity was recorded by using a Low Pass 
Filter with a cut off frequency set to 8 kHz, which enabled acquisition of both LFP and 
underlying SUA. Inspection of the extracellular voltage-traces, after repeated off-line low-
pass filtering (0.1 – 300 Hz), confirmed spontaneous alternations of the LFP between 
activated and deactivated state under urethane anesthesia (Figure 3.2) as has been already 
reported before66,654-657. 
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Figure 3.2: Spontaneous alternation of cortical oscillatory activity between different brain states under 
urethane anesthesia. A) Representative examples of extracellular voltage traces (0.1 - 300 Hz) 
continuously recorded in S1HL (left) and mPFC (right). Approximately at 100 sec, the brain state 
switches from activated state to lower frequency oscillations with higher amplitude. Figures below 
illustrate magnifications during 3 sec in S1HL and 9 sec in mPFC showing different brain states out of 
the continuously recorded voltage trace above. B) Corresponding spectrograms of the low-frequency 
(0.1 - 4 Hz) range. Note the power increase in the low-frequencies of LFPs at approximately 100 sec in 
both cortical areas. 
 
In order to gain statistical power for further LFP analyses under this condition of variable 
cortical state activity, each period of baseline condition before local and systemic injection 
of clonidine was treated as individual case, regardless of whether these recordings were 
obtained from the same rat. By this, out of 30 rats, 23 recordings of ongoing brain activity 
were obtained from S1HL and 41 from mPFC (Table 3.2). A detailed description about the 
structural distribution of simultaneous recordings over all rats, analogous to Table 3.1 is 
provided in section 3.1.2. 
Table 3.2: Number of recordings of ongoing cortical state activity during the period before local and 
systemic injection of clonidine in both cortical structures 
 mPFC S1HL 
Systemic clonidine 20 12 
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Local clonidine 21 11 
Total 41 23 
 
3.1.1. Direct comparison of ongoing neuronal activity in S1HL and mPFC 
For a detailed comparison of the oscillation properties between S1HL and mPFC, the LFP 
was decomposed into 7 classically defined non-overlapping frequency bands29,31,35: SLO 
(0.1 – 1 Hz), Delta (1 – 4 Hz), Theta (5 – 8 Hz), Alpha (9 – 11 Hz), Sigma (12 – 15 Hz), 
Beta (16 – 20 Hz) and Gamma (60 – 90 Hz). As expected, BLP analysis of these frequency 
bands revealed the highest power in low frequency bands in both cortical regions (Figure 
3.3, Supplementary Table 7.1). Following one-way ANOVA with the 7 different frequency 
bands as factors, multiple comparison revealed significantly higher power in SLO and 
Delta frequency bands compared to higher frequency bands from Alpha upwards (S1HL: 
F(6, 154) = 69.21, p < 0.001; mPFC: F(6, 280) = 68.95, p < 0.001). 
Between group comparison of individual BLP in cortical structures showed that BLP in 
medial frequency bands from Theta to Beta range was higher in S1HL compared to mPFC 
(SLO: F(1, 62) = 0.23, p = n.s., Delta: F(1, 62) = 0.00, p = n.s., Theta: F(1, 62) = 8.96, 
p < 0.01, Alpha: F(1, 62) = 7.9, p < 0.01, Sigma: F(1, 62) = 5.09, p < 0.05, Beta: 
F(1, 62) = 4.2, p < 0.05, Gamma: F(1, 62) = 2.74, p = n.s.). This increased synchrony in 
medial frequency bands in S1HL was accompanied by higher underlying single unit 
spontaneous activity (F(1, 202) = 9.84, p < 0.01) of 3.15 ± 0.31 spikes/sec compared to 
1.99 ± 0.22 spikes/sec in mPFC. 
Despite of the differences between neuronal activities in the cortical regions, correlation 
analysis of simultaneous recorded cases only, revealed that the BLP in each frequency band 
correlated positively between the two cortical regions with maximum correlation 
coefficients in Theta and Alpha frequency bands (Table 3.3). 
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Figure 3.3: Average power source density 
(PSD) in the analyzed frequency bands during 
the 4 sec before stimulus-presentation (pre) in 
S1HL and mPFC. Mean ± SE, * p < 0.05; 
** p < 0.01. 
 
Table 3.3: Summary of correlation analysis of 
prestimulus BLP between simultaneously recorded 
S1HL and mPFC in each analyzed frequency band.
Note the maximum correlation coefficient in Theta 
and Alpha frequency bands. 
 Pearsons’s Correlation 
pre SLO r = 0.62, n = 16, p < 0.05 
pre Delta r = 0.51, n = 16, p < 0.05 
pre Theta r = 0.74, n = 16, p < 0.01 
pre Alpha r = 0.73, n = 16, p < 0.01 
pre Sigma r = 0.62, n = 16, p < 0.05 
pre Beta r = 0.53, n = 16, p < 0.05 
pre Gamma r = 0.55, n = 16, p < 0.05 
 
 
In brief, although the LFP spontaneously alternates between activated and deactivated state 
under urethane anesthesia, power in low frequency bands dominates the spectrum as 
commonly reported for brain state under anesthesia658-660. Synchrony in medial frequency 
range as well as associated single unit firing activity was higher in S1HL compared to 
mPFC, indicating a higher activity state. Nevertheless, it still appeared that mPFC and 
S1HL interact with each other especially in the Theta and Alpha frequency band. 
3.1.2. Noradrenergic modulation of spontaneous neuronal activity in S1HL 
and mPFC 
The role of the LC NE system in modulation of neuronal activity in two functionally distinct cortical 
regions was studied by using two pharmacological manipulation techniques: 1) global activation of 
alpha 2-adrenoceptors by systemic bolus injection of alpha 2-adrenergic agonist, clonidine (50 μg/kg, 
i.p.) or 2) constant local infusion of clonidine (50µg/ml, current +50nA to 90nA, for 20 min) into LC. 
The radius of clonidine diffusion was tested by pairing the infusion pipette with a tungsten electrode 
using different distances between the tips. Infusion of clonidine resulted in complete cessation of LC-
firing ( 
Figure 3.4A) 238 μm, 251 μm and 354 μm apart from the infusion site. The duration between infusion 
onset and inhibition of LC neurons increased linearly with the distance between the tips ( 
Figure 3.4B; r = 0.94). 
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Figure 3.4: Electrophysiological monitoring of 
diffusion radius of iontophoretically infused 
clonidine into LC. A) Raw high-passed (300Hz – 
8kHz) extracellular signal recorded in LC with the 
tungsten electrode 354 µm apart from the infusion 
site. Gray area indicates the period of 
iontophoretic infusion of clonidine into LC 
(50 µg/ml, +40 nA to +60 nA, for 20 min), which 
induced complete cessation of neuronal activity. 
Note the artefacts created by the switch to start 
(ON) and stop (OFF) of the infusion. For 
illustration purpose, the period of maximum 
inhibition of neuronal activity in LC was 
shortened (gap). B) Duration between start of the 
infusion of clonidine and maximum inhibition of 
LC-activity recorded by distant tungsten 
electrodes paired to recording/iontophoresis 
microelectrodes. Note the increased duration to 
inhibition dependent on the distance between the 
recording tip and the infusion site. 
 
 
MUA-recording in LC was achieved in 27 out of 30 experiments, out of which monitoring 
of LC activity under pharmacological manipulation was performed in 25 and 15 recordings 
after intra-LC and systemic administration of clonidine, respectively. Previous studies show 
that either method of clonidine administration is expected to inhibit activity of 
noradrenergic neurons in LC205,262,266,267. Therefore, cases were excluded if the 
simultaneously monitored neuronal spontaneous activity in LC was not inhibited. Table 3.4 
provides a detailed overview about the simultaneously recorded structure combinations for 
each experimental manipulation. 
Table 3.4: Number of simultaneous recorded structure combinations under each experimental 
manipulation. 
Structure combinations 
LC 
S1HL 
mPFC 
LC 
mPFC 
LC 
S1HL 
S1HL 
mPFC 
LC 
Systemic 7 3 3 2 2 
51 
 
Local 8 13 3 1 1 
 
While both manipulations deplete the brain from NE132,263-266,269-271 by acting on the 
presynaptic noradrenergic autoreceptors in LC terminals or on somatodendritic 
autoreceptors in LC itself, the systemic injection of clonidine affects additionally 
noradrenergic heteroceptors on postsynaptic cells in LC terminal regions. 
Analysis of the recorded temporal dynamics of LC activity after clonidine administration 
showed that, in agreement with previous reports, systemic clonidine injection resulted in a 
sustained decrease of LC activity (Figure 3.5A). The onset of LC inhibition was typically 
observed after 283.8 ± 30.8 sec. The LC firing reached minimum (71.5 ± 5.4 % change) at 
16.43 ± 0.78 min post-injection (n = 15). One-way ANOVA with repeated measures on 
time confirmed that the clonidine-induced decrease of LC firing was significant compared 
to pre-injection LC activity (F(2.46, 46.74) = 8.545, p < 0.001). Injection of clonidine 
locally into LC resulted in complete cessation of the LC firing that was observed 
376.6 ± 22.8 sec (n = 25) after onset of injection current (Figure 3.5B). The LC inhibition 
lasted as long as the current was passing through the pipette. The firing rate recovered to 
the baseline level 428.9 ± 21.3 sec after termination of clonidine injection. 
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Figure 3.5: The effect of clonidine administration on spontaneous neural activity in LC. A) Prolonged 
decrease of LC firing rate following systemic clonidine administration (0.05 mg/kg, i.p.). Average 
baseline change is plotted for different post-injection times (n = 15 LC MUA recordings). Mean ± SE, 
*** p < 0.001, ** p < 0.01 (one-sample t-test). B) Representative example of a raw extracellular signal 
recorded in LC illustrating complete cessation of LC discharge after local infusion of clonidine into the 
nucleus. Conventions are the same shown in  
Figure 3.4A. 
 
Commonly, NE activates the cortical activity state178-182 and, accordingly, inhibition of LC-
activity or systemic treatment using noradrenergic alpha 2-receptor agonists resulted in 
deactivation183-186. However, how the noradrenergic system modulates power in specific 
frequency bands in primary sensory or medial prefrontal cortical regions is rarely studied. 
Comparison of modulation after systemic and intra-LC clonidine injection between the 
denoted frequency bands revealed different effects on resting state brain activity dependent 
on cortical region and type of manipulation. In S1HL, systemic clonidine injection 
increased BLP in medial frequency bands (Figure 3.6; Theta: t(11) = 3.09, p = 0.01, Alpha: 
t(11) = 5.45, p < 0.001, Sigma: t(11) = 5.59, p < 0.01, Beta: t(11) = 5.70, p < 0.01) while 
local inhibition of LC activity increased BLP in high frequency bands (Sigma: t(10) = 2.91, 
p < 0.05, Beta: t(10) = 3.11, p < 0.05, Gamma: t(10) = 3.44, p < 0.01). Both drug conditions 
induced the strongest effect in Sigma frequency band but did not affect frequency range 
below 4 Hz. 
In mPFC, local inhibition of LC activity did not modulate power in any frequency band. 
However, global activation of alpha 2-adrenoceptors increased BLP in Theta (t(19) = 2.97, 
p < 0.01) and Alpha (t(19) = 2.96, p < 0.05) frequency band and, unexpectedly, decreased 
BLP in SLO frequency band (t(19) = - 2.47, p < 0.05), the latter indicating activation of the 
cortical activity state while power change in S1HL indicates deactivation of the cortical 
state. Respective percentages of average change are provided in Supplementary Table 7.2. 
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Figure 3.6: Noradrenergic modulation of ongoing cortical state in S1HL (cyan) and mPFC (blue) after 
systemic (left) and intra-LC (right) injection of clonidine. Illustrated is the average baseline change of 
the band-limited power (BLP) in the analyzed frequency bands during 4 sec before stimulus-
presentation. Mean ± SE, one-sample t-test: *** p < 0.001, ** p < 0.01, * p < 0.05. 
 
Cortical unit activity is classically reported to be under inhibitory control by NE in 
S1HL228,229,240,661-663 and PFC227,245,247,252. However, increased spontaneous activity was 
also reported in a minority of neurons in PFC252. Inhibitory control by NE is believed to be 
exerted by activation of alpha 2-adrenoceptors249,253,664 but systemic administration of alpha 
2-noradrenergic agonists is also able to increase firing rate of PFC neurons233. Nevertheless, 
since only a minority of PFC neurons was reported to increase neuronal activity in response 
to alpha 2-adrenoceptor activation, on the population level both local inhibition of LC 
activity as well as systemic injection of clonidine are expected to disinhibit single unit 
spontaneous activity in mPFC and S1HL. 
Unit isolation by using electrodes with tetrode configuration provided, in total, 70 and 134 
regular spiking units in S1HL and mPFC, respectively, which satisfied the criteria for a 
single unit (see section 2.1.4 for detail). Remaining recordings were excluded from further 
analysis because either SNR was not sufficient for isolating single units and therefore these 
recordings were treated as MUA (178 in S1HL and 170 in mPFC) or extracted single units 
were classified as putative interneurons (27 units in S1HL an 17 units in mPFC). 
Comparison of the activity of regular spiking single units under condition of noradrenergic 
manipulation revealed differential effects on the firing activity of cortical single units 
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dependent on cortical structure. Table 3.5 summarizes the number and proportion of single 
unit subpopulations differentially modulated during the period of maximal LC inhibition. 
The majority of cortical neurons did not significantly change their spontaneous firing rate 
following clonidine administration, while the firing rate in different proportions of neurons 
in each cortical region was bidirectionally modulated. 
Table 3.5: Number and percentage of populations of cortical neurons dependent on the direction of 
spontaneous activity modulation following local and systemic clonidine administration. 
Direction of modulation 
S1HL mPFC 
systemic local systemic local 
n (%) n (%) n (%) n (%) 
increase 17 (42.5) 15 (31.9) 10 (15.9) 9 (14.1) 
decrease 4 (10) 12 (25.5) 19 (30.2) 9 (14.1) 
unchanged 19 (47.5) 20 (42.6) 34 (54.0) 46 (71.9) 
 
In S1HL, units which increased their firing rate dominated those which decreased activity, 
leading to increased population activity of 94.42 ± 35.83 % and 90.48 ± 36.41 % change 
after systemic (t(39) = 2.64, p < 0.05) and local (t(47) = 2.49, p < 0.05) injection, 
respectively (Figure 3.7). The magnitude of this activation was independent from 
pharmacological method (t(86) = -0.08, n.s.). In mPFC, neither manipulation method 
significantly affected the population SUA (Local: + 13.13 ± 7.88 spikes/sec, t(63) = 1.67, 
n.s.; Systemic: - 14.38 ± 11.21 spikes/sec, t(62) = -1.28, n.s.). This was the case, because, 
compared to S1HL, substantially fewer neurons were affected showing a comparable 
modulation of spontaneous firing rate in both directions. Average baseline change in firing 
rate under drug condition for each population individually is summarized in Supplementary 
Table 7.3. 
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To summarize the effect of NE on cortical 
spontaneous activity, first, either 
pharmacological treatment increased BLP in 
medial to high frequency range with 
maximum effect in Sigma frequency band in 
S1HL. Ongoing BLP in mPFC was only 
modulated after systemic activation of 
alpha 2-adrenoceptors showing an increase in 
Theta and Alpha frequency band while BLP in 
SLO frequency band was surprisingly 
decreased demonstrating activation of cortical 
activity state. 
The underlying population single unit activity 
in S1HL was expectedly disinhibited after either manipulation. A similar effect was also 
assumed for population SUA in mPFC. However, a majority of units were not modulated at 
all and remaining neurons exhibited disinhibition as well as inhibition resulting in a non-
modulated population unit activity. 
3.1.3. Comparison of sensory-evoked neuronal responses in S1HL and mPFC 
3.1.3.1. Examination of effective stimulation parameters 
Following the examination of the noradrenergic modulation of region-specific spontaneous 
neuronal activity, the next question to solve was how sensory processing in both cortical 
regions was modulated by the LC noradrenergic system. In order to answer this question, 
the neuronal response to sensory stimulation was first characterized and compared between 
S1HL and mPFC without any pharmacological manipulation. 
In the beginning, different stimulation protocols were tested in order to ensure reliable 
sensory-evoked modulation of neuronal activity in all three recorded brain regions. 
Frequency coding was tested by using different stimulation frequencies at the same 
 
Figure 3.7: The effect of clonidine 
administration on spontaneous neural activity 
in S1HL (cyan) and mPFC (blue). Bars 
represent the average SUA firing rate change 
after systemic (left panel) and iontophoretic 
(right panel) clonidine administration.  
Mean ± SE, one-sample t-test: * p < 0.05. 
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amplitude of 5 mA: single pulse (SP) and train of pulses (TR). Intensity coding was tested 
by using TR with different amplitudes (1, 2, 3, 4 or 5 mA). 
Frequency coding stimulation protocol was performed in 16 rats. While MUA was 
analyzed in LC (n = 14), single units were extracted from S1HL (n = 39) and mPFC 
(n = 46). Amplitude coding stimulation protocol was performed in another set of 
experiments designed for a project focused on prefrontal neuronal activity and less specific 
to primary sensory areas. Therefore, only 4 rats with recordings in S1HL (n = 13 SUA) but 
16 rats with recordings in mPFC (n = 67 SUA) were subjected to this stimulation protocol. 
Out of these experiments, 14 MUA recordings from LC contributed to analysis. Table 3.6 
summarizes the number of simultaneous recorded structure combinations for each 
stimulation protocol analogous to Table 3.1. 
Table 3.6: Number of simultaneous recorded structure combinations using frequency and amplitude 
coding stimulation protocols. 
Structure combinations 
LC 
S1HL 
mPFC 
LC 
mPFC 
LC 
S1HL 
S1HL 
mPFC 
LC 
Frequency coding 6 6 0 2 2 
Amplitude coding 2 12 0 2 0 
 
Comparison of maximum amplitudes of sensory-evoked responses (Supplementary Table 
7.4) showed that sensory stimulation with high stimulation amplitude of 5 mA evoked 
reliable excitation in LC-MUA and S1HL-SUA independent from stimulation using SP or 
TR (LC-MUA: F(1, 27) = 0.82, p = n.s.; S1HL-SUA: F(1, 27) = 0.82, p = n.s.). Single units 
in mPFC were less sensitive showing significantly higher firing amplitudes in response to 
FSs using TR stimulation compared to SP (Figure 3.8, F(1, 91) = 8.61, p < 0.01). 
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Figure 3.8: The effect of increasing stimulus frequency under constant stimulus strength (5 mA) on 
average maximum neuronal response amplitudes to sensory stimulation in LC (MUA), S1HL and 
mPFC (both SUA). Mean ± SE, *** p < 0.001, * p < 0.05. 
 
Reduced sensitivity of mPFC neurons was confirmed when maximum response amplitudes 
were compared after stimulation with different magnitudes. Repeated measures ANOVA 
with increasing stimulation current as factors indicated that neurons in all three recorded 
structures were modulated dependent on stimulation magnitude (Figure 3.9; LC: 
F(4, 52) = 3.53, p < 0.05, S1HL: F(4, 48) = 12.28, p < 0.001 and mPFC: F(4, 264) = 5.14, 
p < 0.001). 
 
 
Figure 3.9: The effect of increasing stimulus strength on average amplitudes of neuronal responses to 
sensory stimulation in LC (MUA), S1HL and mPFC (both SUA). Note the sequentially increasing 
response amplitudes in LC and mPFC in contrast to neuronal activity in S1HL. Mean ± SE, 
*** p < 0.001, * p < 0.05. 
 
58 
 
After post-hoc multiple comparison analysis, it became apparent that maximum response 
amplitudes in S1HL did not comply with increasing stimulation magnitude but the response 
amplitude to stimulation using a current of 1 mA was significantly higher than to other 
stimulation currents. In contrast, neuronal activity in LC and mPFC showed incrementally 
higher response amplitudes with increasing stimulation currents. The average response 
amplitudes to each stimulation parameter are listed in Supplementary Table 7.5. 
In conclusion, reliable sensory-evoked responses in LC neurons of rats under urethane 
anesthesia were only evoked with very strong, potentially noxious sensory stimulation, 
which is in accordance with the literature125,129,262,665,666. This turned out to be true also for 
mPFC sensory-evoked neuronal activity while neurons in S1HL were reliably activated in 
response to electrical FS stimulation of all parameters tested here. In order to compare, how 
the LC NE system affects sensory processing in distinct brain structures, reliable sensory-
evoked responses had to be ensured and, thus, further experiments were conducted using 
TR stimulation with stimulation currents of 5 mA. 
3.1.3.2. Characterization of cortical state activation in response to 
somatosensory stimulation in S1HL and mPFC 
Inspection of the low-passed (0.1 – 300 Hz) extracellular voltage-traces revealed, already 
described transient cortical activation (TCA) in response to effective somatosensory 
stimulation53,667-672. TCA was characterized by a shift from high amplitude-low frequency 
to low amplitude-high frequency oscillations in both S1HL and mPFC (Figure 3.10A). 
Analysis of the LFP power spectrum confirmed a decrease of power in low frequency range 
(Figure 3.10B top) and an increase of power in high frequency range (Figure 3.10B bottom) 
immediately following the stimulus presentation. 
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Figure 3.10: Somatosensory stimulation induces transient cortical activation (TCA) under urethane 
anesthesia. A) Representative examples of the extracellular voltage traces (0.1 - 300 Hz) recorded in 
S1HL (left) and mPFC (right). Red dashed lines illustrate stimulus-onset. B) Corresponding 
spectrograms of the low-frequency (0.5 - 11.5 Hz, top row) and high-frequency (60 - 120 Hz, bottom 
row) ranges. Note, the foot-shocks (FSs) produced a power decrease in the low-frequencies and power 
increase in the high-frequencies of LFPs in both cortical areas.  
 
Changes in the power spectrum during 1 second after stimulus-presentation were analyzed 
in greater detail by decomposition of the LFP in the aforementioned frequency bands. 
However, since one cycle in SLO frequency band is longer than the analyzed one second, 
this frequency band was excluded from post-stimulus BLP analysis. Representative 
examples of post-stimulus BLP changes in S1HL and mPFC (Figure 3.11) confirmed a 
decrease of BLP in low frequency range along with increased power in Gamma frequency 
band which were most prominent during 1 sec after stimulus onset. 
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Figure 3.11: Representative examples of the stimulus-induced power modulation over time in different 
frequency bands. Stimulus-onset is illustrated by red dashed lines. Dots illustrate each individual FS in 
a train of five pulses (0.5 ms, 5 mA). Bin size = 4 ms.  
 
Because of the variable ongoing cortical activity state under urethane anesthesia, the 
stimulus-induced BLP change was further analyzed relative to the prestimulus period. 
Effective stimulus-related TCA was only considered when one-sample t-test of post-
stimulus BLP change over FSs (n = 25) confirmed a significant decrease in Delta frequency 
band accompanied by a significant increase in Gamma frequency band. Overall, 91.3 % of 
the S1HL recordings (21/23) and 46.3 % of the mPFC recordings (19/41) were classified as 
effectively activated which is henceforth referred to as “TCA+”. Accordingly, the contrary 
group of non-significant cases will be referred to as “TCA-“. Figure 3.12 shows group 
averages of the stimulus-induced BLP change for all TCA+ and TCA- cases in S1HL and 
mPFC. One-sample t-test over cases in the TCA+ group confirmed that the post-stimulus 
BLP change in the Delta and Gamma power was statistically significant in both cortical 
regions (Delta: t(20) = -4.9, p < 0.001 and t(18) = -12.4, p < 0.001; Gamma: t(20) = 8.3, 
p < 0.001 and t(18) = 7.5, p < 0.001 for S1HL and mPFC, respectively). 
TCA- cases in S1HL were assigned as such because decrease in Delta frequency band was 
not significantly different from zero. However, since significant increase in Gamma 
frequency band still indicated cortical activation and the number of TCA- cases was 
negligible in S1HL, all cases in S1HL were pooled and considered as TCA+. 
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Figure 3.12: The TCA in S1HL and mPFC illustrated in BLP change during 1 sec post-stimulus 
interval averaged over 25 repetitions. The vast majority of S1HL cases were classified as effectively 
activated in response to FSs (TCA+) while in mPFC the number of TCA+ cases was comparable to non-
effective cases (TCA-). Mean ± SE, * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
To assess functional differences in stimulus-induced cortical state activation between S1HL 
and mPFC, a two-way ANOVA (frequency bands × structure) between TCA+ cases was 
subsequently performed. It revealed a significant difference in spectral composition 
(F(5,190) = 105.65, p < 0.001) between the two cortical regions (F(1,190) = 14.05, 
p < 0.001). Multiple-comparison analysis showed a weaker decrease of BLP in Delta 
frequency band and stronger increase of power in high frequency range in S1HL compared 
to mPFC (Figure 3.13, Supplementary Table 7.6) indicating a stronger activation of 
neuronal activity in S1HL. 
In addition, the frequency band which did not change the BLP in response to stimulation 
and, thus, built the intersection between decreasing and increasing frequency bands, was 
different between the two cortical regions: in S1HL, the intersection was located in the 
Alpha frequency band (one-sample t-test: t(20) = -0.75, p = n.s.) while in mPFC, it was 
located in the Sigma frequency band (t(18) = 0.09, p = n.s.). Thus, the frequency range of 
increasing BLP was extended to more medial frequency range in S1HL. 
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In summary, electrical FS stimulation evoked 
TCA in both cortical regions which was 
characterized by a region-specific change in 
the power spectrum in response to sensory 
stimulation of the same intensity. 
Specifically, in S1HL, a cortical target of the 
feed-forward somatosensory pathway, the 
stimulus-induced activation was very robust 
and present in nearly all recordings. In the 
associative mPFC, a cortical target of 
multiple pathways related to different 
operations, the change of cortical activity 
state was detected only in about half of the 
cases showing a weaker extent compared to 
S1HL. In brief, sensory stimulation evoked a 
higher cortical activity state in S1HL in agreement with its function in processing of 
somatosensory stimulation. 
3.1.3.3. Understanding the difference between effective and non-effective 
sensory stimulation in mPFC 
While nearly all recorded cases in S1HL were successfully activated in response to FSs, the 
responsiveness in mPFC was reduced to about half of the cases. Previous literature suggests 
that modulation of neuronal activity by sensory stimulation is dependent on cortical layer673 
or dynamics of ongoing activity73,673-679 in the neocortex. 
Therefore, it was first explored, whether the potential to induce a TCA in mPFC was 
dependent on the cortical layer. Consequently, the number of TCA+ versus TCA- groups 
was compared between the depths of the recording sites divided into tertiles. Table 3.7 
summarizes that most of the cases were recorded in the medial layers of mPFC and that 
TCA+ as well as TCA- cases were present independent of recording depth. 
 
Figure 3.13: Comparison of stimulus-induced 
BLP change between TCA+ cases recorded in 
S1HL and mPFC illustrates a generally higher 
activation level in S1HL as opposed to mPFC. 
Color coded arrows indicate region specific 
shift of interceptions. Mean ± SE. * p < 0.05, 
** p < 0.01. 
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Table 3.7: Number of recordings in different cortical depths is comparable between effective and non-
effective cortical state activation. 
 TCA+ TCA- Chi - square 
Superficial (< 400 µm) 
Medial (400 – 800 µm) 
Deep (> 800 µm) 
5 
11 
2 
2 
17 
2 
χ2(1, N = 7) = 1.29, p = n.s. 
χ2(1, N = 28) = 1.29, p = n.s. 
χ2(1, N = 4) = 0.00, p = n.s. 
 
In support, the absolute cortical recording depth, without subdivision into tertiles, was not 
significantly different between TCA+ and TCA- cases (F(1,37) = 1.36, p = n.s.). Thus, the 
effectiveness of sensory stimulation was independent from cortical layer. 
Alternatively, the dependency of FS effectiveness on the cortical activity state preceding 
the sensory stimulation was tested. This was especially reasonable on the background of 
observed spontaneous alternation of cortical activity state under urethane anesthesia. 
Comparison of BLP during 4 seconds immediately before sensory stimulation between 
TCA+ and TCA- groups revealed that BLP in low frequency bands was significantly lower 
in TCA+ cases (Figure 3.14; SLO: F(1,39) = 6.7, p < 0.05, Delta: F(1,39) = 4.09, p = 0.05). 
This implies that the power of ongoing slow oscillatory activity determines sensory 
processing in mPFC. A higher cognitive evaluation and processing of sensory stimulation 
happens only when the system is active while S1HL, as a structure specifically related to 
sensory operations, detects and processes salient sensory input independent of the ongoing 
cortical activity state. 
  
Figure 3.14: BLP in mPFC during 4 sec before stimulus
presentation divided in TCA+ and TCA- cases suggests a 
dependency of stimulus-induced BLP profile on power in 
low frequency range during prestimulus interval. Inset 
shows representative examples of extracellular voltage 
traces (0.1 - 300 Hz) recorded in mPFC during a TCA+ 
(top) and TCA- case (bottom). A robust, transient 
desynchronization followed the FS presentation when pre-
stimulus cortical activity was characterized by relatively 
low amplitude (blue trace), while there was essentially no 
detectable change in the LFP signal during periods with 
predominant high-amplitude slow wave activity (orange
trace). Text indicates the absolute PSD in SLO frequency 
range (0.1-1Hz) during prestimulus interval. Red bars 
mark stimulus-presentation onset. Mean ± SE. * p < 0.05. 
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3.1.3.4. Influence of stimulus-related cortical activity state in mPFC on 
spectral composition of TCA in S1HL 
Previous comparison of ongoing oscillatory activity between the two cortical structures 
revealed that the BLP, especially in Theta and Alpha frequency band, between S1HL and 
mPFC was related to each other (see Section 0). To explore whether stimulus induced 
modulation of BLP is also related between the two cortical regions, all cases from S1HL, 
which were simultaneously recorded with mPFC (n = 16), were divided according to 
effectiveness of sensory stimulation in mPFC. When cortical state in mPFC was effectively 
activated by FS stimulation (n = 7), stimulus-induced BLP in low frequency range was 
significantly decreased in S1HL (Figure 3.15). In contrast, when cortical state in mPFC was 
unaffected (n = 9), low-frequency BLP in S1HL was likewise unaffected. However, BLP in 
high frequency range was still increased in response to sensory stimulation. A summary of 
statistical results for each frequency band is given in Supplementary Table 7.7. 
 
Figure 3.15: Stimulus-induced BLP change during 
1 sec post-stimulus interval in S1HL separated 
according to TCA+ (n = 7) and TCA- (n = 9) cases 
in simultaneously recorded mPFC. Between group 
comparison was performed using one-way 
ANOVA between TCA+ and TCA- cases (black 
asterisks) and within group comparison against 0 
by using one-sample t-test (cyan and orange 
asterisks). Mean ± SE, * p < 0.05; ** p < 0.01; 
*** p < 0.001. 
 
Interestingly, stimulus-induced BLP change in Theta and Alpha frequency bands, which 
showed the strongest correlation between the two structures during spontaneous oscillatory 
activity, were significantly different from each other (Theta: F(1, 14) = 13.03, p < 0.01; 
Alpha: F(1, 14) = 21.48, p < 0.001). Subsequent correlation analysis confirmed a positive 
relationship between poststimulus BLP in S1HL and mPFC, however, this was the case 
only in Theta and not in Alpha frequency band (r = 0.61, n = 16, p < 0.05). 
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Hence, the BLP in Theta frequency band in both cortical regions is related to each other 
during ongoing as well as stimulus-induced state activity. Additionally, the magnitude of 
stimulus-related BLP change in Delta, Theta and Alpha frequency band in S1HL is 
modulated by cortical activation state in mPFC. In combination, this could indicate a top-
down modulation of low frequency spectral composition in S1HL by mPFC while stimulus-
related increase of BLP in high frequency range in S1HL is reliably evoked and 
independent from activity state in mPFC. 
3.1.3.5. Relationships between stimulus-related TCA and underlying 
voltage fluctuations 
The spectral composition of the LFP is dependent on underlying neuronal voltage 
fluctuations. Previous literature suggests that low frequency power reflects subthreshold 
currents, like synaptic activity and other non-spike related transmembrane currents, and 
high frequency power is largely associated with spiking frequency of neurons26,680,681. In 
the following, this study investigates the underlying stimulus-induced voltage fluctuations 
in S1HL and mPFC by examination of SEPs as well as SUA. In mPFC, SEPs and SUA 
were further compared between TCA+ and TCA- recordings. 
SEPs in both cortical regions showed exclusively negative voltage deflections of LFP, 
which confirmed recordings mostly in medial to deep layers74-78. Cases with SEP amplitude 
exceeding twice the standard deviation of baseline voltage were considered as responsive 
and referred to as SEP+. Analogous, cases with SEP amplitude smaller than the threshold 
are referred to as SEP-. 
In both cortical regions, SEP was effectively evoked in all but one TCA+ cases (n = 22 and 
n = 18 for S1HL and mPFC, respectively). Interestingly, threshold-exceeding SEP+ was 
also present in 59.1 % (n = 13) of TCA- recordings in mPFC and, actually, the proportions 
of SEP+ was comparable between TCA+ (n = 18) and TCA- (n = 13) cases 
(Chi2(1, 31) = 0.81, p = n.s.). Additionally, in TCA- cases, the proportions of SEP+ (n = 13) 
and SEP- (n = 9) were neither significantly different (Chi2(1, 22) = 0.73, p = n.s.) 
suggesting that SEP is evoked independent from cortical activity state. 
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The profile of SEPs vastly differed between cortical regions (Figure 3.16). In S1HL, the 
average SEP+ profile exhibited 3 response components with latencies similar to what was 
reported for afferent-specific information transfer: the first transient component exhibited a 
short peak latency of 20.8 ± 1.0 ms typical for transfer of mechanoreceptive information by 
A β-fibers. The second response component was detected after 82.0 ± 2.5 ms followed by a 
third sustained and long latency (309.9 ± 19.8 ms) component characteristic for transferred 
nociceptive information via A δ- and C-fibers, respectively. In contrast, SEP+ profile in 
mPFC consisted of only one single voltage deflection showing average peak latency after 
253.82 ± 17.66 ms.  
 
 
Figure 3.16: Somatosensory stimulation induces SEP under urethane anesthesia. Illustrated are the 
average waveforms of the extracellular voltage trace (0.1 - 300 Hz) during 800ms after stimulus-
presentation (red dashed line at 0 sec) in S1HL and mPFC. In S1HL, SEP consisted of 3 response 
components (1, 2, 3) separated by dashed lines. Inset shows a magnification of the first two short 
latency response components. In mPFC, the average single voltage deflections are separated according 
to TCA+ (blue) and TCA- (orange) cases. Dots illustrate each individual FS in a train of five pulses 
(0.5 ms, 5 mA). Bin size = 5 ms, Mean ± SE. 
 
Next, the SEPs in mPFC were specifically examined depending upon the effectiveness of 
stimulus-related cortical state activation. Therefore, peak latency, amplitude and integral of 
the SEP+ profiles were compared between TCA+ and TCA- cases (Table 3.8). There was 
no significant difference between peak latency (F(1, 29) = 0.12, p = n.s.) or maximum 
amplitude (F(1, 29) = 0.32, p = n.s.) of SEPs between the two groups, however, the 
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integral, as a measurement of the magnitude of SEPs, was significantly larger in TCA+ 
cases compared to TCA- cases (Figure 3.16 right; F(1, 29) = 6.92, p < 0.05). 
Table 3.8: Summary of SEP characteristics in mPFC dependent on effectiveness of cortical state 
activation. Mean ± SE. 
 TCA+ TCA- 
Peak latency (ms) 
Maximum amplitude (mV) 
Integral (μV*sec) 
262.05 ± 13.06 
-0.26 ± 0.04 
-89.07 ± 15.80 
245.58 ± 22.26 
-0.18 ± 0.04 
-19.72 ± 18.44 
 
In short, the response in S1HL was partitioned into three different response components 
reflecting temporally integrated input from afferent pathways conveying somatosensory 
information of different qualities. In mPFC, only one response component was apparent 
which might reflect a mixture of incoming information from different structural signal 
generators at different time courses, so that the individual signals merge to one voltage 
deflection with maximum activity at the time of most incoming information. 
In both cortical regions stimulus-related activation of cortical state was nearly always 
accompanied by an underlying SEP. In mPFC, where neuronal activity was less sensitive to 
sensory stimulation, threshold-exceeding SEPs were still present when the cortical state 
remained unchanged after the stimulus presentation albeit with a weaker magnitude. This 
suggests that, SEPs might be a prerequisite for an activation of the cortical state only if it is 
strong enough. 
SEPs reflect mass neuronal voltage deflections in response to sensory input in a volume of 
brain tissue. Like the LFP, SEPs include subthreshold transmembrane currents as well as 
spiking activity. In contrast, SUA provides information on the level of single action 
potentials and excludes subthreshold membrane currents112. In response to sensory 
stimulation, a strong relation between LFP power in the Gamma frequency band and 
spiking activity is suggested26,680,681. Therefore, in the current study, the spiking activity in 
response to sensory stimulation is assumed to be increased when cortical state is reliably 
activated. This is examined in the following section. 
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Isolated SUA exceeding a threshold of 95 % confidence interval during 1.5 sec after 
stimulus-presentation were classified as “FS-responsive”. The FSs evoked exclusively 
excitatory responses in both cortical regions, which is in accordance to the proposed 
relation to increased BLP in Gamma frequency band during TCA. Because of the 
somatosensory nature of the stimulation, a larger proportion of FS-responsive neurons was 
recorded in S1HL (67.2%), compared to mPFC (35.9%). 
Prior to a detailed description of the single unit response profiles in each cortical structure, 
sensory-evoked population SUA in mPFC was compared between TCA+ and TCA- cases. 
In contrast to SEPs, whose occurrence was independent from effectiveness of stimulus-
induced cortical state activation, the proportion of FS-responsive single units was 
significantly higher in the TCA+ cases compared to TCA- cases (n = 34 vs. 13, 
Chi2(1, 47) = 9.38, p < 0.01). Within the latter, the number of FS-responsive single units 
was significantly lower than unaffected single units (n = 13 vs. 40; Chi2(1, 53) = 13.76, 
p < 0.001). 
Comparable to SEPs, neither peak latency (F(1, 45) = 0.77, p = n.s.) nor maximum 
amplitude (F(1, 45) = 1.91, p = n.s.) differed between TCA+ and TCA- but the magnitude 
of the population single unit response, reflected in the integral of the PSTH, was 
significantly higher in TCA+ (0.73 ± 0.09 Z-Scores*sec) compared to TCA- cases 
(0.33 ± 0.15 Z-Scores*sec, F(1, 29) = 5.28, p < 0.05). 
Hence, a large proportion of responsive units in S1HL and increased stimulus-induced 
single unit activation in mPFC TCA+ cases supports the presumed relationship between 
stimulus-induced cortical activation and single unit firing activity. In S1HL, majority of 
recorded single units were activated in response to sensory stimulation under reliable 
increase of BLP in high frequency range (see section 3.1.3.4). The comparative approach in 
mPFC showed that, when the cortical state was significantly activated, the response 
probability of individual neurons was higher and the magnitude of the population single 
unit response to FSs was larger compared to unaffected cortical activity state. SEPs 
likewise showed a larger magnitude in TCA+ cases but, in contrast to single unit sensory-
evoked responses, the response probability did not differ between TCA+ and TCA- cases 
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(see section 3.1.3.5). This leads to the suggestion that single unit firing activity in response 
to sensory stimulation enhances SEP magnitude which, in turn, activates cortical state. 
3.1.3.6. Characterization of single unit responses to somatosensory 
stimulation in S1HL and mPFC 
The results described above indicated already a higher complexity in neuronal activity 
recorded in the association cortex in contrast to primary sensory areas. This was reflected in 
a decreased, state-dependent sensitivity of stimulus-evoked activation in mPFC compared 
to S1HL, where stimulus-induced activation on all explored levels was very reliable. On the 
other hand, the SEPs were composed out of three distinguishable response components in 
S1HL and only one single voltage deflection in mPFC. Population single unit responses 
averaged from all responsive single units for each cortical region exhibit similar profiles 
(Supplementary Figure 7.3): the population of 47 out of 70 FS-responsive S1HL SUA 
showed a biphasic stimulus-evoked response profile with an average peak latency of 
19.92 ± 0.91 ms and 288.54 ± 9.73 ms, for early and late response components respectively. 
The amplitude of early response was higher (3.33 ± 0.39 Z-Scores) than the amplitude of 
the late response component (1.15 ± 0.18 Z-Scores, t(78) = 2.5; p < 0.05). The single 
voltage deflection of population SUA in mPFC (47 out of 134) exhibited a peak latency of 
200.31 ± 0.27 ms and maximum amplitude of 1.69 ± 0.25 Z-Scores. 
Intuitively, this looks like a simpler response profile in mPFC, however the complexity of 
different brain networks is dependent on the computational demand of the processes which 
has been described to increase from so-called unimodal areas (including primary sensory 
areas) to multimodal networks (including limbic cortices like mPFC)468,682. The bottom-up 
sensory input to S1HL is well explored and the origin of the different response components 
can be related to modality specific information transfer based on their response latency. 
However, mPFC integrates information from multiple cortical and subcortical networks and 
one can imagine that the single voltage deflection on the population level is merged from 
fluctuations created by incoming information which varies vastly, beyond others, in spatial 
and temporal coding as has been indicated before108,109. 
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To provide an insight into underlying voltage fluctuations of individual responsive neurons, 
the stimulus-induced population single unit response in each cortical structure was 
categorized into subgroups depending on response profiles. Specifically, the PSTH profiles 
of individual neurons were subdivided by using K-Means Cluster analysis. Figure 3.17 
illustrates the individual sensory response profiles of each recorded unit (Figure 3.17A) and 
the average response profiles of each group within a cortical structure (Figure 3.17B). 
 
 
Figure 3.17: Somatosensory-evoked single unit responses in S1HL and mPFC. A) The stimulus-induced 
modulation of the firing rate of all isolated single units in S1HL and mPFC sorted according to 
response profile. For each single unit, the firing rate was normalized to Z-Score and averaged over 25 
trials. B) Smoothed average peri-stimulus-time histograms (PSTHs) for each group of single units 
(mean ± SE) in S1HL (left) and mPFC (right). The averages for non-responsive units are not shown. 
Stimulation was applied at time 0 (red dashed line). Dots illustrate each individual FS in a train of five 
pulses (0.5 ms, 5 mA). Bin size = 10ms. 
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Similar to the response profile of the population single unit response to FSs, the S1HL 
neurons displayed a short latency burst which was followed by a second phase of sustained 
excitation in 66.0% of responsive neurons (group 2). The mPFC response profiles were, 
indeed, more complex. Out of the population of responsive neurons, cluster analysis 
provided four groups of response profiles: 1) short latency transient excitation (group 1, 
18.8 %), 2) short latency sustained excitation (group 2, 35.4 %), 3) transient excitation with 
variable latency (group 3, 29.2 %) and 4) long latency sustained excitation (group 4, 
16.6 %). The peak latencies of group 1 to group 4 are 122.0 ± 4.2 ms, 242.1 ± 30.0 ms, 
289.2 ± 24.9 ms and 408.3 ± 25.0 ms and significantly different from each other 
(F(3, 38) = 15.9, p < 0.001) with exception of group 2, which is not significantly different 
from group 3. 
Thus, neurons in S1HL display two populations with response profiles matching the 
processing via different bottom-up sensory afferents. Higher complexity in mPFC was 
supported by the number of populations with different response profiles in addition to a 
vast number of neurons, which are not activated by sensory stimulation. This suggests the 
presence of multiple networks in the mPFC circuitry, wherein incoming activity is merged 
into a monophasic cortical population response. 
3.1.4. Noradrenergic modulation of sensory-evoked neuronal responses in 
S1HL and mPFC 
One functional role classically attributed  to NE in sensory processing, is to increase SNR 
in primary sensory regions via inhibition of spontaneous neuronal activity228,229,235,236,264 
and concurrent enhancement of sensory-evoked responses229,236,238,244. Noradrenergic 
modulation of neuronal activity in prefrontal cortex, however, is reported to be more 
complex. Spontaneous activity was found to be decreased227,245,247,249,252 or increased245,252 
and bidirectional modulation was also reported for stimulus-induced responses245,247,251,256. 
The reported role of NE on cortical activity state, however, seems to be consistent over 
cortical regions. Both excitation of LC neuronal discharge and intracortical or systemic 
infusion of NE have been shown to activate the cortical state in order to promote 
wakefulness and arousal160,179,683-685. 
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In the following, an attempt shall be made to clarify how sensory-evoked neuronal activity 
is modulated by NE on different neuronal levels in functionally distinct cortical regions. 
However, first, the modulation of sensory-evoked activity by pharmacological 
manipulation was explored in LC itself in order to estimate the change of stimulus-induced 
phasic NE release in terminal regions. 
3.1.4.1. Effect of pharmacological manipulation on LC neuronal activity 
Neuronal activity in LC was monitored simultaneously along with recordings of neuronal 
activity in the cortex. Under baseline condition, the LC NE neurons typically responded to 
FSs with a brief excitation (peak latency: 67.08 ± 3.19 ms) followed by prolonged 
inhibition129,147,521,666,686,687 (Figure 3.18). The response amplitude of average LC activity 
recorded during baseline condition before local and systemic injection of clonidine was 
comparable (F(1, 32) = 1.25, p = n.s.). 
 
 
Figure 3.18: The effect of clonidine on sensory-evoked 
responses of noradrenergic neurons in LC. The 
smoothed PSTHs of the normalized firing rate of LC 
multiunit activity (MUA) are plotted during baseline 
(black), iontophoretic application of clonidine in LC 
(red) and after systemic clonidine injection (green). The 
data averaged over 25 trials for each drug condition are 
shown. For illustrative purpose, sensory-evoked response 
during baseline condition was averaged over cases which 
were recorded before local and systemic injection of 
clonidine, respectively. Bin size 10 ms. Inset shows the 
maximum amplitudes of the responses to FS stimulation. 
Note a clonidine-induced decrease of spontaneous LC 
activity, while substantial decrease of evoked responses 
was observed only in case of local LC inhibition. 
Mean ± SE. *** p < 0.001. 
 
As described before, both pharmacological conditions decrease the spontaneous LC activity 
(see section 3.1.2) and, concomitantly, tonic release of NE. Sensory-evoked activity in LC 
was also massively inhibited by local injection of clonidine into the nucleus (Figure 3.18, 
F(1, 37) = 26.39, p < 0.001), similar as reported in a previous study addressing peri-LC 
drug infusion with simultaneous recording of FS-evoked LC activation266. In contrast, 
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systemic administration of clonidine did not significantly affect the amplitude of the evoked 
responses of the LC NE neurons (F(1, 28) = 0.15, p = n.s.). 
Thus, while local drug infusion prevents tonic as well as phasic NE release in LC terminals, 
systemic drug injection leaves the phasic release intact. In consequence, a phasic increase 
of NE release in response to FSs can be expected in LC terminal regions under condition of 
systemic clonidine in addition to global activation of alpha 2-adrenoceptors. The latter, in 
turn, reduces release of NE from LC terminals by presynaptic actions on noradrenergic 
autoreceptors488-491,688 while postsynaptic actions typically lead to hyperpolarization of 
target neurons157. 
3.1.4.2. Noradrenergic modulation of stimulus-induced changes of 
spectral composition in S1HL and mPFC  
NE is consistently reported to activate the ongoing cortical state and, accordingly, systemic 
injection of alpha 2-adrenoceptor agonists is reported to result in cortical deactivation in 
frontal, parietal and temporal cortical regions186,195,689-693. Unilateral manipulation of LC 
activity seems to be insufficient180,183 and, therefore, only systemic injection of clonidine is 
expected to modulate the spectral composition of TCA towards higher power in low 
frequency range. 
Surprisingly, to anticipate this part of the result, it was generally found that both 
manipulations evoked similar effects on cortical state activation as well as single unit 
responses to sensory stimulation save that the effects after systemic injection of clonidine 
were much stronger compared to intra-LC injection. 
Individual comparison of stimulus-related BLP change after either noradrenergic 
manipulation revealed opposing effects on cortical state activity in S1HL and mPFC 
(Figure 3.19). Specifically, global activation of alpha 2-adrenoceptors significantly 
decreased stimulus-induced BLP change in Sigma (F(1, 23) = 17.55, p < 0.001) and Beta 
(F(1, 23) = 8.88, p < 0.01) frequency bands in S1HL while BLP change in the same 
frequency bands were increased in mPFC (Sigma: F(1, 39) = 10.34, p < 0.01, Beta: 
F(1, 39) = 4.88, p < 0.05). The increase in Sigma frequency band in mPFC could also be 
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observed after inhibition of LC activity by local infusion of clonidine (F(1, 41) = 5.63, 
p < 0.05) while in S1HL, none of the bands were affected by the latter treatment. 
 
 
Figure 3.19: Noradrenergic modulation of stimulus-related BLP change in S1HL (top row) and mPFC 
TCA+ cases (bottom row) after systemic clonidine injection (green) and under local inhibition of LC 
activity (red). Note the contrary modulation of the same frequency bands in the cortical regions. 
Mean ± SE, * p < 0.05, ** p < 0.01, ***p < 0.001. 
 
It was shown before that stimulus-induced cortical state activation in mPFC is inversely 
dependent on power during ongoing slow oscillations between 0.1 and 1 Hz (SLO, see 
section 3.1.3.3). Systemic clonidine administration unexpectedly decreased power in this 
frequency band (see section 3.1.2). In combination with increased stimulus-induced BLP 
change in Beta frequency band, which is associated with enhanced cortical activity48,49, this 
raises the question whether the number of TCA+ cases, in which cortical state could be 
effectively activated by sensory stimulation, increased after clonidine administration. 
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Accordingly, TCA- cases, in which FS-stimulation initially could not activate the cortical 
state in mPFC, were again tested for responsiveness to FSs under drug condition (Local: 
n = 10; Systemic: n = 12). One-way ANOVA followed by multiple comparison analysis for 
each frequency band individually, revealed indeed significant increase of BLP in Sigma 
(Local: F(1, 19) = 4.76, p < 0.05, Systemic: F(1, 23) = 7.37, p < 0.05), Beta (Local: 
F(1, 19) = 8.64, p < 0.01, Systemic: F(1, 23) = 7.13, p < 0.05) and Gamma (Local: 
F(1, 19) = 4.36, p = 0.05, Systemic: F(1, 23) = 6.33, p < 0.05) frequency band after either 
drug injection method (Figure 3.20). Detailed results are summarized in Supplementary 
Table 7.8. One-sample t-test of stimulus-induced BLP change against zero did not show 
significances in any frequency band during drug-free condition. However, after local 
clonidine infusion into LC, BLP in Beta (t(9) = 3.60, p < 0.01) and Gamma (t(9) = 2.91, 
p < 0.05) frequency band was significantly increased in response to FS stimulation. This 
modulated frequency range was extended to Sigma frequency band after systemic clonidine 
injection (Sigma: t(11) = 3.64, p < 0.01, Beta: t(11) = 4.39, p < 0.01, Gamma: t(11) = 4.72, 
p < 0.01). BLP in low frequency range was not affected by any pharmacological 
manipulation (Supplementary Table 7.9). 
 
 
Figure 3.20: Noradrenergic modulation of stimulus-related BLP change in mPFC TCA- cases after 
systemic clonidine injection (left) and under local inhibition of LC activity (right). Between group 
comparison was performed using one-way ANOVA between baseline and drug condition (green and 
red asterisks) and within group comparison against 0 with one-sample t-test (black asterisks). 
Mean ± SE, * p < 0.05, ** p < 0.01, ***p < 0.001. 
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In conclusion, both reduction of noradrenergic tone by inhibition of LC activity as well as 
global activation of alpha 2-receptors induced activation of cortical activity state in mPFC 
even though the activity of noradrenergic neurons in LC was inhibited. This effect was 
presumably enabled by decreased power of slow oscillations during prestimulus interval. 
In cases, in which sensory stimulation activated the cortical state already under baseline 
condition, poststimulus BLP in Sigma and Beta frequency bands were increased in mPFC 
and decreased in S1HL. 
Given that cortical power in Sigma frequency range is associated with sleep processes36,37 
and power in Beta frequency band with cortical activation48-50, unidirectional modulation of 
both frequency bands under clonidine condition indicate a simultaneous inhibition of sleep-
promoting and wake-promoting activity in S1HL and simultaneous activation of both in 
mPFC. 
3.1.4.3. Noradrenergic modulation of SEPs and single unit responses to 
sensory stimulation in S1HL and mPFC  
Referring to the reported role of NE in sensory regions, to increase SNR by decrease of 
spontaneous neuronal activity, depletion of cortical NE expectedly disinhibited spontaneous 
activity in S1HL (see section 3.1.2). A corresponding inhibition of the sensory-evoked 
responses in S1HL might be only expected after intra-LC infusion of clonidine and 
associated inhibition of phasic activation of LC neurons in contrast to systemic injection. 
Nevertheless, a reduction of cortical sensory-evoked responses to FSs can still be assumed 
after systemic treatment because of the global activation of pre- and postsynaptic inhibitory 
alpha 2-adrenoceptors. Accordingly, the population activity represented by SEPs is 
expected to be reduced in S1HL. 
In mPFC, NE was reported to bidirectionally modulate single unit responses to sensory 
stimulation which might be dependent on neuronal population245-248,251,252,254-256. Therefore, 
a differential modulation of the four mPFC neuronal groups is expected which should, 
however, not affect the SEPs as population response. 
To explore the underlying voltage fluctuations of the spectral composition of the LFP, first, 
SEPs were compared between baseline and drug conditions whereby data for baseline 
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condition was combined from baseline before local and baseline before systemic 
administration of clonidine. In S1HL, the maximum amplitude of the early (first short 
latency transient component) and late response component as well as the integral of the 
entire voltage deflection or late response component only, were analyzed separately. It was 
found in S1HL that local inhibition of LC activity decreased the amplitude of the late 
response component (F(1, 32) = 4.02, p = 0.05, Figure 3.21A right). However, neither 
manipulation method affected any of the other parameters (Supplementary Table 7.10). 
In mPFC, analysis of maximum amplitude and integral of the single voltage deflection was 
subdivided into TCA+ and TCA- cases (Table 3.9). 
Table 3.9: Number and percentage of recorded SEPs in mPFC subdivided into effectiveness of sensory 
stimulation for each pharmacological condition. 
 TCA+ TCA- 
Systemic Clonidine 
Local Clonidine 
7 (38.89 %) 
11 (61.11 %) 
8 (61.54 %) 
5 (38.46 %) 
 
In contrast to SEPs in S1HL, local injection of clonidine did not have any significant effect 
on any parameter; however, systemic injection of clonidine decreased the integral of the 
voltage deflection in TCA+ cases only (Figure 3.21, F(1, 24) = 5.92, p < 0.05). In TCA- 
cases, neither the amplitude nor the integral were significantly affected. SEP amplitudes 
and integrals including statistical comparison are summarized in Supplementary Table 7.11 
and Supplementary Table 7.12 for TCA+ and TCA- cases, respectively. 
In summary, pharmacological manipulation differentially modulated SEPs in the cortical 
structures. While systemic activation of alpha 2-adrenoceptors decreased SEP only in 
mPFC TCA+ cases, this treatment did not affect any response parameters in S1HL. Local 
inhibition of LC activity, on the other hand, reduced the amplitude of only the late response 
component in S1HL. In addition, in mPFC, a reduction of SEP amplitude as well as integral 
was indicated for TCA- cases, however, this modulation was not significant. 
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Figure 3.21: The effect of clonidine administration on maximum amplitude (top row) and integral 
(bottom row) of SEP in S1HL (left column) and mPFC (right column). In S1HL, combined two short-
latency response components (Early) and the late response component (Late) were analyzed 
individually. Recordings in mPFC were separated in TCA+ and TCA- cases. Mean ± SE, * p < 0.05. 
 
Finally, noradrenergic modulation of sensory-evoked single unit responses was compared 
between S1HL and mPFC. First, the effects of clonidine on the population of cortical 
neurons that showed significant responses to FS during baseline (‘initially responsive’ 
neurons) were analyzed independent from cortical state activation. To recall briefly, 
different populations of neurons were found in S1HL as well as mPFC dependent on their 
profile in response to electrical FSs. In S1HL, two populations were characterized which 
differed on the presence of a late response component. In mPFC, four populations with 
different latencies and response durations were found (see section 3.1.3.6). 
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Figure 3.22: The modulation of individual groups of single unit responses to somatosensory stimulation 
in A) S1HL and B) mPFC after clonidine administration. Smoothed average PSTHs of the responses to 
FS during baseline (S1HL: cyan, mPFC: blue), iontophoretic injection of clondine into LC (red) and 
systemic clonidine injection (green) are plotted. Insets show magnifications of transient response 
components. Color coded bars above the response profiles illustrate significantly different bins between 
baseline and drug condition. The group classification is the same as shown on Figure 3.17. Stimulation 
was applied at time 0. Bin size = 10ms. 
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Exploration of response characteristics of individual groups of neurons under drug 
conditions in both cortical regions revealed that S1HL group 2 and mPFC group 1, 2 and 
4 neurons were mostly affected. S1HL group 1 did not show any modulation in response to 
clonidine administration and mPFC group 3 neurons showed only minor effects. 
Specifically, systemic clonidine administration resulted in substantial decrease of the 
average Z-Scores of the response in S1HL group 2 neurons and in mPFC group 1 and 2 
neurons (as revealed by two-way repeated measures ANOVA with 10 ms-bins as repeated 
measures) (Figure 3.22). In S1HL, the group 2 neurons showed a significant decrease of the 
response amplitude between 0.05 to 0.32 sec (Figure 3.22A, F(1, 20) = 11.14, p < 0.01). In 
mPFC, the affected interval was 0.15 to 0.25 sec (F(1, 4) = 35.37, p < 0.01) in group 1 
neurons and 0.11 to 0.49 sec (F(1, 10) = 15.31, p < 0.01) in 6 out of 8 group 2 neurons 
(Figure 3.22B). The two remaining group 2 neurons drastically increased average Z-Scores 
(Supplementary Figure 7.4, F(1, 2) = 26.54, p < 0.05). Increase of the average Z-Scores was 
also occasionally revealed by pairwise comparison of each bin in mPFC group 3 neurons, 
however, the overall response magnitude did not significantly change (F(1, 6) = 3.23, n.s.). 
On the background that this group represents a merged population of mPFC neurons with 
different properties, a modulation was not expected because potential modulation effects 
would cancel each other out. The inhibition of noradrenergic transmission by local injection 
of clonidine into LC decreased only the late response component of the neurons in group 2 
of S1HL between 0.19 to 0.53 sec (F(1, 38) = 15.71, p < 0.001) while the short latency 
component was preserved. Note, that SEP in S1HL was likewise modulated under this 
condition. Similarly, in mPFC, neurons of group 1, which showed a transient response 
profile, were not affected while the later response components of neurons which showed a 
sustained excitation were decreased. Group 2 neurons were decreased in the interval 
between 0.28 - 0.65 sec (F(1, 18) = 12.51, p < 0.01) and group 4 neurons showed a 
reduction between 0.43 to 0.61 sec (F(1, 8) = 7.18, p < 0.05). 
In brief, systemic clonidine injection led to a reduction of activity during the entire 
response duration in affected neuronal groups while local inhibition of LC activity 
shortened the response duration. Overall, these effects led to a decreased number of initially 
responsive units after either clonidine condition in both cortical areas (Table 3.10). Neurons 
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in S1HL showed the strongest effects after systemic injection of clonidine by significantly 
decreasing the number of initially responsive neurons about ~ 60 % (Chi2(1, 25) = 4.84, 
p < 0.05). In mPFC, the proportion decreased about ~ 40 %. Local inhibition of LC activity 
decreased the proportion to a similar amount in both cortical regions. 
Table 3.10: Number of responsive single units in each group within a cortical structure after systemic 
and local clonidine injection (clo) in comparison to the number of responsive units under baseline 
condition (base). Percentage indicates the proportion of neurons which kept responsiveness after 
clonidine injection.  
Groups 
S1HL mPFC 
systemic local systemic local 
n(clo)/n(base) n(clo)/n(base) n(clo)/n(base) n(clo)/n(base) 
Group 1 4/7 6/9 0/3 4/6 
Group 2 3/11 11/20 3/8 6/9 
Group 3 - - 4/4 5/10 
Group 4 - - 3/3 3/5 
Total 7/18 (39%) 17/29 (59%) 10/18 (56%) 18/30 (60%) 
 
Next, we expanded our analysis on the initially non-responsive neurons in each brain region 
and observed so-called ‘gating’ effect, which was present only in mPFC after either 
pharmacological manipulation. About 30 % of initially non-responsive neurons became 
responsive after systemic application of clonidine and approximately a quarter after local 
LC inhibition (Figure 3.23A). The post-stimulus interval of significant increase of response 
amplitude was 0.11 to 0.88 sec after systemic (F(1, 28) = 22.64, p < 0.001) and 0.17 to 
0.61 sec after local clonidine injection (Figure 3.23B; F(1, 16) = 27.74, p < 0.001). 
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Figure 3.23: The sensory-gating effect in mPFC after systemic (left) and local (right) administration of 
clonidine. A) The normalized firing rate of all initially non-responsive single units is plotted after either 
clonidine injection. B) Smoothed average PSTHs of the gated neurons under baseline and drug 
condition. Stimulation was applied at time 0. Bin size = 10ms. Insets illustrate the difference between 
the maximum amplitude in baseline (B) and after local (L) or systemic (S) clonidine injection. 
 
In combination with the decreased number of initially responsive neurons under clonidine 
condition, a redistribution of active cortical pyramidal neurons was observed in mPFC, 
maintaining the overall number of responsive neurons comparable to baseline condition 
after either clonidine application (Figure 3.24; Systemic: Chi2(1, 43) = 1.14, n.s.; Local: 
Chi2(1, 59) = 0.42, n.s.).  
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Figure 3.24: The effect of clonidine administration on the number of responsive single units in mPFC. 
The number of initially responsive neurons (blue) was reduced under condition of systemic clonidine 
(green) and local inhibition of LC activity (red). This effect was accompanied by simultaneous gating 
effects of initially non-responsive single units (shaded green and red after systemic and local injection of 
clonidine, respectively) which resulted in a drug induced redistribution of activated neurons without 
changing the population size. 
 
In the current study, noradrenergic modulation of sensory-evoked responses was studied 
independent from drug-induced effects on spontaneous activity by analyzing firing rates 
normalized to Z-Scores. Therefore, it would be interesting whether a decrease of 
spontaneous activity uncovered the sensory evoked response and induced the gating effects. 
Interestingly, spontaneous activity of the affected population of neurons was not reduced 
under either drug condition in comparison to the baseline spontaneous activity (Systemic: 
F(1, 26) = 0.50, p = n.s.; Local: F(1, 16) = 0.17, p = n.s.). In contrast, although only after 
systemic clonidine application, the population of gated neurons exhibited a higher 
spontaneous activity under clonidine condition compared to the neurons which preserved 
unresponsiveness (2.15 ± 0.42 spikes/s vs. 1.14 ± 0.23 spikes/s; F(1, 43) = 6.47, p < 0.05). 
These results suggest that the gated neurons belong to a population with specific 
electrophysiological properties. 
A further question to ask resulted from the belief that the firing rate of SUA is positively 
related to power in high frequency range (see section 3.1.3.5). An increase of high 
frequency power was observed in mPFC TCA- cases after local and systemic injection of 
clonidine, which were unaffected by sensory stimulation under baseline condition. To test 
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whether this effect is related to the drug-induced gating effects of mPFC single units, the 
magnitude of sensory-evoked responses in gated neurons was compared between TCA+ 
and TCA- cases under each drug condition. Therefore, the integral over 1 sec immediately 
after stimulus presentation was compared between baseline and clonidine condition. The 
number of gated neurons subdivided into cortical activity groups for each pharmacological 
manipulation is summarized in Table 3.11. 
Table 3.11: Number of gated neurons out of the population of initially non-responsive (non-resp.) single 
units in mPFC after either pharmacological manipulation for TCA+ and TCA- cases, respectively. 
 Systemic (n(gated)/n(non-resp.)) Local (n(gated)/n(non-resp.)) 
TCA+ 
TCA- 
9/23 
5/22 
2/22 
7/18 
 
When recorded in TCA- cases, the population of gated neurons vastly increased the 
response magnitude after local (F(1, 12) = 49.17, p < 0.001) and systemic (F(1, 8) = 7.17, 
p < 0.05) injection of clonidine (Figure 
3.25). This effect was also observed in 
TCA+ cases but only under condition of 
systemic clonidine injection 
(F(1, 16) = 11.44, p < 0.01), while local 
inhibition of LC activity did not have an 
effect (F(1, 2) = 0.03, p = n.s.). 
In conclusion, cortical NE deprivation 
results in gating of single unit responses to 
sensory stimulation which seems to 
mediate the drug-induced increase of power 
in high frequency range in initial TCA- 
cases. 
 
 
 
 
Figure 3.25: The effect of clonidine on gated single 
units in mPFC dependent on stimulus-evoked 
cortical state activation. Bars illustrate the average 
integral over 1 sec after stimulus onset of the PSTH 
in response to FSs separated in TCA+ and TCA-
cases. Mean ± SE, * p < 0.05, *** p < 0.001. 
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3.2. Noradrenergic modulation of the midbrain dopaminergic system 
All sensory information, which is integrated by mPFC, is a result of multiple bottom-up 
processes from many different brain regions. The LC is known to globally project to every 
brain structure, with the exception of basal ganglia. Thus, NE is able to modulate incoming 
sensory information already at early processing stages including the modulation of neuronal 
activity in other neuromodulatory systems than the noradrenergic LC. Out of these, 
especially the dopaminergic system has been described to play a major role in processing of 
salient sensory information329-339 and the dopaminergic VTA in the midbrain is strongly 
modulated by NE119,377,477-482,492,493,495-497,500-503,506-509. Hence, the question of how the 
noradrenergic system modulates the neuronal activity in the dopaminergic ventral midbrain, 
which synergistically contributes to the effects in the cortex described in the previous 
section, was explored in a separate set of experiments. Here, simultaneous recordings in 
LC, VTA and mPFC were performed in 15 rats, albeit data from mPFC contributed to the 
previous study. Although the VTA consists of different neuronal types, including 
dopaminergic, glutamatergic and GABAergic neurons309-320, MUA was analyzed in order to 
study the net outcome of sensory processing of the VTA. Furthermore, the population of 
dopaminergic neurons represents more than 70 % of all neurons in the VTA318 and, 
presumably, dominates potential effects. In order to explore the noradrenergic modulation 
of MUA in the dopaminergic VTA specifically related to LC-activity, local infusion of 
clonidine into the LC was used only while global activation of alpha 2-adrenoceptors by 
systemic clonidine injection was spared in the experimental protocol. Sensory stimulation 
was performed according to the stimulation protocol used before. 
3.2.1. Noradrenergic modulation of spontaneous activity in the ventral 
midbrain 
Most of the recordings in the ventral midbrain were performed in the VTA (Figure 3.26A) 
while two out of 15 recordings were performed in the lateral dopaminergic SNc. 
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Figure 3.26: Positions of electrodes in the ventral 
midbrain and related modulation of recorded 
spontaneous activity in urethane anesthetized rats. 
A) Coronal schematic views showing the recording 
sites in the VTA (filled dots) and Substantia Nigra 
pars compacta (SNc, circles) with increasing (red) 
or decreasing (blue) spontaneous activity in 
response to ipsilateral inhibition of LC activity. 
Numbers illustrate distance from bregma in mm 
for each section. Inset illustrates the antero-
posterior extent of recording sites by aid of a color 
coded bar in a sagittal view of the brain. Top 
numbers indicate distance from bregma, bottom 
numbers distance from interaural line and vertical 
numbers depth in mm. B) Bars illustrate the 
average percentage of change of baseline 
spontaneous activity after local infusion of 
clonidine into LC. Color code matches the electrode 
positions in A. In one recording the spontaneous 
activity was not modulated (Non). Mean ± SE, 
** p < 0.01, * p < 0.05. 
 
 
First, the modulation of spontaneous MUA by local inhibition of LC activity was explored 
for each recording. Therefore, a paired-sample t-test over 50 bins during 0.5 sec 
prestimulus interval (bin size = 10 ms) between baseline and drug condition was performed. 
This analysis revealed a bidirectional modulation of spontaneous MUA dependent on 
recording site in the ventral midbrain (Figure 3.26B). Sites with a decrease in MUA firing 
rate (t(8) = -4.48, p < 0.01) were recorded in the anterior and lateral VTA (n = 9) illustrated 
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as blue dots in Panel A. Sites with an increase in MUA firing rate (n = 5, t(4) = 2.69, 
p = 0.05) were recorded in the medial VTA (red dots, n = 3) or SNc (red circles, n = 2). 
Only one recording site did not show any significant modulation in spontaneous MUA 
(gray). 
3.2.2. Validation of parameters for effective stimulation in the VTA 
Comparable to recordings in LC, S1HL and mPFC (see section 3.1.3.1), different 
stimulation protocols were tested in order to ensure reliable sensory-evoked modulation of 
neuronal activity in the VTA whereby this time, only amplitude coding was tested. Similar 
to neuronal responses to sensory stimulation observed in LC and mPFC, neuronal responses 
in the VTA were exclusively excitatory and showed incrementally higher response 
amplitudes with increased stimulation 
current from 1 mA to 5 mA (Figure 3.27; 
F(4, 70) = 4.51, p < 0.01). The 
corresponding average maximum firing 
amplitudes are provided in Supplementary 
Table 7.13. 
Therefore, further experiments were 
conducted using TR stimulation with 
stimulation current of 5 mA to explore 
reliable sensory evoked responses in the 
VTA comparable to neuronal responses in 
LC and mPFC. 
 
3.2.3. Noradrenergic modulation of multi unit responses to sensory 
stimulation in the ventral midbrain 
Next, the magnitude of neuronal MUA responses to sensory stimulation was compared 
between baseline condition and under inhibition of LC neuronal activity. 
 
Figure 3.27: The effect of FS using TR stimulation 
with increasing stimulus strength on average 
amplitudes of population single unit responses in the 
ventral midbrain. Note sequentially increased 
response amplitude with increased stimulus 
strength. Mean ± SE, *** p < 0.001. 
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Theoretically, the two different dopaminergic structures in the ventral midbrain, VTA and 
SNc, have very different functions. While the dopaminergic neurons in VTA are known to 
play a role in sensory processing among other functions340-342, neuronal activity in SNc are 
mostly discussed in relation to motoric processes694. Therefore, sensory-evoked responses 
recorded in SNc were analyzed separately from responses recorded in VTA. Comparison of 
the integral of sensory-evoked responses during 0.5 sec poststimulus interval between 
baseline and drug condition revealed an overall decreased response magnitude in the 
average VTA population (Figure 3.28 left; F(1, 25) = 5.41, p < 0.05), independent from 
direction of spontaneous activity modulation. MUA recorded in two sites in the SNc did not 
show any effect (Figure 3.28 right; F(1, 3) = 0.06, p = n.s.). 
 
 
Figure 3.28: Single unit responses to FSs in the VTA and SNc. Smoothed average PSTHs during 
baseline condition (yellow) and under local inhibition of LC activity (red) are shown. Stimulation was 
applied at time 0 (black dashed line). Bin size = 10 ms. Insets illustrate the difference between the 
integral over 0.5 sec during baseline (B) and clonidine (C) condition. Mean ± SE, * p < 0.05. 
 
In conclusion, removal of stimulus-related phasic release of NE into the VTA generally 
diminished ventral tegmental sensory signaling. In contrast, the sensory-evoked responses 
in the SNc are not modulated by NE. Since phasic activity generally leads to higher release 
of neurotransmitters in target regions134,348,359-366, a reduction of sensory-evoked phasic 
responses in VTA dopaminergic neurons, results in a decrease of available DA in mPFC 
during sensory processing. 
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3.3. Dopaminergic modulation of sensory gating 
In the previous experiment, a decrease of stimulus-induced excitation of neurons in the 
dopaminergic VTA was observed when the tonic and phasic activity of the noradrenergic 
system was inhibited by local infusion of clonidine into LC. Under this condition, the 
release of NE as well as DA is reduced in mPFC which resulted in the complex effects 
described in section 3.1. 
Next, sensory processing in mPFC was explored under specific manipulation of the 
dopaminergic system while leaving the noradrenergic system intact. A new set of 
experiments was designed in order to explore both the modulation of neuronal activity in 
mPFC and the behavioral outcome after processing of sensory stimulation. Therefore, non-
anesthetized rats were tested on sensory gating by using two different standard sensory-
gating paradigms: PPI and ASG. 
Thirteen rats were simultaneously 
tested on both sensory gating 
paradigms. Concurrently, SEPs were 
recorded in PrL, confirmed by 
histological examination of the 
recording sites (Figure 3.29). In two 
out of 13 rats, the recording was not 
successful and only the magnitude of 
the behavioral acoustic startle 
response detected by the piezoelectric 
sensor under the floor was analyzed. 
Before testing, the midbrain 
dopaminergic system was 
pharmacologically manipulated by 
drug infusion via bilaterally 
implanted cannulae targeting the 
ventral midbrain (Figure 3.30).  
 
Figure 3.29: Coronal schematic views showing the 
electrode positions in the PrL in awake rats tested on 
sensory gating. Numbers illustrate distance from bregma 
in mm for each section. Inset illustrates the antero-
posterior extent of recording sites by aid of a colored bar 
in a sagittal plane of the brain. Top numbers indicate 
distance from bregma, bottom numbers distance from 
interaural line and vertical numbers depth in mm, 
respectively. 
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The pharmacological manipulation was specifically designed to explore the role of 
dopaminergic modulation of sensory gating in mPFC. To recap briefly, alpha 2-
adrenoceptors were activated by local infusion of clonidine into the ventral midbrain in 
order to generally decrease dopaminergic transmission to VTA target structures. 
Furthermore, infusion of κ-opioid agonist U69593 and dopaminergic D2-receptor agonist 
quinpirole was used to selectively inhibit dopaminergic transmission to mPFC or non-PFC 
target structures, respectively. Saline infusion was used as control condition. 
 
Figure 3.30: Coronal views showing the 
tips of chronically implanted bilateral 
cannulas used for drug infusion into the 
ventral midbrain. A) Representative 
histological section showing lesions 
created by implanted cannulas into the 
ventral midbrain (left). Red circles 
indicate estimation of drug diffusion in 
the tissue. Coronal schematic view of 
corresponding section (right) shows 
estimated drug diffusion in VTA 
(orange) as well as partly in SNc 
(yellow). B) Schematic views illustrate 
tips of implanted infusion cannulas for 
all rats tested on sensory gating. 
Corresponding tips of bilateral cannulas 
are connected by a red line. Numbers 
illustrate distance from bregma in mm 
for each section. Inset illustrates the 
antero-posterior extent of infusion sites 
by aid of a colored bar in a sagittal 
plane of the brain. Top numbers 
indicate distance from bregma, bottom 
numbers distance from interaural line 
and vertical numbers depth in mm, 
respectively. 
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3.3.1. Characterization of PPI and ASG under baseline condition 
First, the behavioral and neuronal effects of sensory stimulation are described under saline 
condition only. For the PPI paradigm, 65 sessions were recorded out of which 52 sessions 
included SEP recordings from mPFC. Effective PPI was confirmed by decrease of the ASR 
from -0.66 ± 0.09 mV to -0.19 ± 0.02 mV when prepulse was presented 100 ms prior to 
startle pulse (Figure 3.31A, F(1,129) = 23.65, p < 0.001). Simultaneous recording in mPFC 
revealed that PPI was also present on the neuronal level (Figure 3.31B) as the amplitude of 
the SEP was significantly decreased from -0.12 ± 0.01 mV to -0.06 ± 0.01 mV when 
prepulse was paired with a startle pulse (Figure 3.31B; F(1,103) = 18.37, p < 0.001). 
 
 
Figure 3.31: Prepulse Inhibition of the acoustic startle response (ASR) and corresponding prefrontal 
SEPs after infusion of saline into the ventral midbrain. A) The amplitude of the ASR in response to 
startle stimulus (broad band noise, 20ms, 100dB) only (Non-gated) was reduced when a prepulse 
(10kHz, 20ms, 75dB) was presented 100 ms prior to the startle stimulus (Gated). Bars illustrate average 
magnitude of the ASR. B) PPI was also evoked at the neuronal level. Comparable to the ASR in A, 
presentation of a prepulse prior to a startle stimulus (prepulse + Startle) reduced the amplitude of the 
SEP in response to startle stimulus only (Startle only). Arrow illustrates neuronal response to 
presentation of prepulse. Mean ± SE, *** p < 0.001. 
 
The ASG paradigm was tested simultaneously with PPI. The parameters used for this 
stimulation were identical to the parameters used for the prepulse in the PPI paradigm. 
Since this stimulation was not as salient as the startle pulse used for PPI, the SNR of the 
neuronal signal was much lower. The average amplitude of the SEP in response to 
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condition stimulus was -0.05 ± 0.00 mV compared to -0.12 ± 0.01 mV in response to startle 
pulse only. According to the literature, the amplitude of the neuronal response to condition 
stimuli is supposed to be larger than the amplitude of the response to test stimuli in healthy 
animals. Therefore, sessions were excluded when, due to low SNR, this condition was not 
fulfilled for average amplitude of SEPs. In total, data out of 40 sessions represent the 
sensory gating effect in mPFC neuronal activity (Figure 3.32) in which the average 
amplitude of the neuronal response to test stimuli was confirmed to be significantly smaller 
than to condition stimuli (0.05 ± 0.00 mV vs. 0.02 ± 0.00 mV; F(1,79) = 49.11, p < 0.001). 
 
 
Figure 3.32: Auditory Sensory Gating of SEP in 
mPFC after infusion of saline into the ventral 
midbrain. A superposition of average SEPs in 
response to two identical auditory stimuli (10kHz, 
20ms, 75dB), presented 500 ms apart from each 
other, is illustrated. Naturally, the SEP in response 
to the second stimulus (Test stimulus) is reduced in 
comparison with the SEP in response to the first 
stimulus (Condition stimulus). Mean ± SE. 
 
 
3.3.2. Dopaminergic modulation of sensory gating in mPFC 
ASR and SEPs, which were reduced due to sensory gating mechanisms, induced by either 
prior presentation of the prepulse or condition stimulus, are henceforth referred to as 
“gated” responses. Accordingly, responses to only startle stimulus or to condition stimulus 
are referred to as “non-gated” responses. 
The magnitude of sensory gating is illustrated as percentage of inhibition relative to the 
non-gated response. However, modulation of sensory gating might have different 
underlying mechanisms. An impairment of PPI, for example, is illustrated by a decrease of 
percentage of PPI (%PPI), which might result from either an increase of the gated response 
or a decrease of the non-gated response. Therefore, the absolute response amplitudes are 
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additionally illustrated in order to compare the underlying mechanisms between the drug 
effects and between the paradigms. 
3.3.2.1. Modulation of sensory gating under general decrease of 
dopaminergic transmission 
Activation of alpha 2-adrenoceptors by infusion of clonidine into the ventral midbrain was 
performed in 22 sessions which were compared to corresponding sessions under saline 
condition. PPI of the ASR was not affected by this treatment (Figure 3.33A; 
F(1, 43) = 0.02, p = n.s.): neither the amplitude of the non-gated ASR (F(1, 43) = 0.02, 
p = n.s.) nor the gated ASR (F(1, 43) = 0.00, p = n.s.) was modulated. However, the PPI of 
the SEP (n = 18) was significantly reduced from 67.98 ± 10.24 % to 39.66 ± 10.00 % 
(Figure 3.33B left; F(1, 35) = 3.91, p = 0.05). This reduction resulted from a significant 
increase of the amplitude of gated SEP (F(1, 35) = 5.21, p < 0.05) from -0.04 ± 0.01 mV to 
-0.09 ± 0.01 mV (Figure 3.33B right). Nevertheless, ASG (n = 13) was not affected by this 
treatment (F(1, 27) = 0.35, p = n.s.) indicating a different sensory gating mechanism than 
for PPI (Figure 3.33C). Neither the amplitude of SEP in response to condition stimulus 
(-0.05 ± 0.00 mV and -0.04 ± 0.00 mV for saline and drug condition, respectively) nor the 
amplitude of SEP to test stimulus (-0.03 ± 0.00 mV and -0.02 ± 0.00 mV for saline and 
drug condition, respectively) differed between saline and drug condition (condition 
stimulus: F(1, 27) = 0.29, p = n.s.; test stimulus: F(1, 27) = 0.03, p = n.s.). 
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Figure 3.33: Modulation of sensory gating after infusion of clonidine into the ventral midbrain. Degree 
of sensory gating is illustrated as percentage of inhibition relative to the non-gated response (left 
column). Absolute response amplitudes are additionally illustrated (right column). A) Average 
percentage of Prepulse Inhibition of the ASR (PPI, left) and average amplitudes of gated and non-gated 
ASR (right) are compared between saline and drug condition. B) The prefrontal SEPs are compared 
between saline and drug injection analogous to A. C) Average percentage of Auditory Sensory Gating 
(ASG, left) and average amplitudes of non-gated and gated SEPs in response to Condition and Test 
stimuli (right) are compared between saline and drug condition. Mean ± SE, * p < 0.05. 
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3.3.2.2. Modulation of sensory gating under decrease of dopaminergic 
transmission selectively to mPFC 
Infusion of the the κ-opioid agonist U69593 was performed in 23 sessions to selectively 
inhibit the dopaminergic transmission to mPFC. 
 
Figure 3.34: Modulation of sensory gating after infusion of U69593 into the ventral midbrain. 
Conventions are the same shown in Figure 3.33. Arrows indicate shift of the amplitude balance between 
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gated and non-gated responses resulting in modulation of percentage of sensory gating (left). 
Mean ± SE, * p < 0.05. 
 
Comparable to the condition after infusion of clonidine into the ventral midbrain, this 
treatment left the PPI of the ASR unaffected (Figure 3.34A; F(1, 45) = 0.7, p = n.s.) but 
reduced the PPI of SEP (Figure 3.34B left; n = 15; F(1, 29) = 4.6, p < 0.05) from 
63.60 ± 11.32 % to 27.36 ± 12.55 %. However, in contrast to the effect under clonidine 
condition, reduced PPI resulted from a non-significant increase of the amplitude of gated 
SEP amplitude from -0.07 ± 0.02 % to -0.08 ± 0.01 % when startle stimulus was preceded 
by prepulse (F(1, 29) = 0.2, p = n.s.), in combination with a non-significant decrease of 
non-gated SEP amplitude from -0.16 ± 0.02 % to -0.12 ± 0.02 % when startle stimulus was 
presented only (Figure 3.34B right; F(1, 29) = 1.1, p = n.s.). Likewise, but in contrast to 
effects under clonidine condition, percentage of ASG was significantly decreased 
(F(1, 27) = 5.83, p < 0.05) from 81.06 ± 3.89 % to 61.54 ± 7.09 %. This happened because 
of a slight increase of the amplitude of gated SEP (F(1, 27) = 2.48, p = n.s.) from 
-0.01 ± 0.00 mV to -0.02 ± 0.00 mV combined with a slight decrease of non-gated SEP 
(Figure 3.34C; F(1, 27) = 0.7, p = n.s.) from -0.07 ± 0.01 mV to -0.05 ± 0.01 mV. Hence, 
when dopaminergic transmission was selectively decreased in mPFC, PPI and ASG seemed 
to share underlying gating mechanisms. 
3.3.2.3. Modulation of sensory gating under decrease of dopaminergic 
transmission in ventral midbrain target regions other than mPFC 
Finally, the dopaminergic D2-receptor agonist quinpirole was infused into the ventral 
midbrain of 22 rats (21 rats including recordings of SEPs in mPFC) with the aim to inhibit 
dopaminergic transmission to all target regions except mPFC. This pharmacological 
manipulation, however, did not have any effect on the tested parameters (Figure 3.35, 
Supplementary Table 7.14). 
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Figure 3.35: Sensory gating was not modulated after infusion of quinpirole into the ventral midbrain. 
Conventions are the same shown in Figure 3.33. 
 
Together, pharmacological manipulation of the ventral midbrain only affected sensory 
gating when dopaminergic transmission to mPFC was reduced. Infusion of both clonidine 
and U69593 resulted in sensory gating deficits only at the neuronal level, while the ASR 
was not affected by any of the drugs. Observed sensory gating deficits appeared to have 
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different mechanisms: after infusion of clonidine, the gating effect of the prepulse was 
eliminated while after infusion of U69593, a shift in the balance of the amplitude of gated 
and non-gated SEP resulted in a decreased percentage of PPI as well as ASG. The latter, 
however, was not affected under clonidine condition. In conclusion, mPFC is essential in 
order to adequately extract biologically relevant sensory information but only when DA 
release in this brain structure is provided. 
4. Discussion 
4.1. Noradrenergic modulation of sensory processing in two functionally distinct 
cortical regions 
The first part of this thesis aimed to resolve the question about how neuronal activity during 
functionally different sensory processing in primary sensory and higher association cortical 
areas is modulated by the catecholaminergic neuromodulator NE. Simultaneous recording 
of LFP and SUA in S1HL and mPFC under constant monitoring of LC neuronal activity 
enabled a direct comparison of spontaneous and sensory-evoked neuronal activity under 
identical experimental conditions. 
4.1.1. Somatosensory stimulation addressed dermal nociceptors 
Electrical transcutaneous stimulation into the hind paw with different stimulation 
parameters revealed several indicators suggesting that stimulation was of a nociceptive 
nature: 1) Unlike neuronal activity in LC and mPFC, response amplitude in S1HL was not 
dependent on stimulus intensity. Previous literature shows that amplitude modulation of 
neuronal activity in S1 was observed in response to innocuous somatosensory stimulation 
but as soon as peripheral A δ- or C-fibers were addressed by noxious somatosensory 
stimulation, neuronal activity responded with constant amplitude reporting the presence of 
the stimulation only79. 2) According to previous studies, LC noradrenergic neurons in rats 
under urethane anesthesia, like in the present study, only respond to noxious somatosensory 
stimulation125,128-130. 3) Cortical sensory-evoked responses emerged to be only excitatory. 
However, previous studies, examining the response profiles of neurons in the S1 and the 
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PFC to different strengths of stimulation, showed that the neurons are excited or inhibited 
to natural sensory stimulation81,695,696. Interestingly, particular strong or noxious sensory 
stimulation evoked exclusively excitatory response profiles70,105,695. 4) Finally, reported 
biphasic response profile in S1HL84,92 as well as tonic sustained response in mPFC70, 
resembling recorded profiles in response to electrical FS stimulation in the current study, 
has been observed to be characteristic for peripheral nociceptive stimulation. In conclusion, 
the somatosensory stimulation with the parameters used here was of noxious nature and, 
thus, sensory information was processed in brain structures belonging to the pain matrix11-
18. 
4.1.2. Comparable effects between local and systemic clonidine administration 
suggests that reduced NE release mainly affected sensory processing in 
both cortical regions 
Manipulation of the noradrenergic system was performed by local infusion of clonidine into 
LC and by systemic injection of clonidine. In response to either pharmacological 
manipulation, the spontaneous activity of LC noradrenergic neurons was decreased, as 
already demonstrated in previous studies205,262,266,270,271,697. The phasic excitation of LC 
neurons to peripheral FS stimulation, however, was differentially affected. Specifically, 
local injection of clonidine into LC expectedly decreased the phasic sensory-evoked 
response as demonstrated before266 but, surprisingly, the response after systemic injection 
of clonidine was preserved. This effect might result from a selective action of clonidine on 
excitatory imidazoline-receptors on neurons in the PGi698 which mediates the 
somatosensory response in LC146,699. Activation of imidazoline-receptors exerts additional 
excitatory drive on LC noradrenergic neurons268,700 supposedly overwhelming the 
inhibitory action of clonidine on alpha 2-adrenoceptors within LC. Consequently, local 
somatodendritic LC inactivation suppressed tonic and phasic release of NE in LC terminal 
regions132,266,269-271,701,702 but systemic injection of clonidine is expected to leave the phasic 
release intact. On the other hand, since clonidine is ubiquitously present after systemic 
injection, activation of inhibitory alpha 2-noradrenergic autoreceptors in the presynaptic 
membrane of LC afferents might inhibit terminal release of NE488-491,688 despite phasic 
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activation of LC neurons. In the current study, the overall effects were mostly comparable 
between the two drug conditions albeit the global effects after systemic injection were 
regularly stronger than after local unilateral inhibition of LC activity. Therefore, a general 
deprivation of NE from the CNS by predominant actions on somatodendritic and terminal 
presynaptic alpha 2-noradrenergic autoreceptors is assumed. 
4.1.3. Cortical NE deprivation activated ongoing cortical state in higher 
association cortex while deactivation was observed in primary sensory 
cortex 
The main and most surprising result was an activation of the ongoing cortical activity state 
in mPFC after systemic injection of clonidine while ongoing cortical state in S1HL was 
expectedly deactivated after either pharmacological manipulation method. Naturally, the 
neuronal firing activity in LC is strongly related to behavioral state of vigilance in rats170-
173, cats174 and monkeys175. Accordingly, noradrenergic neurons in LC are active during 
awake state and associated release of NE activates cortical state. Over the course of slow 
wave sleep, LC neuronal activity is decreased until it ceases during REM sleep. 
Consequently, artificial reduction of NE release by local LC inactivation or systemic 
activation of presynaptic alpha 2-autoreceptors is expected to induce cortical deactivation. 
Previous studies show that systemic injection of alpha 2-adrenoceptor agonists increases 
power in low frequency range186, creates a slow wave sleep-like cortical state and induces 
resting behavior in animals193-196 and humans187-192. Correspondingly, systemic treatment 
with alpha 2-adrenoceptor agonists is used in clinics as sedative and thus, to induce resting 
state197-199. In contrast to the present study, these effects were shown in non-anesthetized 
rats and humans. General anesthesia, however, is also known to induce a sleep-like state 
characterized by high amplitude-low frequency oscillation pattern63-65 although urethane 
anesthesia is special by demonstrating spontaneous alternations of cortical activity between 
activated and deactivated state66,67. Therefore, urethane anesthesia resembles natural sleep 
via integration of REM-like cortical state activity. This was confirmed in the current study 
and, under this condition, systemic and intra-LC injection of clonidine induced expected 
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increase of power in medial frequency range with maximum effect in sleep-related Sigma 
frequency band, but only in S1HL. 
4.1.4. Systemic injection of clonidine induced cortical activation in mPFC in 
favor of internal long-range cortico-cortical interaction 
Prefrontal cortical state was activated after systemic clonidine administration, which was 
reflected in decreased power in SLO frequency band accompanied with an increase in 
power in Theta and Alpha frequency range. Power in SLO frequency band is usually 
associated with synchronized oscillation in Sigma frequency band and thus with a transition 
from awake to sleep state in animals30,32 and humans703. Transition from slow wave sleep to 
REM sleep is characterized by activation of cortical state resembling awake state, however 
including muscle atonia, regular eye movements and dreaming704,705. In both sleep states, a 
deafferentation of the cortex is discussed in favor of an intrinsic thalamo-cortical, cortico-
cortical and cortico-hippocampal information processing27,37,706-710. Increased power in 
Theta and Alpha frequency band might be beneficial for such interactions. Indeed, a close 
relationship between power in Theta and Alpha frequency band was reported in PFC706, not 
only during Theta-related memory processes711-713 but also during Alpha-related internal 
mental activities, for example meditation714. More specific, in non-awake condition, it was 
shown that power in Theta frequency band increases during REM sleep in humans715,716 
and rats717. During awake state, increased power in Theta frequency band was observed 
during performance of memory-related tasks in humans711,718-721 and rats722-725 or during 
experience of emotional memory in humans726 and rodents717,727. Power in Alpha frequency 
band is commonly associated with internally directed cortical operations during the resting 
state in absence of sensory input43-45 but it was also related to memory-related cognitive 
processes711,728-731. In summary, power in Theta and Alpha frequency range is increased 
during conditions requiring cortical state activation for internal cognitive processes related 
to memory functions in mPFC. Global actions on pre- and postsynaptic alpha 2-
adrenoceptors by systemic clonidine injection, might promote these processes by 
uncoupling of the cortex from the outside world and enhancement of long-range 
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communication in Theta and Alpha frequency range with related structures outside of 
mPFC. 
4.1.5. Power in Theta and Alpha frequency range in S1HL is modulated by 
cortical activity state in mPFC 
Such a long-range interaction in Theta and Alpha frequency range was also indicated 
between mPFC and S1HL in the current study. This was observed during baseline condition 
after comparison of TCA in S1HL distinguished by effectiveness of cortical state activation 
in mPFC (TCA+ vs. TCA-). The analysis revealed, interestingly, that only power increase 
in high frequency range in S1HL was highly sensitive to sensory stimulation while 
modulation of spectral composition in low frequency range was dependent on effectiveness 
of FS stimulation in mPFC. In particular, a decrease of power in low frequency range was 
only significant when cortical state in mPFC was effectively activated in response to 
sensory stimulation. Thereby, BLP changes in Theta and Alpha frequency range differed 
significantly between conditions. Interestingly, a strong relationship of power in these two 
frequency bands between S1HL and mPFC was also observed during ongoing cortical state 
activity. Previous literature demonstrated long-range fronto-parietal or fronto-temporal 
interactions in Theta and Alpha frequency range during internal mental processing, i.e. top-
down processing, in humans712,726,728,732 while power in high frequency range is rather 
locally generated26,712. Alternatively, correlated power especially in low frequency range 
between mPFC and S1HL does not necessarily reflect functional coupling between the two 
brain regions but might result from so-called volume conduction. Accordingly, it is 
believed that low frequencies travel further through the neuronal tissue than high 
frequencies26,733,734. This is related to the commonly observed “1/f” power distribution of 
LFP, implying an inverse relation of the magnitude of LFP power to its temporal 
frequency658-660 which was also observed in the present study. If, however, effects like 
volume conduction would lead to the cortico-cortical interactions in Theta and Alpha 
frequency bands observed here, then BLP in the lowest Delta frequency band would also be 
related between the two cortical regions. 
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Another possibility might be that a third structure modulates power in low frequency range 
in mPFC and S1HL in a similar manner. However, top-down modulation of S1 by higher 
brain areas in favor of accurate sensory perception has already been demonstrated before735. 
In conclusion, a top-down functional modulation of power in Theta and Alpha frequency 
range in S1HL by cortical activity state in mPFC can be assumed, while increase of power 
in high frequency range in response to sensory stimulation is regulated by local neuronal 
activation within the primary sensory region. 
4.1.6. Sensitivity differences to sensory stimulation between S1HL and mPFC 
might functionally result from differences in neuronal excitability during 
ongoing cortical state 
Activation of the cortical state in mPFC by systemic clonidine injection was additionally 
indicated by increased probability of TCA in response to electrical FS stimulation. Under 
drug-free baseline condition, significant neuronal activation in mPFC was only selectively 
evoked (as estimated on different neuronal levels such as TCA, SEP and SUA) even though 
the peripheral somatosensory stimulation was of noxious nature. In contrast, neuronal 
activity in S1HL was highly sensitive to somatosensory stimulation. In general, the 
decreased response sensitivity in mPFC in comparison to S1HL pyramidal neurons might 
result from lower power in medial frequency bands accompanied by lower single unit 
spontaneous firing rate. This indicates decreased baseline excitability in mPFC pyramidal 
neurons during ongoing cortical state under urethane anesthesia. A similar difference in 
neuronal excitability state between mPFC and primary visual cortex was reported in awake 
mice65. Anesthesia, however, induced a cortical state with contrasting oscillation pattern in 
comparison to the current study. Under isoflurane anesthesia, power in the frequency 
spectrum < 40 Hz in mPFC was higher compared to primary visual cortex65. Ketamine 
anesthesia induced a state in which BLP in prefrontal Beta and Gamma frequency bands 
was higher than in S164. Nevertheless, spectral composition between primary sensory and 
prefrontal regions was never compared under urethane anesthesia which, as demonstrated, 
exhibits an incomparable physiological state to other commonly used anesthetics. 
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4.1.7. Reduction of cortical NE release induced responsiveness to sensory 
stimulation in initial mPFC TCA- cases while power in Sigma and Beta 
frequency bands was differentially modulated in S1HL and mPFC TCA+ 
cases 
Sensory-related activation of mPFC was inversely related to cortical state activity during 
prestimulus interval under baseline condition. Consequently, TCA was evoked in about half 
of the cases when BLP in SLO frequency band was low, while cortical state in residual 
cases remained unaffected (TCA-) during high power in SLO frequency band. Hence, 
S1HL, which was reliably activated in response to noxious stimulation, detects and 
processes sensory input, irrespective of whether the system is active or not, however, for 
higher cognitive processing, the system has to active. 
When the cortex was deprived from NE by either experimental manipulation, initial TCA- 
cases, unexpectedly, became activated in response to sensory stimulation albeit the spectral 
composition was different from the initial definition of TCA. Instead of significant decrease 
of power in Delta frequency band accompanied by a significant increase of power in 
Gamma frequency band, stimulus-induced cortical state activation under clonidine 
condition was represented by increased power in high frequency range only, while power in 
low frequency range was unaffected. In accordance with the general notion that power in 
Gamma frequency band is related to unit firing activity26,680,681, initially non-responsive 
single units showed gating effects which were directly related to the stimulus-evoked 
increase in high frequency band. 
Prefrontal TCA+ cases kept their responsiveness to sensory stimulation but their spectral 
composition was modulated.  Specifically, stimulus-induced BLP change in Sigma and 
Beta frequency band was increased in mPFC under condition of systemic clonidine, which, 
interestingly, was just contrary to decreased BLP change in the same frequency bands in 
S1HL. Decrease of power in Sigma frequency range is associated with increased cortical 
state activation and, thus, indicates enhanced probability to process incoming noxious 
information although the ongoing cortical state is highly deactivated in S1HL. Accordingly, 
simultaneous increase of stimulus-related BLP change in Sigma frequency band in mPFC 
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suggested resting state processing and, thus, a lower priority in higher order processing of 
sensory stimuli. Together these results postulate that under anesthetized condition and 
along with using systemic alpha 2-adrenoceptor agonists, information about noxious 
sensory stimulation might still be able to access the system. However, this occurs without 
an interpretation of the biological meaning by processes in cognitive regions like mPFC. In 
short, the stimulation might be sensed but not perceived. On the other hand, cortical state 
activation of initially non-affected TCA- cases indicates enabled higher order cognitive 
processing of sensory stimulation in mPFC. Nonetheless, about modulation of sensory 
perception can be only speculated as experiments here were performed in anesthetized 
condition. Therefore, more research in non-anesthetized subjects is needed in order to 
explore whether noxious sensory stimulation is perceived under sedated condition. 
Noradrenergic modulation of stimulus-related BLP change in Beta frequency band was 
homologous to BLP change in Sigma frequency band in both cortical regions. Classically, 
power in Beta frequency band is related to sensorimotor functions and activation of the 
cortical state48,49. Synchronization in Beta frequency band was observed in response to 
voluntary, passive or imagined movements736-740 as well as to movements which were 
induced by electrical muscle stimulation737. A muscle twitch of the foot was indeed 
observed in response to intradermal electrical FS stimulation which might have induced 
transient increase of power in Beta frequency band. However, homologous modulation of 
stimulus-related power change in sleep-related Sigma and activity-related Beta frequency 
band under condition of systemic clonidine is hard to interpret, especially on the 
background that the modulation in S1HL and mPFC is quite contrary to each other. On the 
other hand, homologous modulation of BLP in different frequency bands is not necessarily 
functionally related to each other. It is not uncommon that certain cortical regions engage in 
different neuronal interactions exhibiting distinct spectral profiles for local encoding and 
remote integrative functions26,741-744. 
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4.1.8. Depletion of cortical NE release reduced SNR in S1HL while local 
network properties in mPFC were reorganized by redistribution of 
neuronal activity 
Modulation of cortical activity state reflects only the net outcome of underlying voltage 
fluctuations during different experimental conditions. Further exploration of SEPs and SUA 
revealed that neuronal activity in mPFC was not generally activated by a decreased NE tone 
in LC target regions. Instead, affected neurons in mPFC showed a complex modulation 
pattern suggesting a drug-induced reorganization of activated neurons in the local network, 
thus resulting in a generally activated cortical state. Specifically, in addition to 
aforementioned gating effects in initially non-responsive single units, amplitude of sensory 
evoked responses in initially responsive single units was decreased after either 
pharmacological manipulation. Moreover, spontaneous activity was similarly 
bidirectionally modulated as already reported in previous work227,245,247,252. In contrast, NE 
in sensory regions is known to promote SNR by inhibition of spontaneous 
activity228,229,240,661-663 and enhancement of synaptic excitation228,229,236-239. Accordingly, 
deprivation of NE in the brain resulted in decreased SNR and hence decreased neuronal 
responsiveness under condition of deactivated cortical state in S1HL. 
The differential modulation of neuronal activity between S1HL and mPFC probably results 
from divergent receptor composition in the two cortical regions. Alpha 1-adrenoceptors are 
most prominent in PFC225 while alpha 2-adrenoceptors are predominant in parietal and 
temporal cortical regions where sensory cortices are located 225,230,231. Functionally, the 
latter was reflected in the stronger reduction of responsiveness in S1HL compared to mPFC 
after systemic injection of clonidine which acts on postsynaptic alpha 2-adrenoceptors. It 
therefore leads to a decrease in the excitability of the pyramidal neurons256 in addition to 
presynaptic inhibition of NE release488-491,688,701,745-748. In mPFC, adequate activation of 
alpha 1-adrenoceptors is essential for cognitive functions in rodents, monkeys and 
humans443,446-453. It was shown that mPFC has a higher demand for NE223,749, presumably 
because alpha 1-adrenoceptors exhibit a lower affinity than alpha 2-adrenoceptors234. 
During baseline conditions, this demand is covered by heterogeneously organized LC 
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projections and activity state of LC noradrenergic neurons223, e.g. phasic NE release in 
response to salient stimuli or cognitive engagement126,127,134. Alpha 2-adrenoceptors are 
additionally expressed in PFC225,230,231 which suggests that the bidirectional noradrenergic 
modulation of neuronal activity in mPFC results from different neuronal populations with 
distinct receptor properties. Consequently, postsynaptic activation of alpha 2-adrenoceptors 
reduces neuronal activity in one population, while actions on alpha 1-adrenoceptors 
enhance synaptic drive in another population. Accordingly, removal of NE from mPFC 
reorganized the local neuronal network activities by disinhibition due to missing actions on 
alpha 2-adrenoceptors and deactivation by missing actions on alpha 1-adrenoceptors in 
respective populations. 
Beyond an apparent population-dependent noradrenergic modulation of single units, 
complex composition of functionally divergent networks in mPFC is reflected in the 
number of neuronal subpopulations, defined by different PSTH profiles in response to 
sensory stimulation. In contrast to S1HL, where two groups could be distinguished by 
whether or not a late response component was present, four groups were extracted in mPFC 
of which one was even merged out of intermixed profiles (group 3). Additionally, the SEP 
in S1HL was composed of clearly distinguishable response components which have been 
previously reported2,80-85. In comparison, a single merged voltage deflection was observed 
in mPFC, most likely integrated from incoming sensory information arising from multiple 
afferent structures108,109. Certainly, sensory-evoked responses in mPFC do not consist of a 
pure somatosensory component but a composition resulting from integrating information 
incoming from various structures of the limbic system. This is further suggested by the 
observed longer response latency of > 120 ms. Information flows from the medial part of 
the thalamus either directly to the mPFC750 or indirectly via the Amygdala68,751, the HPC752, 
the Insula750 or other structures of the limbic system109,750 integrating the sensory aspect of 
the stimulus to higher cognitive components109. Processing of information between these 
different contributing networks might result in the different groups of prefrontal response 
profiles, which are merged into one single voltage deflection at the population level. This 
complex cortical population responsiveness to salient sensory stimulation in mPFC depends 
therefore on the afferent input and local organization of the cortical microcircuitry and NE 
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apparently orchestrates the network properties by suppression of irrelevant and 
accentuation of relevant information within the network. The aim would be to adequately 
evaluate the biological relevance of the stimulus and integrate complex properties of 
sensory information along with matching input from other, non-sensory brain structures in 
order to coordinate an appropriate behavioral outcome. 
4.1.9. Neuronal responses to noxious stimulation are sustained by phasic NE 
release in cortical regions 
A detailed observation of suppressive effects of noradrenergic manipulation on single unit 
responses to noxious stimulation noticeably revealed that systemic injection of clonidine 
reduced the entire response profile in the cortical regions under study. In contrast, local LC 
inactivation suppressed only the late response components in the two cortical structures. 
This might be attributed to, firstly the long response latency of LC noradrenergic neurons 
(~ 70 ms) in relation to the short latency phasic response component in S1HL (~ 20 ms). 
Secondly, this could be explained by the general delayed time course of LC mediated 
effects due to slow conduction velocity of thin, non-myelinated axons of catecholaminergic 
neurons and slow dynamics of NE release753,754. Accordingly, it was demonstrated that NE 
release in S1 in response to strong salient events occurs within a range of 100 – 350 ms755. 
Furthermore, priming phasic activation of LC neurons increased excitatory cortical 
neuronal responses to forepaw stimulation in S1 only with a long interstimulus interval of 
200 – 300 ms243. These time windows are comparable to the modulation periods of the 
delayed response components in S1HL and mPFC single units after local injection of 
clonidine in the current study. Modulation of the late response components only, instead of 
entire response profiles, indicates dependency from phasic release of NE which results in a 
fourfold higher concentration of neuromodulator in cortical tissue compared to tonic 
release134. This concentration is effective to act on depolarizing, low-affinity alpha 1-
noradrenergic receptors234 in order to sustain sensory-evoked single unit activity in LC 
cortical target regions which has been previously demonstrated246. Amplification of 
stimulus-related neuronal activation by NE was additionally demonstrated by reduction of 
SEPs in mPFC TCA+ cases under condition of NE deprivation by systemic clonidine 
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injection. SEPs in TCA- cases were already of smaller magnitude during baseline 
condition. Given the background that the neuronal activity of LC noradrenergic neurons is 
directly related to the cortical activity state170-173, this might be related to a decreased NE 
release when cortical state is more deactivated. Nevertheless, a further decrease of 
amplitude and magnitude was indicated in mPFC TCA- cases after local LC inactivation 
albeit not significantly. Confirmation of this effect together with examination of a 
functional relationship would be a potential subject to future studies. 
4.2. Noradrenergic modulation of the midbrain dopaminergic system 
4.2.1. Noradrenergic modulation of ventral midbrain spontaneous activity is 
dependent on localization of the recorded population within VTA 
In addition to the LC noradrenergic system, neuronal activity in the midbrain dopaminergic 
VTA modulates neuronal activity in mPFC via the mesocortical DA system. Furthermore, it 
was shown that the VTA is engaged in salient sensory processing including nociceptive 
input326-328,332,336,337,340,516-520. When neuronal activity in LC was unilaterally inhibited in the 
current study, population spontaneous activity in ipsilateral VTA was bidirectionally 
modulated. Interestingly, this modulation was dependent on the localization of the recorded 
population within the VTA: MUA recordings which were performed in the anterior and 
lateral VTA demonstrated decreased spontaneous firing activity while in the posterior-
medial VTA increased spontaneous firing was observed. Previous observations showed that 
dopaminergic neurons within the VTA reduced their firing activity and associated DA 
release in VTA target regions when the concentration of NE was enhanced by intra-VTA 
infusion of NE or systemic injection of selective NERI496-498. Accordingly, VTA 
dopaminergic neurons enhanced firing activity after lesion of LC494,496, which was also 
demonstrated here in the population activity recorded from posterior-medial VTA after 
local LC inactivation. Nevertheless, this does not indicate that dopaminergic neurons are 
exclusively located in the posterior-medial VTA. In recent years, it was demonstrated that 
dopaminergic neurons in the VTA show less uniform properties than dopaminergic neurons 
in the SNc307,756,757. In fact, dopaminergic neurons in the VTA are very diverse in their 
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electrophysiological properties and molecular characteristics including receptor 
composition758-762. Additionally, the functional identity of VTA dopaminergic neurons 
depends on their afferent and efferent connectivity761-764 which is related to dopaminergic 
modulation of behavioral functions765. It was specifically shown that reward and aversion 
are modulated by dopaminergic populations in the VTA with diverging 
electrophysiological and molecular properties299,300,345,373,766. Neurons from the laterodorsal 
tegmentum preferentially synapse on dopaminergic neurons within the VTA which project 
to the NAc and code for rewarding events. On the other hand, aversive events are processed 
in a pathway originating in neurons of the lateral Habenula which synapse on VTA 
dopaminergic neurons projecting to the mPFC. These meso-prefrontal dopaminergic 
neurons are located in the medio-posterior VTA299,300,345,762 just like the neuronal 
populations which increased the spontaneous firing when LC neuronal activity was 
inhibited in the present study. 
4.2.2. Phasic release of NE in VTA enhances sensory processing 
Independent from localization within the VTA, the magnitude of the sensory-evoked multi 
unit response to noxious stimulation was suppressed when the noradrenergic transmission 
from LC was inhibited. This implies that NE in VTA is needed to reinforce sensory 
processing of VTA net outcome. Consequently, phasic release of both NE from LC134,135,767 
and DA from VTA329-339 in response to noxious stimulation was reduced in the mutual 
target structure mPFC. Hence, the observed effects in the previous section most likely 
reflect synergistic modulation of prefrontal neuronal activity by catecholaminergic systems. 
Reduction of noradrenergic tone induced a reorganization of the neuronal activity in mPFC 
local networks which was reflected in bidirectional modulation of cortical activity state and 
SUA. A possible outcome of this modulation pattern might be the suppression of irrelevant 
and accentuation of relevant information, a brain function called Sensory Gating. Very 
early studies from the 1980s demonstrated that neurotoxic lesion of the dorsal 
noradrenergic bundle by local 6-OHDA infusion, which deprives the forebrain from NE but 
not DA, impairs the ability to ignore irrelevant stimuli in rats158,768-770. Sensory Gating 
deficits are, however, not only induced by suppression of NE release in frontal brain 
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regions but also by changes in neuronal activity of the mesocortical dopaminergic system. 
This is discussed in the next section. 
4.3. Dopaminergic modulation of sensory gating 
4.3.1. DA in mPFC is essential for adequate sensory gating 
The importance of prefrontal DA release in modulation of PPI and ASG was explored by 
selective inhibition of DA release 1) in mPFC, 2) in VTA target structures besides mPFC or 
3) all VTA target structures. This approach revealed that DA in mPFC is essential for 
adequate sensory gating. However, PPI was only modulated at the neuronal level while 
behavioral ASR remained unaffected. When DA release from VTA was generally 
suppressed in all VTA target structures, including mPFC, only PPI was impaired by 
decreased effectiveness of the prepulse. Selective reduction of DA release in mPFC 
impaired PPI as well as ASG by both a decreased effectiveness of the prepulse and 
decreased sensitivity to startle pulse alone. However, when DA release in mPFC was not 
manipulated, sensory gating was unaffected although several other limbic target structures 
(e.g. NAc, HPC, amygdala, …) were deprived from DA. Impaired PPI based on a 
hypodopaminergic state in mPFC has been reported before580,602-605. However, the effect 
was associated with a related top-down disinhibition of neuronal activity of prefrontal 
glutamatergic afferents to NAc or VTA614-616. This, consequently, increases extracellular 
DA release in NAc607,614,621,622 and leads to sensory gating deficits570,592-594. According to 
previous literature, neuronal activity in mPFC is strongly associated with dopaminergic 
transmission in NAc606-613 . This is why it can be assumed that a reduction of DA in NAc 
similarly impairs sensory gating, resulting in an inverted-U shaped dose-response function 
which is not uncommon in regards to mPFC functions447,453,461,771. In support, disruption of 
PPI after local infusion of dopaminergic D2-agonists into NAc632,633 in addition to a 
contribution of dopaminergic autoreceptors634, which reduce release of DA upon 
activation369,377,590, was reported. Nevertheless, in the present study, reduction of accumbal 
DA did not affect sensory gating, neither PPI nor ASG. 
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In conclusion, under conditions of decreased dopaminergic transmission, top-down 
interactions from mPFC are critically involved in sensory gating deficits. Common 
neurophysiological disorders, which are associated with sensory gating deficits, are 
Parkinson’s disease772-775 or depression776-778 and since both are related to 
hypodopaminergic states, the mPFC might be an adequate target for symptom-related 
therapy. 
4.3.2. PPI and ASG might share neuronal mechanisms under certain 
conditions 
Another interesting question, which was repeatedly discussed in previous literature, was 
whether PPI and ASG share similar neuronal mechanisms551-554. Brain functions related to 
both paradigms are disturbed in schizophrenic patients and share some pharmacological, 
methodological and neurobiological aspects779-781. 
It was shown earlier that inhibition of noradrenergic transmission reduces VTA sensory-
evoked responses. Clonidine infusion into ventral midbrain might have similar effects by 
inhibition of NE release via actions on presynaptic α2-noradrenergic receptors488-
491,688,701,745-748. Additionally, clonidine reduces spontaneous activity of neurons by post-
synaptic effects507,636. Thus, the spontaneous and sensory-evoked activity in VTA is 
decreased which reduces the release of DA in all VTA target regions including mPFC. 
Consequently, prefrontal spontaneous and sensory-evoked activity is increased247,782. The 
increased spontaneous activity might mask the neuronal response to non-salient stimuli like 
the prepulse and, hence, reduces its effectiveness. 
Infusion of κ-opioid agonist into the ventral midbrain additionally affected ASG in contrast 
to infusion of clonidine, after which only PPI was reduced. Thus, DA in mPFC seems to be 
critically important for ASG. Furthermore, the underlying mechanisms of PPI and ASG are 
slightly different. While presentation of the prepulse became ineffective when 
dopaminergic transmission to VTA target regions was generally reduced after clonidine 
infusion into the ventral midbrain, infusion of κ-opioid agonist changed the balance 
between prepulse effectiveness and sensitivity to startle stimulus only. Consequently, the 
ASR to the former was increased while the ASR to the latter was decreased, which, 
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together resulted in decreased PPI. Modulation of ASG was comparable suggesting 
common neuronal mechanisms for PPI and ASG when mPFC was selectively depleted of 
DA. 
In conclusion, a general statement whether PPI and ASG share common mechanisms is 
difficult. However, it might be possible that under certain conditions, like selective 
reduction of dopaminergic transmission in mPFC, sensory gating mechanisms are 
comparable. In contrast, when dopaminergic transmission is generally reduced, 
mechanisms are different. At least in healthy human subjects and rats as well as after 
systemic injection of D2-receptor agonists in humans and rats, differential mechanisms for 
PPI and ASG had been demonstrated552,585,783. Nevertheless, common mechanisms under 
specific conditions cannot be ruled out. 
4.3.3. Inhibition of mPFC dopaminergic transmission affects only neuronal 
signals but not behavioral ASR 
Observed sensory gating deficits after inhibition of DA release in mPFC affected only the 
neuronal PPI and ASG but not the behavioral ASR in case of PPI. Nevertheless, impaired 
PPI of the ASR was reported after local neurotoxic lesion of dopaminergic terminals in 
mPFC602,603 or local infusion of D1- or D2-receptor antagonist into mPFC580,604,605. In the 
present study, the release of DA was manipulated at the somatodendritic level within the 
VTA. Nevertheless, there is no reason why the decrease of DA release in mPFC should 
notably differ between those methods. However, in the present study, the infusion of the 
drugs into the ventral midbrain was not performed continuously over the course of the 
sessions but > 2 minutes before presentation of the first sensory stimulation. Therefore, the 
observed effects might be weakened by washout of the drug which began already before the 
sessions started. A repetition of the experiments is therefore suggested under continuous 
infusion of the drugs over the entire duration of the sessions in order to ensure a constant 
drug concentration within the ventral midbrain. 
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4.4. Further methodological considerations 
Major methodological consideration in the current work concerns the pharmacological 
manipulations of catecholaminergic systems by local drug infusions. 
Local infusion of clonidine into LC, which was used in the first two studies of this work in 
order to explore the noradrenergic modulation of neuronal activity in S1HL, mPFC and 
VTA, was based on classical electrophysiological guidance by the distinctive activity 
pattern of noradrenergic neurons. This approach, however, does not provide any 
information about the detailed localization of the electrode within LC. In addition, the 
diffusion width of clonidine within the tissue can hardly be estimated. Therefore, neither an 
incomplete inhibition of the LC nucleus nor activation of alpha 2-adrenoceptors in 
structures outside of LC can be excluded. Based on previous literature, the closest structure 
expressing clonidine binding sites is the subcoeruleus nucleus adjacent to LC and the 
medial vestibular nucleus 200 µm apart from LC231,784,785. 
In preceding pilot experiments, the diffusion of clonidine in LC was visualized by chemical 
attachment of the fluorescent marker rhodamine to apraclonidine. Diffusion of this 
chemical compound in LC was confined to ~100 – 150 µm (Supplementary Figure 7.5). 
However, because of the much bigger molecule size, diffusion was not comparable to 
diffusion of clonidine alone786-788. In addition, iontophoretic injection of this chemical 
compound did not reliably inhibit neuronal activity in LC, presumably because 
iontophoretic transport becomes more difficult with larger molecules789-791. Therefore, 
unmarked clonidine was used for pharmacological manipulation during the experiments 
and the radius of drug diffusion was > 354 μm estimated by distant recordings from the 
infusion site. Therefore, it can be assumed that observed effects are induced by at least 
partial inhibition of LC neuronal activity. 
Dopaminergic modulation of sensory Gating was explored by local drug infusion into the 
ventral midbrain. Restricted drug infusion within the VTA is very difficult because of other 
dopaminergic structures (e.g. SNc or retrorubral field) in direct vicinity. Therefore, 
pharmacological manipulation of indirect pathways in addition to direct mesocortical, 
mesoaccumbal and mesostriatal pathways cannot be excluded. 
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Furthermore, the manipulation of DA release was based on reported receptor composition 
on dopaminergic neurons within the VTA. However, this does not exclude that other types 
of neurons, e.g. glutamatergic or GABAergic neurons, in the heterogeneous VTA are 
affected by infused agonists. In conclusion, observed effects represent the net outcome of 
pharmacological manipulation in the ventral midbrain. On the other hand, dopaminergic 
neurons represent ~70 % of the VTA310,312,315,318 and SNc is not majorly involved in 
sensory gating but in motor functions291,295-297. Thus, observed results might reflect a good 
approximation of ventral tegmental dopaminergic modulation of sensory gating. 
4.5. Outlook and future studies 
A direct comparison of sensory processing in S1HL and mPFC required utilizing 
stimulation parameters which reasonably activated neuronal populations in all recorded 
structures. However, under urethane anesthesia, neurons in LC, VTA and mPFC could only 
be reliably activated with high amplitude sensory stimulation which primarily activated the 
somatosensory pain system. The LC noradrenergic system is critically involved in 
modulation of pain-related sensory processing15,792,793 and impairment of noradrenergic 
modulation of nociceptive stimuli lead to pathological pain experiences like hyperesthesia 
or neuropathic pain794-798. Nevertheless, it would be interesting to repeat the first two 
studies with presentation of innocuous physiological sensory stimulation in awake or 
naturally sleeping rats instead of noxious stimulation in urethane anesthetized animals. 
Furthermore, in the present work, the noradrenergic modulation of the VTA net sensory 
processing was explored. However, it would be especially interesting to disentangle 
observed net effects according to neuronal specificity. Detailed information about 
individual noradrenergic modulation of dopaminergic, GABAergic and glutamatergic 
neurons within the VTA might help to develop specific treatment of, for example, 
schizophrenia or depression. 
Finally, an interesting observation in the current study was a convergence of sensory-
evoked BLP change in Sigma and Beta frequency bands under condition of systemic 
clonidine injection. Specifically, BLP change in Sigma and Beta frequency bands increased 
in mPFC and decreased in S1HL (see section 3.1.4.2, Figure 3.19). However, during 
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baseline condition BLP change in the same frequency bands differed between the two 
cortical regions (see section 0 Figure 3.3). An interesting idea behind this observation 
would be whether systemic injection of clonidine increases Sigma and Beta frequency 
coherence between prefrontal and primary sensory regions and, if yes, whether and how 
this affects sensory processing during sedation. 
5. Summary 
In urethane anesthetized rats, when the cortex spontaneously alternates between an 
activated and a deactivated state, neuronal activity in S1HL and mPFC is responsive to 
noxious somatosensory stimulation, although the sensitivity differs between the two 
cortical regions. While sensory-evoked responses in mPFC are only evoked when LFP 
power in low frequency range is reduced and the cortical state is more activated, neuronal 
activity in S1HL is highly sensitive, apparently independent from cortical state activity. 
However, only stimulus-related increase of power in high frequency range is highly reliable 
in S1HL but decreased power in low frequency range, especially power in Theta and Alpha 
frequency bands, is dependent on the cortical activity state in mPFC. This dependency 
might reflect top-down interactions between these two cortical regions presumably in favor 
of memory-related processes not only during processing of noxious stimuli but also 
spontaneous activity. 
Decreased sensitivity of prefrontal neuronal responsiveness in comparison with S1HL was 
also reflected in SEPs and SUA. In addition, single units in S1HL responded to FSs with 
maximum activation while responses in mPFC were tuned to stimulus strength implicating 
the functions of the respective cortical regions: Neurons in S1HL code for presence and 
maybe localization of noxious stimuli while neurons in mPFC reflect higher cognitive 
processing presumably with the aim to prevent the origin of noxious stimulation in the 
future. 
NE in cortical regions is known to activate cortical state during arousal and increase the 
SNR of underlying single unit responses to sensory stimulation which was repeatedly 
demonstrated in primary sensory regions of the brain. Removal of NE from LC terminal 
regions therefore expectedly deactivated ongoing cortical activity state in S1HL resembling 
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sleep-like oscillation pattern while SNR of single unit responses to FSs was decreased. 
Ongoing cortical activity state in mPFC, however, was more activated. Spectral 
composition under noradrenergic deprivation suggested redistribution of spectral power in 
favor of internally directed long-range cognitive processing. Bidirectional modulation of 
spontaneous as well as sensory-evoked activity of underlying single unit activity in mPFC 
suggested a reorganization of active local networks. This reorganization is orchestrated by 
NE, presumably, in order to adequately evaluate the biological relevance of the stimulus 
and integrate sensory and non-sensory information. 
Within the VTA, NE is required to improve noxious somatosensory processing. Hence, 
decreased sensory-evoked response after LC inactivation reduced phasic release of DA in 
addition to NE. Therefore, observed reorganization of local networks in mPFC results from 
synergistic actions of both catecholaminergic systems. A discussed possible outcome of 
catecholaminergic modulation of noxious somatosensory processing in mPFC includes 
enhanced sensory gating by suppression of irrelevant and accentuation of relevant network 
information. This prefrontal cortical function was specifically explored in the last study of 
this work, albeit restricted to modulation by the ventral midbrain dopaminergic system in 
awake rats. Specific manipulation of DA release in ventral midbrain target regions revealed 
that DA in mPFC is essential for both sensory gating paradigms: PPI and ASG although 
modulation appeared only on the neuronal level while the ASR was not affected. Previous 
reports discuss PPI deficits after manipulation of prefrontal neuronal activity as purely 
related to modulation of neuronal activity in NAc. In combination with present results, it is 
suggested that prefrontal DA is essential to ensure adequate prefronto-accumbal 
interactions which, in turn, are necessary for sensory gating. 
Together, this work demonstrated that catecholamines are needed to improve sensory 
processing in functionally distinct cortical and subcortical brain regions. Thereby, classical 
improvement of SNR is not the only mechanism but also the catecholaminergic modulation 
of complex local network dynamics contributes to processing of relevant or irrelevant 
sensory information. 
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7. Supplemental Material 
 
Supplementary Figure 7.1: Distribution of duration of AHP, spike width and trough-to-peak-ratio of 
recorded single units in the cortical regions revealed a population of putative (put.) interneurons (red) 
and a population of putative pyramidal neurons (black). 
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Supplementary Figure 7.2: Representative example of artifact removal in a fraction of continuously 
recorded data from one session. Illustrated are triggers to auditory stimulation using clicks, Startle 
stimulus only (Startle), Startle stimulus preceded by prepulse (Pre + Startle) and prepulse stimulus only 
(top row). The local field potential recorded from mPFC is shown in the medial row above the signal 
induced by movements of the animal recorded from the piezoelectric sensors under the floor (bottom 
row). Red shaded area indicates period of removed data because of high amplitude artifacts due to 
excessive movements easily distinguishable from sequentially increased amplitude of the neuronal 
signal due to change of cortical state activity to low frequency oscillations (arrows). 
 
 
Supplementary Figure 7.3: Somatosensory stimulation induces single unit responses under urethane 
anesthesia. Illustrated are the PSTHs averaged over 25 repetitions during 1.5 sec after stimulus-
presentation (red dashed line at 0 sec). PSTHs of population single unit response in S1HL consist of a 
short latency response component followed by a late response component. In mPFC the response 
profile resembles the SEP profile. Binwidth 10ms, Mean ± SE. 
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Supplementary Figure 7.4: Two exceptional single units out of mPFC group 2 increased sensory-evoked 
excitation under condition of systemic clonidine while, commonly, the responses of all neurons in both 
cortical regions were decreased under drug condition. Average PSTH of responses to sensory 
stimulation under baseline and drug condition are shown (left). The Stimulation was applied at time 0. 
Bin size = 10ms. Maximum amplitude of the response profile (right) illustrates the increase of excitation 
under systemic clonidine condition. Mean ± SE, * p < 0.05. 
 
 
 
Supplementary Figure 7.5: Color photomicrograph of a coronal section through the LC region around 
the infusion site of iontophoretically applied apraclonidine labelled with rhodamine (yellow; 50 mg/ml, 
+50 to +90 nA, 20 min). Dashed line delimits LC nucleus. IV. = IV. ventricle; Me5 = mesencephalic 
trigeminal nucleus. Note, the diffusion width of the injected compound amounts to ~100 – 150 µm. 
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Supplementary Table 7.1: Average power source density during 4 sec prestimulus interval for each 
analyzed frequency band in S1HL and mPFC during baseline condition. Mean ± SE. 
Frequency bands S1HL mPFC 
pre SLO 
pre Delta 
pre Theta 
pre Alpha 
pre Sigma 
pre Beta 
pre Gamma 
0.1125 ± 0.0116 dB 
0.1969 ± 0.0177 dB 
0.0616 ± 0.0050 dB 
0.0231 ± 0.0019 dB 
0.0171 ± 0.0015 dB 
0.0125 ± 0.0011 dB 
0.0060 ± 0.0005 dB 
0.1226 ± 0.0138 dB 
0.1961 ± 0.0181 dB 
0.0467 ± 0.0023 dB 
0.0184 ± 0.0006 dB 
0.0141 ± 0.0006 dB 
0.0104 ± 0.0004 dB 
0.0051 ± 0.0002 dB 
 
Supplementary Table 7.2: Average baseline change of BLP during 4 sec prestimulus interval following 
local and systemic clonidine administration for each analyzed frequency band in S1HL and mPFC. 
Mean ± SE. 
 S1HL mPFC 
% Change 
systemic % Change local 
% Change 
systemic % Change local 
pre SLO 3.41 ± 12.91 11.71 ± 23.62 -23.48 ± 9.25 13.94 ± 12.52 
pre Delta 4.08 ± 9.64 21.17 ± 30.61 -14.08 ± 7.92 2.37 ± 8.06 
pre Theta 49.43 ± 15.34 8.76 ± 7.99 21.52 ± 7.07 -5.59 ± 3.92 
pre Alpha 90.08 ± 15.82 21.79 ± 10.28 12.69 ± 4.69 3.85 ± 3.16 
pre Sigma 112.81 ± 19.33 40.45 ± 13.27 -7.02 ± 4.78 0.88 ± 3.17 
pre Beta 63.35 ± 10.65 32.07 ± 9.84 -10.05 ± 3.79 -0.35 ± 3.00 
pre Gamma 6.60 ± 3.13 7.45 ± 2.06 -2.57 ± 1.87 5.44 ± 1.80 
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Supplementary Table 7.3: Average baseline change of firing rate in populations of cortical neurons 
dependent on the direction of spontaneous activity modulation following local and systemic clonidine 
administration. Mean ± SE. 
Direction 
of 
modulation 
S1HL mPFC 
% Change 
systemic % Change local 
% Change 
systemic % Change local 
increase +212.64 ± 73.56 +288.77 ± 96.26 +112.77 ± 46.91 +87.77 ± 29.42 
decrease -66.32 ± 20.47 -37.35 ± 18.06 -68.48 ± 6.63 -48.27 ± 16.21 
unchanged +22.48 ± 15.96 +19.64 ± 17.39 -21.54 ± 7.24 +10.54 ± 6.4 
 
Supplementary Table 7.4: Average maximum firing amplitudes of unit activity in LC, S1HL and mPFC 
in response to electrical foot-shock (FS) stimulation using single pulse (SP) or train (TR) stimulation 
with 5 mA stimulation current. Mean ± SE. 
 SP TR 
LC-MUA (norm. spikes/sec) 
S1HL-SUA (Z-Scores) 
mPFC-SUA (Z-Scores) 
6.68 ± 0.78 
21.69 ± 2.92 
4.56 ± 0.74 
8.62 ± 1.99 
21.69 ± 2.71 
8.95 ± 1.30 
 
Supplementary Table 7.5: Average maximum firing amplitudes (spikes/sec) of units in LC, S1HL and 
mPFC in response to TR stimulation using increasing stimulation currents from 1 mA to 5 mA, 
Mean ± SE. 
 LC-MUA S1HL-SUA mPFC-SUA 
1 mA 
2 mA 
3 mA 
4 mA 
5 mA 
60.92 ± 9.53 
81.13 ± 12.05 
89.07 ± 12.45 
95.97 ± 12.93 
95.37 ± 12.01 
47.54 ± 5.59 
31.67 ± 3.62 
34.40 ± 4.57 
30.96 ± 4.03 
34.31 ± 3.10 
13.33 ± 1.24 
15.74 ± 1.69 
16.46 ± 1.83 
17.89 ± 1.87 
20.53 ± 2.06 
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Supplementary Table 7.6: Summary of stimulus-induced BLP change in S1HL dependent on TCA+ 
and TCA- cases in mPFC. Given is the average BLP change for each analyzed frequency band in 
addition to statistical evaluation of the change using one-sample t-test against 0. Mean ± SE. 
 
TCA+ TCA- 
post BLP change one-sample t-test post BLP change one-sample t-test 
Delta 
Theta 
Alpha 
Sigma 
Beta 
Gamma 
-30.34 ± 6.98 % 
-20.74 ± 6.94 % 
-17.85 ± 4.43 % 
5.36 ± 6.01 % 
32.09 ± 11.26 % 
77.32 ± 20.07 % 
t(6) = -4.35, p < 0.01 
t(6) = -2.99, p < 0.05 
t(6) = -4.03, p < 0.01 
t(6) = 0.89, p = n.s. 
t(6) = 2.85, p < 0.05 
t(6) = 3.85, p < 0.01 
-9.69 ± 7.24 % 
4.69 ± 3.16 % 
6.50 ± 3.12 % 
23.05 ± 6.36 % 
44.79 ± 11.89 % 
52.51 ± 11.80 % 
t(8) = -1.34, p = n.s. 
t(8) = 1.49, p = n.s. 
t(8) = 2.08, p = n.s. 
t(8) = 3.62, p < 0.01 
t(8) = 3.77, p < 0.01 
t(8) = 4.45, p < 0.01 
 
Supplementary Table 7.7: Comparison of stimulus-induced change in BLP between S1HL and mPFC 
in TCA+ cases only. Given are the average change in BLP for each analyzed frequency band in S1HL 
and mPFC in addition to statistical evaluation of the difference between cortical regions. Mean ± SE. 
 S1HL mPFC One-Way ANOVA 
Delta 
Theta 
Alpha 
Sigma 
Beta 
Gamma 
-22.47 ± 4.56 % 
-10.93 ± 5.06 % 
 -3.41 ± 4.57 % 
16.69 ± 4.83 % 
38.84 ± 7.56 % 
65.56 ± 7.91 % 
-36.19 ± 2.93 % 
-23.25 ± 3.55 % 
-11.46 ± 2.08 % 
0.25 ± 2.91 % 
13.74 ± 2.66 % 
40.27 ± 5.37 % 
F(1, 38) = 6.12, p < 0.05 
F(1, 38) = 3.82, p = n.s. 
F(1, 38) = 2.39, p = n.s. 
F(1, 38) = 8.05, p < 0.01 
F(1, 38) = 9.03, p < 0.01 
F(1, 38) = 6.70, p < 0.05 
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Supplementary Table 7.8: Effect of clonidine injection on average stimulus-induced change of BLP in 
TCA- cases in mPFC. Listed is BLP change under baseline and corresponding drug condition for either 
manipulation in each frequency band individually. Mean ± SE. Statistical evaluation of difference 
between baseline and drug condition is additionally provided. 
 
Baseline (Systemic) 
(% Change) 
Systemic 
(% Change) 
One-way ANOVA 
Delta 
Theta 
Alpha 
Sigma 
Beta 
Gamma 
1.09 ± 4.48 
2.70 ± 2.40 
0.05 ± 1.85 
0.95 ± 3.24 
2.74 ± 3.18 
4.78 ± 2.48 
-9.14 ± 4.78 
-12.85 ± 7.40 
1.21 ± 3.23 
15.43 ± 4.24 
15.39 ± 3.51 
14.88 ± 3.15 
F(1, 23) = 2.44, p = n.s. 
F(1, 23) = 3.99, p = n.s. 
F(1, 23) = 0.10, p = n.s. 
F(1, 23) = 7.37, p < 0.05 
F(1, 23) = 7.13, p < 0.05 
F(1, 23) = 6.33, p < 0.05 
 
Baseline (Local) 
(% Change) 
Local 
(% Change) 
One-way ANOVA 
Delta 
Theta 
Alpha 
Sigma 
-5.78 ± 3.67 
-0.01 ± 4.15 
-0.85 ± 4.33 
-3.10 ± 2.38 
-11.67 ± 7.69 
-6.08 ± 4.76 
-2.29 ± 5.16 
8.53 ± 4.77 
F(1, 19) = 0.45, p = n.s. 
F(1, 19) = 0.92, p = n.s. 
F(1, 19) = 0.05, p = n.s. 
F(1, 19) = 4.76, p < 0.05 
Beta 
Gamma 
0.79 ± 2.29 
2.99 ± 2.08 
14.25 ± 3.96 
13.81 ± 4.75 
F(1, 19) = 8.64, p < 0.01 
F(1, 19) = 4.36, p = 0.05 
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Supplementary Table 7.9: Clonidine-induced cortical state activation in initially TCA- cases in mPFC. 
Change in poststimulus BLP under baseline and drug condition for each frequency band was tested 
against 0 (one-sample t-test). Note a significantly increased power in high frequency range after either 
pharmacological manipulation. 
 
Supplementary Table 7.10: Comparison of SEP characteristics in S1HL between baseline and clonidine 
condition after either pharmacological manipulation. Note identical values under baseline conditions 
due to combined average of baseline before local and baseline before systemic injection. Mean ± SE. 
 Baseline Systemic Statistics 
Max. Amplitude early (mV) 
Max. Amplitude late (mV) 
Integral entire profile (mV * sec) 
Integral late (mV * sec) 
-0.55 ± 0.07 
-0.31 ± 0.04 
-0.02 ± 0.00 
-0.04 ± 0.02 
-0.55 ± 0.10 
-0.26 ± 0.04 
-0.02 ± 0.01 
-0.06 ± 0.00 
F(1, 34) = 0.00, p = n.s. 
F(1, 32) = 1.59, p = n.s. 
F(1, 34) = 0.37, p = n.s. 
F(1, 32) = 1.41, p = n.s. 
 Baseline Local Statistics 
Max. Amplitude early (mV) 
Max. Amplitude late (mV) 
-0.55 ± 0.07 
-0.31 ± 0.04 
-0.51 ± 0.07 
-0.23 ± 0.04 
F(1, 33) = 0.31, p = n.s. 
F(1, 32) = 4.02, p = 0.05 
Integral entire profile (mV * sec) 
Integral late (mV * sec) 
-0.02 ± 0.00 
-0.04 ± 0.02 
-0.02 ± 0.00 
-0.05 ± 0.02 
F(1, 33) = 1.22, p = n.s. 
F(1, 32) = 0.09, p = n.s. 
 Baseline (Systemic) Systemic 
Delta 
Theta 
Alpha 
Sigma 
Beta 
Gamma 
t(11) = 0.24, p = n.s. 
t(11) = 1.12, p = n.s. 
t(11) = 0.03, p = n.s. 
t(11) = 0.29, p = n.s. 
t(11) = 0.86, p = n.s. 
t(11) = 1.93, p = n.s. 
t(11) = -1.91, p = n.s. 
t(11) = -1.74, p = n.s. 
t(11) = 0.37, p = n.s. 
t(11) = 3.64, p < 0.01 
t(11) = 4.39, p < 0.01 
t(11) = 4.72, p < 0.001 
 Baseline (Local) Local 
Delta 
Theta 
Alpha 
Sigma 
Beta 
Gamma 
t(9) = -1.57, p = n.s. 
t(9) = -0.00, p = n.s. 
t(9) = -0.20, p = n.s. 
t(9) = -1.30, p = n.s. 
t(9) = 0.34, p = n.s. 
t(9) = 1.44, p = n.s. 
t(9) = -1.46, p = n.s. 
t(9) = -1.28, p = n.s. 
t(9) = -0.44, p = n.s. 
t(9) = 1.79, p = n.s. 
t(9) = 3.60, p < 0.01 
t(9) = 2.91, p < 0.05 
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Supplementary Table 7.11: Comparison of SEP characteristics in mPFC TCA+ cases between baseline 
and clonidine condition after either pharmacological manipulation. Note identical values under 
baseline conditions due to combined average of baseline before local and baseline before systemic 
injection. Mean ± SE. 
 Baseline Systemic Statistics 
Max. Amplitude (mV) 
Integral (mV * sec) 
-0.29 ± 0.04 
-0.08 ± 0.01 
-0.19 ± 0.03 
-0.03 ± 0.01 
F(1, 24) = 1.60, p = n.s. 
F(1, 24) = 5.92, p < 0.05 
 Baseline Local Statistics 
Max. Amplitude (mV) 
Integral (mV * sec) 
-0.29 ± 0.04 
-0.08 ± 0.01 
-0.25 ± 0.05 
-0.06 ± 0.02 
F(1, 28) = 0.00, p = n.s. 
F(1, 28) = 0.32, p = n.s. 
 
Supplementary Table 7.12: Comparison of SEP characteristics in mPFC TCA- cases between baseline 
and clonidine condition after either pharmacological manipulation. Note identical values under 
baseline conditions due to combined average of baseline before local and baseline before systemic 
injection. Mean ± SE. 
 Baseline Systemic Statistics 
Max. Amplitude (mV) 
Integral (mV * sec) 
-0.26 ± 0.05 
-0.05 ± 0.01 
-0.21 ± 0.04 
-0.05 ± 0.01 
F(1, 20) = 0.16, p = n.s. 
F(1, 20) = 0.54, p = n.s. 
 Baseline Local Statistics 
Max. Amplitude (mV) 
Integral (mV * sec) 
-0.26 ± 0.05 
-0.05 ± 0.01 
-0.14 ± 0.02 
-0.02 ± 0.01 
F(1, 17) = 2.44, p = n.s. 
F(1, 17) = 3.97, p = n.s. 
 
Supplementary Table 7.13: Average maximum firing amplitudes (spikes/sec) of neurons recorded in the 
ventral midbrain in response to electrical FS stimulation using increasing stimulation currents from 
1 mA to 5 mA. Mean ± SE. 
 
Ventral midbrain population SUA 
(max. Spikes/Sec) 
1 mA 23.45 ± 1.39 
2 mA 25.12 ± 1.72 
3 mA 27.45 ± 1.87 
4 mA 28.61 ± 1.90 
5 mA 30.55 ± 2.00 
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Supplementary Table 7.14: Comparison of explored parameters during sensory gating after non-
effective ventral midbrain infusion of D2-receptor agonist quinpirole. Given are average percentages of 
PPI and ASG in addition to respective absolute amplitudes of SEPs and ASR in response to different 
stimulus parameters during control and drug condition and statistical comparison between those 
conditions. Mean ± SE. 
 Saline Quinpirole ANOVA 
PPI ASR (%) 65.41 ± 3.65 64.68 ± 2.48 F(1, 43) = 0.03, p = n.s. 
Gated ASR (mV) -0.15 ± 0.04 -0.17 ± 0.03 F(1, 43) = 0.15, p = n.s. 
Non-gated ASR (mV) -0.41 ± 0.08 -0.44 ± 0.08 F(1, 43) = 0.07, p = n.s. 
PPI SEP (%) 52.57 ± 11.48 55.38 ± 9.22 F(1, 41) = 0.04, p = n.s. 
Gated SEP (mV) -0.05 ± 0.02 -0.06 ± 0.01 F(1, 41) = 0.18, p = n.s. 
Non-gated SEP (mV) -0.11 ± 0.02 -0.12 ± 0.01 F(1, 41) = 0.03, p = n.s. 
ASG (%) 52.38 ± 9.00 61.07 ± 7.44 F(1,27 ) = 0.55, p = n.s. 
Gated ASG (mV) -0.02 ± 0.01 -0.02 ± 0.01 F(1, 27) = 0.01, p = n.s. 
Non-gated ASG (mV) -0.05 ± 0.01 -0.06 ± 0.01 F(1, 27) = 1.28, p = n.s. 
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